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Summary 
 
The functional specialization of sphingolipids (SLs) is determined by their structural 
diversity and their unique expression patterns according to cell type and degree of 
differentiation. Ultra long chain (ULC) SLs characterized by an N-acyl moiety longer 
than 26 carbon atoms in length are primarily expressed in mature male germ cells 
and epidermal keratinocytes. To unveil the functional role of these unconventional 
SLs, it is necessary to define their biosynthetic requirements at the molecular level. 
In mammals, fatty acids are incorporated into SLs at the stage of ceramide 
synthesis by a family of six homologue enzymes, the ceramide synthases (CerS1–6). 
By analyzing the expression levels of the CerS family in skin, as well as in juvenile 
and in “germ cell-free” testis, solely CerS3 mRNA distinctively correlated with the 
presence of ULC-SLs. As found in vitro, the synthesis of ceramides with cerotoyl- 
(26:0) and montanoyl-residues (28:0) required CerS3, as demonstrated by a non-
radioactive and detergent-free enzymatic assay established in living human cells 
expressing CerS3. For this purpose, activated ULC-acyl-CoAs as assay substrates 
and ceramide internal standards for mass spectrometric quantifications were 
specifically synthesized.  
The crucial role of CerS3 in the synthesis of ULC-SLs could be further confirmed 
with CerS3 deficient mice. Mass spectrometric analysis of epidermal extracts 
established acyl-CoAs ranging from 24 to 36 carbon atoms in length as substrates of 
CerS3 in vivo. CerS3 deficiency resulted in a complete loss of ceramides with acyl-
chains longer than 24 carbon atoms, including all ω-hydroxy-ULC-ceramides. 
Consequently, the total epidermal ceramides were drastically reduced by 90% 
leading to a severe impairment of the epidermal permeability barrier and ultimately to 
premature neonatal death. 
The metabolic defect of CerS3 mice gave rise to a multitude of alterations 
associated with the maturation and terminal cornification of keratinocytes. At the 
stratum granulosum (SG), diminished size in filaggrin-containing granules and 
reduced number of loricrin-containing granules were accompanied by aberrant 
processing of filaggrin and decreased levels of loricrin. At the stratum corneum (SC), 
remnants of glycogen, nuclear material and organelle structures were detected at the 
Summary 
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first corneocyte layers. CerS3d/d mice exhibited a markedly thickened and compact 
SC that could be associated with the persistence of corneodesmosomes, eventually 
resulting from the reduced expression of the protease cathepsin D at the SG and SC. 
Additionally, the defective degradation of corneodesmosomes led to the distinctive 
persistence of the embryonic peridermal layer in newborn mutant epidermis. 
Furthermore, CerS3 deficient mice exhibited disorganized lamellar sheets that yield 
the formation of non-lamellar lipid agglomerates, rather than building up evenly 
distributed lipid unit lamellar structures.  
The compromised skin integrity of mutant mice facilitated the severe invasion of 
pathogens evidenced by the increased microbial growth and the formation of 
pseudohyphae prior to colonization by Candida albicans on cultured skin biopsies. 
In summary, these results demonstrated the prerequisite of a functional CerS3 for 
the generation of ULC-SLs, which play an essential role in skin barrier function and 
male fertility. The phenotypic alterations derived from the in vivo depletion of CerS3 
suggested in addition a crucial regulatory function that could be encoded within the 
homeobox domain. Taken all together, these findings established the basis for the 
identification and diagnosis of potential human skin disorders associated with a 
CerS3 dysfunction. 
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Zusammenfassung 
 
Die funktionelle Spezialisierung von Sphingolipiden (SL) wird durch ihre strukturelle 
Vielfalt und durch die spezifischen Expressionsmuster in Abhängigkeit von Zelltyp 
und Grad der Differenzierung festgelegt. Ultra-langkettige ("Ultra Long Chain", ULC) 
SL, die sich durch einen N-Acylsubstituenten mit einer Kettenlänge vom mehr als 26 
C-Atomen auszeichnen, werden primär in reifen männlichen Keimzellen und 
Keratinozyten der Epidermis exprimiert. Um die funktionelle Rolle dieser 
ungewöhnlichen SL zu verstehen, ist es notwendig, zuerst ihre Biosynthese auf einer 
molekularen Basis zu begreifen. 
Bei Säugetieren werden Fettsäuren von einer Familie von 6 homologen Genen, 
den sog. Ceramidsynthasen (CerS1–6), während der Ceramidsynthese in SL 
eingebaut. Mit der Bestimmung der Expressionslevel dieser CerS-Familie in der 
Haut, sowie im juvenilen und „keimzellenfreien“ Hoden konnte einzig die CerS3-
mRNS mit dem Vorkommen der ULC-SL korreliert werden. Die In vitro-Synthese von 
Ceramiden mit Cerotin- (26:0) oder Montansäureresten (28:0) setzt die CerS3-
Aktivität voraus. Dies konnte anhand eines erstmalig etablierten, nicht-radioaktiven 
und detergenzfreien, enzymatischen Tests, basierend auf vitalen humanen Zellen die 
CerS3 exprimieren, nachgewiesen werden. Zu diesem Zweck wurden ULC-acyl-CoA 
als Substrate sowie Ceramide mit verkürzter Sphingoidbase speziell synthetisiert, 
und die letzteren als interne Standards für massenspektrometrische Quantifizierung 
eingesetzt. 
Die bedeutende Rolle von CerS3 bei der Synthese von ULC-SL konnte durch 
Untersuchungen an CerS3-defizienten Mäusen weiter untermauert werden. 
Differenzielle massenspektrometrische Untersuchungen wiesen Acyl-CoA mit einer 
Kettenlänge von 24 bis 36 Kohlenstoffen als Substrate von CerS3 in vivo aus. 
CerS3-Defizienz führte zu einem kompletten Verlust der Ceramide mit einer 
Kettenlänge von mehr als 24 Kohlenstoffatomen, einschließlich aller ω-Hydroxy-ULC-
Ceramide. Die Gesamtzahl aller Ceramide der Epidermis war um 90% reduziert, was 
zu einer starken Beeinträchtigung  der Wasserpermeabilitätsschranke der Epidermis 
und letztlich zu einem vorzeitigen neonatalen Tod führte. 
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Der metabolische Defekt der CerS3-Mutanten äußerte sich in einer Vielzahl von 
phänotypischen Veränderungen in Reifung und terminaler Verhornung der 
Keratinozyten. Im Stratum granulosum (SG) wurde eine Reduktion in der Größe der 
Filaggringranula als auch der Loricringranula beobachtet, begleitet von einer 
fehlerhaften Prozessierung des Filaggrins und einem Abfall des Loricringehaltes im 
SG. In den ersten Korneozytenschichten des Stratum corneum (SG) konnten Reste 
von Gykogen, Zellkernmaterial und Organellen nachgewiesen werden. CerS3d/d-
Mäuse zeigten ein deutlich verdicktes und kompaktes SC. Ursache hierfür ist wohl 
die Persistenz von Corneodesmosomen, bedingt u.a. durch eine niedrige 
Konzentration der Protease Cathepsin D im SG und SC. Weiterhin führte der 
defiziente Abbau von Corneodesmosomen zum Erhalt des Periderms auf der Haut 
von neugeborenen Knockout-Tieren. Zusätzlich wiesen CerS3-defiziente Mäuse 
ungeordnete lamelläre Lipidschichten auf, die zur Bildung von nichtlamellaren 
Lipidagglomeraten führten und nicht zu den gleichmäßig gespreiteten, lamellär 
strukturierten Lipideinheiten zwischen den Corneozyten.  
Die in ihrer Funktion kompromittierte Haut der Mutanten erleichterte in 
Biopsiekulturen erhöhtes mikrobiologisches Wachstum von Pathogenen/ Candida 
albicans, die Bildung von invasiven Pseudohyphen und anschließende Kolonisierung 
in tiefere Schichten. 
Zusammenfassend zeigen diese Ergebnisse die Notwendigkeit einer intakten 
CerS3 für die Bildung von ULC-SL, die eine essentielle Rolle in der Funktion der 
Hautbarriere und bei der männlichen Fortpflanzung spielen. Die phänotypischen 
Veränderungen, die durch Abwesenheit intakter CerS3 in vivo hervorgerufen werden, 
deuten auf eine zusätzliche regulatorische Funktion dieses Proteins hin, die 
innerhalb der Homeobox-Domäne kodiert sein könnte.  
Die vorliegenden Resultate sind Grundlage für die Identifikation und Diagnose 
potentieller menschlicher Hauterkrankungen, die auf einer CerS3 Fehlfunktion 
beruhen könnten. 
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1.1. Sphingolipids 
 
Sphingolipids (SLs) were first described by Johann L.W. Thudichum as natural 
chemical constituents of the brain (Thudichum, 1884). Today, sphingolipids and their 
glycosylated derivatives are best described by their structural properties. Ceramide is 
the core of most sphingolipids and serves as the anchor of glycosphingolipids (GSLs) 
in the outer leaflet of the cellular plasma membrane. Biochemically, ceramide is an 
amino alcohol composed of a fatty acid linked by an amide bond to a long chain base 
(LCB), most commonly sphingosine (Figure 1). On the other hand, glycosphingolipids 
are amphiphatic molecules composed of the hydrophobic ceramide backbone and a 
hydrophilic oligosaccharide chain. Together with sphingomyelin (SM), a ceramide 
with a phosphorylcholine head group, these are the major type of sphingolipids 
ubiquitously expressed in all eukaryotic cells, as well as some prokaryotic organisms 
and viruses. 
 
 
 
Figure 1. Structure of major sphingolipid classes.  
Ceramides, glycosphingolipids and sphingomyelins are biosynthesized via the 
condensation of an activated fatty acid with a sphingoid base linked by an amide 
bond, and are represented here by a palmitoyl moiety (yellow) and a sphingosine 
base (orange), respectively.  
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The structural diversity of sphingolipids is a prerequisite for their functional 
specialization in different tissues or cell types. The fatty acid moiety differs in chain 
length and various degrees of saturation, hydroxylation, and esterification, which 
contributes significantly to this structural complexity. This remarkable diversity is 
further enhanced by the combination of naturally occurring long chain bases, mainly 
sphingosine, sphinganine (dihydrosphingosine) and phytosphingosine 
(4-hydroxysphinganine). However, more than 60 species of sphingoid bases have 
been reported [(Karlsson, 1970), for review see (Pruett et al., 2008)]. The 
heterogeneity of sphingolipid structures peaks with the great variation of 
carbohydrate moieties, with around 500 structures already characterized. In 
combination, this huge molecular diversity creates thousands of different structures, 
whose functions are just starting to be elucidated.  
Sphingolipids have been shown to be expressed in a unique cell-type specific 
manner. Their expression patterns are determined by cellular differentiation, 
degeneration, development, cell cycle and viral or oncogenic transformations 
(Hakomori, 1981; Majoul et al., 2002; Muramatsu, 2000).  
In the extracellular side of the plasma membrane, sphingolipids have been 
reported to be involved in a wide variety of cellular processes including adhesion, 
proliferation and transport. These are facilitated either by direct lectin binding (Yang 
et al., 1996), direct contact to membrane receptors and transporters (Yamashita et 
al., 2003), or eventually establishing platforms for concentrating these proteins within 
the membrane (Lang, 2007).  
Glycosphingolipids can act as recognition molecules for toxins, viruses and 
bacteria at the cell surface, where their complex oligosaccharide chain serve as a 
binding site for these pathogens (Schnaar, 1991). Furthermore, simple sphingolipids, 
namely ceramide, sphingosine and sphingosine-1-phosphate (S1P), have been 
shown to function as bioactive molecules in a large variety of signaling events (Lahiri 
and Futerman, 2007). Ceramide and S1P appear to have opposite roles in signaling 
transduction pathways. While ceramide has been shown to induce apoptosis by 
regulating the activity of some proteins to which it binds, e.g. kinase suppressor of 
Ras, phospholipase A2 or cathepsin D (Heinrich et al., 1999; Ruvolo, 2003), the latter 
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has been implicated in cell proliferation and differentiation (Spiegel and Milstien, 
2003).  
Sphingolipids also play a role in the pathogenesis of diverse diseases, being the 
most prominent the inherited lysosomal storage diseases caused by the malfunction 
of enzymes involved in sphingolipid catabolism (Kolter and Sandhoff, 1999). 
Furthermore, sphingolipids contribute to the development of a multitude of diseases 
including neurodegenation (Grimm et al., 2005), cancer progression (Hakomori, 
1996), diabetes (Aerts et al., 2007; Stratford et al., 2004) and pathogen invasion 
(Arikawa et al., 2002; Bibel et al., 1992). 
 
1.2. Ultra long chain sphingolipids 
 
In mammalian cells, the most abundant fatty acid (FA) moieties incorporated into 
membrane lipids range between 16 and 24 carbon atoms in length. In sphingolipids, 
they are primarily saturated or monounsaturated, whereas polyunsaturated fatty 
acids are additionally expressed in phosphoglicerolipids and cholesterol esters. 
Generally, fatty acid residues of 14 to 20 carbon atoms in length are denominated as 
long chain fatty acids (LC-FAs), whereas acyl residues with 22 to 26 carbon atoms 
are refered in this study as very long chain fatty acids (VLC-FAs) (Figure 2). 
VLC-FAs have been found in most human tissues, generally bind by an amide 
linkage to sphingolipids, or esterified to cholesterol esters and phospholipids (Poulos, 
1995). Sphingolipids containing VLC-FAs (VLC-SLs) are enriched in certain tissues, 
particularly in myelin sheaths of the brain (O'Brien and Rouser, 1964; Pakkala et al., 
1966) and in kidney (Sandhoff et al., 2002), where they mostly occur as their 
α-hydroxylated derivatives. 
Sphingolipids containing acyl residues with a chain length of 28 to 36 carbon 
atoms have also been found in mammalian cells (Poulos, 1995; Sandhoff, 2009), and 
are denominated here as ultra long chain sphingolipids  (ULC-SLs). Despite the 
constitutive expression of VLC-SLs, the occurrence of ultra long chain SLs is 
restricted to testis/spermatozoa, and the epidermis. In epidermal keratinocytes, ULC-
sphingolipids up to 36 carbon atoms in length are mainly saturated or 
monounsaturated, whereas in the testis ULC-SLs are polyunsaturated (Figure 2). 
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Structurally, ULC-SLs differ greatly from their shorter chain homologues. These 
differences might be required for their functional specialization. The composition and 
function of ULC-SLs in both tissues will be described in detail in the following 
sections, and is the topic discussed throughout this study.   
 
 
 
Figure 2. Comparison of sphingolipid structures differing by the carbon chain 
length and saturation of their fatty acid residues. 
The majority of sphingolipids found in the plasma membrane of mammalian cells 
contains saturated long chain (LC-) and very long chain (VLC-) fatty acid residues 
ranging primarily between 16 to 24 carbon atoms. Ultra long chain (ULC-) 
sphingolipids with a fatty acid moiety of 28 to 36 carbon atoms are exclusively found 
in the epidermis and the testis. Epidermal sphingolipids, mostly ceramides and 
glucosylceramides, contain primarily saturated (or monounsaturated) ULC-acyl 
moieties of 30–36 carbon atoms. Most epidermal ULC-SLs are hydroxylated or 
esterified with linoleic acid or to proteins of the cornified envelope at the Cω position 
of their fatty acid residue. Testicular ULC-acyl residues range from 28 to 32 carbon 
atoms and possess multiple unsaturations (4 to 6). They are mostly incorporated into 
complex GSLs. 
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The rod outer segments (ROS) of the retina have been reported to contain the 
highest levels of ULC-FAs (Poulos, 1995). Aveldaño and co-workers could show that 
these polyunsaturated (4–6 double bonds) fatty acids (PUFAs) ranging from 30 to 36 
carbon atoms were incorporated into phosphoglycerolipids, namely 
phosphatidylcholine (Aveldano and Sprecher, 1987). In 2010, Brush and colleagues 
could demonstrate the expression of ULC-PUFAs in acidic GSLs. However, the 
authors failed to detect ULC-PUFAs incorporated into neutral sphingolipids, including 
sphingomyelin (Brush et al., 2010). The function of ULC-PUFAS glycosphingolipids in 
retina has not yet been clarified, however Brush and colleagues speculated on a 
possible role of ULC-SLs or ULC-PUFA glycosphingolipids in the pathogenesis of the 
retinal Stargardt disease (STDG3). Patients suffering this autosomal dominant 
disease carry mutations in the elongation of very long chain fatty acid 4 gene 
(Elovl4), which have been involved in the synthesis of ULC-FAs (vide infra). Although 
the pathogenesis of STDG3 is more likely to be caused by the lack of ULC-PUFA 
phosphatidylcholines in the membrane of photoreceptor cells (McMahon et al., 
2007b), retinal ULC lipids are beyond the main focus of this study. 
 
1.3. Metabolism of ultra long chain sphingolipids 
 
1.3.1. Sphingolipid metabolism and topology 
De novo synthesis of sphingolipids is initiated in the cytosolic face of the endoplasmic 
reticulum (ER) via the condensation of the amino acid L-serine with an activated fatty 
acid. This first acylation is catalyzed by the pyridoxalphosphate dependent serine 
palmitoyltransferase (SPT) and is the rate-limiting step of the sphingolipid synthetic 
pathway (Figure 3). The mammalian SPT complex is a heterodimer composed of 
three subunits (SPTLC1–3), and exhibits the highest specificity towards 
palmitoyl-CoA (16:0-CoA), thereby generating a long chain base (LCB) of 18 
carbons, 3-ketosphinganine (Hornemann et al., 2007). The ketone moiety of this 
intermediate is subsequently reduced by a NADPH-depending reductase yielding 
sphinganine.  
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Figure 3. De novo sphingolipid biosynthesis.  
The enzymes involved in sphingolipid biosynthesis are integral membrane proteins 
localized within the ER and the Golgi apparatus (here shown in dark red). The 
primary LCB contained in the majority of SLs and GSLs is derived from the 
intermediate (2S,3R)-2-aminooctadecane-1,3-diol, namely sphinganine. 
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N-acylation of sphinganine with an activated fatty acid proceeds leading to the 
formation of dihydroceramide. Likewise, sphingosine generated via the “salvage 
pathway” can be directly acylated to produce ceramide (Figure 4). The condensation 
of these and other endogenous long chain bases with a fatty acid – activated as a 
coenzyme A derivative – is facilitated by the ceramide synthases (CerSs, officially 
Lass). To fulfill the synthesis of the great variety of naturally occurring 
(dihydro)ceramides, which mainly differ in the chain length, hydroxylation and 
number of unsaturations of their fatty acid moieties, a family of six homologue 
enzymes is required in mammals, CerS1–6. This key step in the sphingolipid 
metabolic pathway will be extensively discussed during this study. Finally, 
dihydroceramide synthesized via the de novo pathway is dehydrogenated to 
ceramide by the dihydroceramide desaturase.  
 
 
 
Figure 4. De novo and salvage (dihydro)ceramide synthesis catalyzed by the 
ceramide synthases. 
CerSs facilitate the acylation of D-erythro-sphinganine derived from the de novo 
synthesis, as well as D-erythro-sphingosine from the salvage pathway to generate  
D-erythro-dihydroceramide and D-erythro-ceramide, respectively. 
 
 
Ceramide is a key metabolite required in a huge variety of cellular processes and 
is the common precursor for all complex glycosphingolipids and sphingomyelins. 
Most enzymes involved in the ceramide metabolic pathway have been reported to be 
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membrane-bound proteins localized in the cytosolic side of the ER (Mandon et al., 
1992; Michel and van Echten-Deckert, 1997). However, as the biosynthesis of GSLs 
and SMs takes place in the Golgi apparatus, ceramide must be efficiently transported 
from the ER to the Golgi compartment (Figure 5). This transfer occurs via a vesicular 
and a non-vesicular protein-mediated manner (Perry and Ridgway, 2005).  
 The majority of complex GSLs are derived from the simplest GSL, 
glucosylceramide (GlcCer). The glucosylation of ceramide is catalyzed by 
glucosylceramide synthase (GCS, officially UGCG) and takes place in the cytosolic 
side of the cis-Golgi cisternae (Futerman and Pagano, 1991; Jeckel et al., 1992), or 
potentially in a sub-compartment of the ER (Ardail et al., 2003). A vesicular flow is 
thought to be the major transport mechanism to deliver ceramide to the Golgi 
apparatus for the synthesis of complex GSLs. For further processing, GlcCer must 
translocate to the luminal side of the Golgi compartment. There, it is converted into 
lactosylceramide (LacCer) and maybe further glycosylated to generate all complex 
GSLs (Lannert et al., 1998).  
Instead, the galactosylation of ceramide leading to GSL of the gala series takes 
place in the luminal leaflet of the Golgi apparatus (Sprong et al., 1998). The synthesis 
of galactosylceramide (GalCer) is catalyzed by the ceramide UDP-galactosyl-
transferase (CGT, officially UGT8). GalCer is primarily expressed in the brain and the 
kidney, where it is also sulfated.  
SM synthesis requires the transport of Cer from the cytosolic side of the ER to the 
luminal side of the Golgi. This transfer is thought to be mediated mainly by the 
ceramide transfer protein (CERT) (Hanada et al., 2003). In the Golgi, sphingomyelin 
synthase (SMS) catalyzes the transfer of phosphorylcholine from phosphatidylcholine 
(PC) to ceramide. To date, two SMS isoforms have been described in mammals, 
SMS1 and SMS2, the former being ubiquitously expressed and localized exclusively 
in the Golgi apparatus, and the latter specifically expressed in round spermatids and 
early elongated spermatids of the testis and additionally localized at the plasma 
membrane (Huitema et al., 2004; Igarashi, 2010; Lee et al., 2007; Mitsutake et al., 
2010). 
Ultimately, newly synthesized sphingolipids are delivered to the plasma membrane 
where they influence membrane functions. 
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Figure 5. Schematic representation of sphingolipid metabolism. 
The biosynthesis of GSL and SM occurs in the ER and the Golgi apparatus of 
mammalian cells and involves vesicular and non-vesicular protein-mediated 
transport. Sphingolipid processing and trafficking occurs primarily in the trans-golgi-
network (TGN) previously to be exocytosed to the plasma membrane. Sphingolipid 
catabolism takes place in the lysosomes, where water-soluble hydrolases 
sequentially degrade their carbohydrate residues. Sphingolipids require the endocytic 
pathway involving early and late endosomes prior to reach the catabolic lysosomal 
machinery. Scheme modified from (Sandhoff, 2007). 
 
 
 Sphingolipids are constitutively degraded in the lysosomes by water-soluble 
hydrolases that sequentially cleave off their carbohydrate residues. Simple 
sphingolipids, namely ceramide and sphingomyelin, are degraded by specific 
lysosomal ceramidases and sphingomyelinases. For their degradation, sphingolipids 
at the PM are internalized by endocytosis, sorted in endosomes and delivered into 
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intraendosomal vesicles to the lysosomes. Once degraded, their building blocks 
might serve for the synthesis of newly required metabolites. 
 
1.3.2. Synthesis of ultra long chain sphingolipids 
Unconventional ULC-SLs require an additional synthetic machinery to complete their 
biosynthesis. On one hand, a fatty acid elongation system capable of synthesizing 
activated fatty acids with a chain length up to 36 carbon atoms is required. In 
mammals, the elongation of fatty acids beyond the length of 16 carbon atoms is 
catalyzed by members of the elongation of very long chain fatty acids gene family, 
the Elovl genes. On the other hand, ULC-FAs have to be incorporated into a 
sphingoid base for the generation of ULC-SLs. Therefore, a ceramide synthase with 
a high affinity towards activated ULC-FAs is additionally required. 
 
1.3.2.1. The elongation of very long chain fatty acids family (Elovl) 
Fatty acids up to 16 carbon atoms are sequentially elongated in two carbon atom 
steps by the cytosolic fatty acid synthase (FAS) protein complex. The primary end-
product is palmitate (16:0), which after activation to its coenzyme A derivative is 
translocated to the ER. There, the fatty acid elongation of LC-, VLC- and ULC-FAs is 
achieved during a four-step reaction cycle, where members of the Elovl gene family 
encode for the first regulatory condensing enzyme (Figure 6). Elovl proteins employ 
malonyl-CoA as an acyl donor for the addition of two-carbon units to a fatty acyl-CoA, 
and thereby generating 3-ketoacyl-CoA by means of decarboxylation. The 
3-ketoacyl-CoA reductase catalyzes the reduction of the carbonyl group to alcohol 
yielding 3-hydroxyacyl-CoA. Dehydration follows resulting in the synthesis of trans-2-
enoyl-CoA, which is finally reduced to generate the elongated fatty acyl-CoA (for a 
description of fatty acid nomenclature see supplemental Table A1 and A2). 
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Figure 6. Synthesis of LC-, VLC- and ULC-CoAs. 
Elovl proteins residing in the ER catalyze the rate-limiting step of the fatty acid 
synthesis consisting of the condensation of a precursor fatty acid with malonyl-CoA. 
The formed 3-ketoacyl-CoA derivative is reduced, dehydrated and further reduced 
resulting in the formation of a fatty acyl-CoA with an additional two-carbon unit in its 
chain.  
 
 
In mammals, the Elovl gene family consists of seven members (Elovl1–7), which 
are reported to be localized within the ER membrane. Their tissue expression and 
substrate affinity regulates the specific fatty acid species expressed in each cell type. 
At the beginning of this study, reliable data concerning the distinct distribution and 
substrate specificity of these enzymes in eukaryotic cells was rather limited. To date 
increasing numbers of reports including studies in transgenic mice are available 
(Table 1). In summary, the synthesis of saturated and monosaturated LC-CoAs 
seems to be facilitated by Elovl6, which produces stearoyl-CoA (18:0), and by Elovl1, 
Elovl3, and Elovl7, that take over to generate VLC-CoAs. Polyunsaturated LC- and 
VLC-CoA biosynthesis from essential fatty acid precursors is catalyzed by Elovl2 and 
Elovl5 (Guillou et al., 2009).  
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Enzyme 
Name 
Previous 
Names1 
Tissue mRNA expression 
Fatty acyl-CoA substrate 
Carbon number Unsatura.2 
Elovl1 Ssc1 Brain, ub.3 18-24 S, M 
Elovl2 Ssc2 Testis, liver 20-24 P 
Elovl3 Cig30 BAT4, WAT4, seb.glands4, liver 18-24 S, M 
Elovl4 - Retina, brain, skin 28-30 S, P 
Elovl5 Helo1 Liver, testes, ub. 18-20 P 
Elovl6 - Liver, WAT, ub. 16 S, M 
Elovl7 - Kidney, pancreas, ub. 18-24 S, M 
 
1 Ssc1: sequence similarity to Cig30 1; Ssc2: sequence similarity to Cig30 2; Cig30: cold-
inducible glycoprotein of 30 kDa; Helo1: homolog of yeast long chain polyunsaturated fatty 
acid elongation enzyme 
2 Unsaturations. S: saturated; M: monounsaturated; P: polyunsaturated. 
3 Ubiquitously expressed. 
4 BAT: brown adipose tissue; WAT: white adipose tissue; Seb. glands: sebaceous glands. 
 
Table 1. Tisssue distribution and substrate specificity of the Elovl proteins. 
Tissue expression and substrate preferences of the Elovl proteins described in this 
table were obtained from (Guillou et al., 2009; Leonard et al., 2004). Lipid profile 
changes due to depletion of Elovl3 is associated with triacylglycerides (Westerberg et 
al., 2004). 
 
 
Recent studies indicate that the biosynthesis of ULC-CoAs seems to be restricted 
to Elovl4 expression. The highest transcript levels are found in retina, brain, skin, and 
to a lesser extent in the testis (Mandal et al., 2004). In vivo depletion of Elovl4 
revealed an essential requirement of ULC-CoAs in epidermal sphingolipids. Elovl4 
mutant mice exhibited a depletion of ω-hydroxy-ceramides with fatty acyl residues of 
28 and longer carbon atoms in their chain length. Additionally, an accumulation of 
ceramides with 26 carbon acyl residues suggested cerotoyl-CoA (26:0-CoA) to be a 
bona fide Elovl4 substrate (Li et al., 2007). In 2008, in vitro studies using 
overexpressing cells could show that Elovl4 is required for the synthesis of saturated 
and polyunsaturated ULC-CoAs (Agbaga et al., 2008). To date, no other elongase 
has been reported to have affinity towards both saturated and unsaturated fatty 
acids. 
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1.3.2.2. The ceramide synthase family (CerS) 
Acyl-CoAs are incorporated into sphingolipids at the stage of ceramide sythesis (see 
Figure 3 and 4). This acylation of a spingoid base is catalyzed by the ceramide 
synthase (CerS) family, which operates in the “salvage pathway” to generate 
ceramide, in addition to the de novo synthetic pathway yielding dihydroceramide 
(vide supra).   
Ceramide synthases were originally denominated longevity assurance genes 
(Lass, still their official gene name) for their replication capacity upon its deletion and 
for their role in determining yeast longevity (D'Mello N et al., 1994). Since the yeast 
Lag1 gene was discovered, several of their homologues have been identified in a 
wide variety of eukaryotic organisms, including mammals (supplemental Table A3). 
Whereas one enzyme solely appears to encode for a ceramide synthase in 
D. melanogaster (Bauer et al., 2009), three homologues are required in C. elegans 
(Menuz et al., 2009) and S. cerevisiae (Schorling et al., 2001; Vallee and Riezman, 
2005). In mammals, six homologue genes constitute the ceramide synthase family 
(CerS1–6). CerSs exhibit a tissue specific distribution, in addition to distinct 
preferences towards the chain length and saturation grade of their acyl-CoA 
substrates (Table 2). Thus, their tissue expression pattern determines the distinct 
ceramide composition possible in each cell type. For instance, CerS1 is primarily 
expressed in the brain, where it catalyzes the formation of ceramide preferentially 
containing a stearic acid moiety, the major ceramide species in this organ 
(Venkataraman et al., 2002).   
Currently, the preferences for ULC-CoAs have not been appointed to any of the 
ceramide synthases. However, their substrate affinity was either determined in 
overexpressing cells lacking ULC-CoAs, or in in vitro ceramide synthase assays with 
acyl-CoA substrates ranging from 16 to 26 carbon atoms. Nevertheless, CerS2 and 
CerS3 seem to preferentially incorporate acyl-CoAs with the longest carbon atom 
chains included in those studies. Interestingly, CerS3 is exclusively expressed in 
testis and skin (Laviad et al., 2008), both tissues being the major source of 
ULC-CoAs. Therefore, we hypothesized that CerS3 could be a potential candidate 
responsible for the generation of ceramides containing ULC-CoAs. The investigation 
of the ceramide synthase(s) involved in the biosynthesis of ULC-SLs, as well as the 
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functional role of these unconventional sphingolipids are the major topics to be 
discussed in this study. 
 
Enzyme 
Name 
Previous 
Names1 
Tissue mRNA 
expression 
Acyl-CoA 
substrate 
References for 
substrate affinity 
CerS1 Lass1, Uog1 Brain, skeletal muscle 18 
(Venkataraman et al., 
2002) 
CerS2 Lass2, Trh3 Kidney, liver 22-24 (Laviad et al., 2008) 
CerS3 Lass3, T3L Testes, skin 18-24 (Mizutani et al., 2006) 
CerS4 Lass4, Trh1 Liver, heart, skin 18-22 (Riebeling et al., 2003) 
CerS5 Lass5, Trh4 Ub.2 16-18 (Riebeling et al., 2003) 
CerS6 Lass6, Trh1-like Intestine, kidney, ub. 14-16 (Mizutani et al., 2005) 
 
1 Lass: longevity assurance homolog; Uog1: upstream of GDF1; Trh: translocating chain-
associating membrane protein homolog; T3L: Trh3-like protein. 
2 Ubiquitously expressed. 
 
Table 2. Tisssue distribution and substrate specificity of the CerS proteins. 
Tissue expression was summarized from (Laviad et al., 2008). 
 
1.4. Expression of ultra long chain sphingolipids 
 
1.4.1. The testis 
The testis consists of highly convoluted loops of the seminiferous tubules embedded 
in interstitial tissue. The former functional compartment is required for sperm cell 
formation, whereas the main function of the latter involves hormone production. 
In the coiled loops of the seminiferous tubules, spermatozoa are continuously 
produced from differentiated germ cells after each spermatogenic cycle (Figure 7). 
The supporting Sertoli cells are required during spermatogenesis to deliver nutrients 
to germ cells, as well as for maintenance of the integrity of the seminiferous 
epithelium, regulation of differentiating germ cells, and for the phagocytosis of 
residual bodies left by spermatids upon transformation into spermatozoa. 
Additionally, Sertoli cells are crucial for the establishment of the blood-testis barrier 
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(BTB), a junctional complex that generates the physical barrier separating the 
seminiferous epithelium into an adluminal and a basal compartment.  
 On the other hand, Leydig cells in the insterstitium are the endocrine cells 
responsible for androgen production, mainly testosterone. Additionally, myeloid cells 
are localized in the interstitium enclosed within the lymphatic endothelium.  
 
1.4.1.1. The spermatogenic cycle 
Spermatogenesis is a complex and highly regulated process by which diploid 
spermatogonia differentiate into mature haploid spermatozoa. This transformation 
takes place in the seminiferous tubules and involves three stages known as 
spermatocytogenesis, spermatidogenesis and spermiogenesis. During 
spermatocytogenesis, spermatogonial stem cells (SG) located at the basal lamina 
are subjected to numerous mitotic divisions within a highly proliferative phase. These 
rapid successive divisions generate different type A spermatogonia that can be 
distinguished by the amount of chromatin in the nuclear envelope. Sequentially, 
spermatogonia initiate various differentiation steps leading to type B spermatogonia, 
followed by the formation of primary spermatocytes (SC), i.e. preleptotene and 
leptotene spermatocytes (plSC and lSC). These primary spermatocytes initiate the 
long lasting prophase of the first meiotic division, and thereby entering the stage of 
spermatidogenesis. During this phase, primary spermatocytes migrate through the 
active blood testis barrier to the adluminal compartment, which distinct milieu favors 
the development of meiosis I leading to the formation of the secondary 
spematocytes. There, pachytene spermatocytes (pSC) enter the second meiotic 
division ending in the formation of haploid spermatids with a unique genetic 
rearrangement. Spermiogenesis proceeds with the transformation of round 
spermatids (rST) into elongated spermatids (eST) and finally into fully differentiated 
spermatozoa (Sza). This requires massive morphological changes of the spermatids, 
including the development of the flagellum required for motility, the formation of an 
acrosome membrane containing digestive enzymes necessary for fertilization, 
nuclear transformation, and elimination of excess cytoplasm by the excretion of a 
residual body (rb). 
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Spermatozoa generated with each spermatogenic cycle must be released into the 
lumen of the seminiferous tubules during a process known as spermiation. Following, 
spermatozoa are transported into the epididymis were their maturation is completed.  
The complete spermatogenic cycle requires five mitotic and two meiotic divisions. 
Only the first mitotic division generates two separated daughter cells. All subsequent 
divisions of differentiating germ cells generate sister cells that remain connected by 
intercellular bridges due to an incomplete cytokinesis, and thereby sharing one 
unique cytosol and plasma membrane. 
 
 
 
Figure 7. Schematic representation of the spermatogenic cycle in mice. 
In the seminiferous tubules of the testis, spermatogonial stem cells (SG) adhered at 
the basal lamina (BL) proliferate generating spermatogonia type B that differentiate 
into preleptotene and leptotene spermatocyte (pl/lSC), which are the most 
differentiated germ cells present at post natal day (PN) 10. These primary SCs must 
traverse the blood-testis barrier (BTB) and further differentiate into pachytene 
spermatocytes (pSC), which are present at PN 15 of the first spermogenic cycle. At 
PN 20, the first round spermatids (rST) are formed and 10 days later the tubules 
contain significant amount of elongated spermatids (eST). These must further 
differentiate to generate spermatozoa (Sza), which are released into the lumen of the 
tubules from PN 35 onwards, and transported into the epididymis where they acquire 
full maturation. In the interstitium (IS) between adjacent tubules, androgen producing 
Leydig cells (LC) are located. Scheme modified from (Sandhoff, 2009).  
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1.4.1.2. Testicular polyenoic ultra long chain sphingolipids 
In addition to simple sphingolipids, i.e. ceramides and sphingomyelins, mouse testis 
express complex glycosphingolipids of the ganglio (Gg-) and the globo (Gb-) series. 
In previous work of our department, the comparison of GSL patterns of fertile and 
infertile mouse models led to the finding of a novel class of complex GSLs (Sandhoff 
et al., 2005). Structural analysis of these 8 novel molecules revealed a fucose 
residue attached to their ganglio-series oligosaccharide chains. Interestingly, the 
novelty relied on the fatty acid residue incorporated in these complex GSLs, being 
almost exclusively polyunsaturated (4 to 6 double bonds) and with a chain length of 
28 to 32 carbon atoms (Figure 8). Previously, sphingolipids containing ULC-PUFA 
residues have only been described as minor components incorporated into 
sphingomyelin of various mammals (Robinson et al., 1992). 
 Investigations of the specific GSL expression patterns of fertile GM3/Siat9-/- and 
infertile GM2S/Galgt1-/- mice linked the presence of the neutral subset of fucosylated 
GSL (FGSL) containing the ULC-PUFA moieties to be required for male fertility in 
mice (Sandhoff et al., 2005). Infertile mice lacking this neutral subset due to a genetic 
disruption of the GM2S/Galgt1-/- developed multinucleated giant cells at the stage of 
spermatid formation. The intercellular bridges connecting the sister spermatids were 
lost, leading to an arrest of spermatogenesis in these mutant mice. Whereas lack of 
these unconventional fatty acid residues, and/or lack of the complex fucosylated 
carbohydrate structure of this neutral FGSL are required for male fertility, is still to be 
elucidated.  
 Therefore cell-stage expression patterns of ULC-PUFA sphingolipids, in addition to 
the identification and in vivo depletion of the CerS(s) responsible for their 
biosynthesis, will be required to get insight into the molecular function and specific 
role of ULC-SLs in spermatogenesis. 
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Figure 8. GSL structures expressed in mouse testis. 
Testicular GSL structures are respresented within their synthetic pathways of the 
ganglio- and globo-series. GSLs absent in fertile GM3S/Siat9-/- and infertile 
GM2S/Galgt1-/- mice are enclosed in a blue and red square, respectively.  
  
1.4.2. The epidermis 
The mammalian skin is composed of two morphologically distinct layers: the 
overlying epidermis, which provides the primary barrier against desiccation, 
xenobiotics and pathogens; and the underlying dermis, which provides the strength 
and flexibility of the skin and accounts for the majority of its thickness. The latter is 
mostly constituted of fibroblasts, which secrete the connective tissue matrix mainly 
composed of collagen fibrils and elastin fibres. Instead, the primary cells of the 
epidermis are keratinocytes, which undergo progressive differentiation, maturation 
and cornification from the basal lamina to the outermost superficial cell layer 
(Figure 9).  
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1.4.2.1. Epidermal structure and keratinocyte differentiation 
Epidermal differentiation is a highly dynamic process where keratinocytes are 
continuously regenerated from the proliferative stratum basale and shed upon their 
terminal stage of cornification. During this process, keratinocytes must undergo a 
series of profound changes involving their complete cellular structure and 
composition (Figure 9).   
  
 
 
Figure 9. The epidermal structure. 
The epidermis is a self-renewing tissue, where keratinocytes at the stratum basale 
progressively differentiate and migrate through the stratum spinosum and the stratum 
granulosum to terminally differentiate in the stratum corneum, where they finally shed 
during desquamation. Right, PAS-methylene blue-Azur II staining of neonatal mouse 
skin. KG: keratohyalin granules. Scheme (left) modified from (Sandhoff, 2009).  
 
 
 Keratinocytes residing at the stratum basale (SB) are characterized by the 
expression of keratins K5 and K14. These structural proteins, together with 
microtubules and microfilaments, constitute the cytoskeleton of basal epithelial cells. 
Upon leaving the basal lamina, keratinocytes become less proliferative and begin 
their apical migration reaching the stratum spinosum (SS). At the spinous layers, a 
complete new set of structural proteins is synthesized, mainly K1 and K10. At a more 
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advanced stage starts the synthesis of lipids and early structural proteins (involucrin, 
transglutaminases) required for the formation of the cornified envelope (CE). The 
cornified envelope consists of a highly cross-linked protein structure that replaces the 
plasma membrane of terminally differentiated keratinocytes, i.e. corneocytes. These 
structural proteins of the CE are covalently bound to the corneocyte-lipid envelope 
(CLE), and together provide the primary and essential epidermal barrier (Candi et al., 
2005). In parallel to the synthesis of lipids and enzymes required for the 
establishment of the CE and CLE, the formation of the secretory lamellar body 
organelle (LB) occurs at the upper SS layers. The main function of this unique 
multifunctional organelle is to deliver lipids, enzymes, antimicrobial peptides, among 
other metabolites, and secrete them primarily at the interface of the upper epidermal 
layers, i.e. the stratum granulosum (SG) and the stratum corneum (SC) (Elias et al., 
2006).    
 At the SG, the keratinocyte maturation proceeds with the expression of loricrin and 
profilaggrin, main constituents of the keratohyalin granules (KG), which structural 
proteins will be incorporated to the CE. The most profound changes during 
keratinocyte differentiation occur between the maturation of nucleated keratinocytes 
of the SG to enucleated corneocytes of the SC. At this interface, the majority of 
lamellar bodies secrete their contents, transglutaminases (TGs) cross-link proteins 
that generate the CE (involucrin, loricrin) and organelles of the viable epidermal 
layers are progressively degraded.  
 Morphologically, keratinocytes develop a flattened shape concomitantly with their 
differentiation yielding the squamous corneocytes. This terminally differentiated 
keratinocytes are devoid of nuclei, organelles and plasma membrane. Instead, the 
highly cross-linked proteins of the CE serve as a scaffold where lipids of the CLE are 
covalently bound.  
 The terminal keratinocyte differentiation leads to a highly regulated proteolytic 
process of specialized cell-cell junctions, i.e. corneodesmosomes, that concludes in 
the desquamation of the outermost corneocytes. The proteolytic cleaveage of 
corneodesmosomes requires the degradation of secreted extracellular corneosomal 
proteins (i.e. corneodesmosin), as well as of specific cadherins (i.e. desmogleins) by 
various proteases (i.e. kallikreins and cathepsins). The altered expression of 
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proteases, or alteration in the concentration of protease inhibitors, and other factors 
such as calcium concentration, pH and water content, results in a defect in 
corneocyte shedding, thereby altering desquamation leading to various pathologies 
(e.g. ichthyoses). 
 
1.4.2.2. Embryonic epidermis and the periderm 
At the initial embryonic stages of development, a transient epidermal layer known as 
periderm is formed from the embryonic ectoderm. During the early embryonic period, 
the epidermis consists of two cell layers, the inner proliferative basal keratinocytes 
and the outer periderm cells. At the embryonic/fetal transition, the basal keratinocytes 
start to stratify leaving the periderm cell layer at the epidermal surface. Peridermal 
cells cease to divide and increase in surface area, while characteristic blebs are 
being formed. Later in fetal development, complete stratification is reached with the 
formation of a thin stratum corneum underneath the peridermal cell layer. Nuclear 
degradation of peridermal cells proceeds with the subsequent disaggregation of the 
periderm, a process that occurs concomitantly with the barrier formation (Hardman 
and Byrne, 2006). In mice, the epidermal barrier is estimated to develop from 
embryonic day E16.5 to be completed at E18.5 (in mice born at day 19) (Hardman et 
al., 1998). 
 
 
 
Figure 10. Development of embryonic epidermis. 
Epidermis develops from the embryonic ectoderm by subsequent stratification of 
basal keratinocytes. The transient peridermal layer located at the surface might 
serves as a protective layer for the developing epidermis. Present until the late fetal 
stage (P < 16.5), the periderm disaggregates during the prenatal period (P > 18.5). 
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Although the function of the periderm is not completely understood, its role as a 
protective layer for embryonic skin has been suggested. The fact that the periderm is 
sealed with tight junctions supports this hypothesis. Differing from epidermal tight 
junctions, peridermal cells express claudin-6 (Morita et al., 2002). Keratins, namely 
K6, K16 and K17, are additionally expressed in this transient epidermal layer 
(Hardman and Byrne, 2006). 
 
1.4.2.3. Stratum corneum pH 
Along with the keratinocyte terminal differentiation, a remarkable pH gradient is 
established. In humans, the initial neutral pH (∼6.8) at the lower SC decreases with 
cornification reaching an acidic pH (∼4.5–5.3) at the surface of the SC. The 
generation of this “acid mantle” is influenced by exogenous as well as endogenous 
mechanisms. Whereas exogenous sources such as microbial metabolism or lactate 
formation from sweat appear to contribute to a minor extent to the pH gradient, the 
endogenous formation of free fatty acids from phospholipids, in addition to the proton 
secretion from the Na+/H+ antiporter at the keratinocyte PM, and the trans-urocanic 
acid production are the major contributors of the acidic pH. This acidic mantle at the 
surface of the SC is required to modulate SC integrity and cohesion, to provide 
resistance to antimicrobial activity, and to maintain the epidermal permeability barrier 
homeostasis (Fluhr and Elias, 2002). 
 
1.4.2.4. Intercellular junctions of the epidermis 
The epidermis contains various types of cell-cell junctional complexes, that are 
required for maintaining cellular adhesion, controlling transport of solutes and 
foremost, regulate the epidermal barrier function. Epidermal intercellular junctions are 
comprised of communication junctions (gap junctions), mechanical junctions 
(adherens junctions and desmosomes) and tight junctions.  
Communication junctions are commonly denominated as gap junctions and are 
composed of two transmembrane half-channels, i.e. connexons, each consisting of 
an assembly of six connexins that form a continuous channel between neighboring 
cells thereby directly connecting their cytoplasms (Figure 11). The channel created 
by connexons is about 2 to 4 nm, thus enabling the passage of ions and small 
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molecules up to 1 kDa. By regulating the flow of these molecules, gap junctions are 
directly involved in the chemical communication between neighboring cells forming a 
functional synchronized syncytium (Haftek et al., 2006). 
Mechanical junctions are involved in cellular adhesion by connecting intracellular 
cytoskeletal proteins of adjacent cells. The adherens junctions (zonulae adherentes) 
connect F-actin filaments via the classical cadherin-catenin complexes between two 
neighboring cells. Instead, desmosomes (maculae adherentes) are keratin-
associated protein complexes that are distinctive of epidermal tissues.  
 
 
 
Figure 11. Epidermal intercellular junctions. 
Model describing mechanical junctions (desmosomes and adherens junctions, A and 
C), communication junctions (gap junctions, B) and tight junctions (D), including the 
major proteins associated with each junctional complex. PM: Plasma membrane; 
ZOs: Zonula occludens proteins. Modified from (Lüllmann-Rauch, 2003) 
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The intercellular connections of actin-associated adherens junctions are 
constituted by transmembrane cadherins that form calcium dependent homodimers 
with cadherins of adjacent cells (Figure 11). Epidermal cell cohesion is achieved by 
anchoring the intracellular portion of these cadherins (P-cadherin and E-cadherin) to 
intracellular catenins (α-catenin, β-catenin, γ-catenin/plakoglobin and δ-catenin). The 
intercellular space created by this cell-cell junction is about 15 to 20 nm. Adherens 
junctions are distributed over the entire viable layers of mammalian epidermis 
(Brandner et al., 2010). 
Desmosomes are junctional protein complexes built up by the desmosomal 
cadherins (desmogleins and desmocollins) and the intracellular plaque proteins 
(plakoglobin and desmoplakin) (Figure 11). Intercellular cadherins serve as anchor 
sites for the attachment of adjacent cells. They span across the PM of nucleated 
keratinocytes or through the CE of corneocytes, binding to the intermediate filaments 
(keratins) via the plaque proteins. 
Keratinocyte maturation modulates the number, size and composition of 
desmosomes. At the SB, desmosomes increase upon differentiation to the SS. At the 
interface between SG and SC, desmosomes undergo a series of profound changes 
including the integration of the junctional complexes into the CE. These 
morphological changes lead to the formation of the corneodesmosomes. At the first 
layers of the SC, i.e. stratum compactum, corneodesmosomes are almost evenly 
distributed over the entire surface of the corneocytes. As cornification advances, non-
peripheral corneodesmosomes distributed at basal and apical regions, are first 
degraded by LB-secreted proteases. In the upper SC, i.e. stratum disjunctum, the 
degradation of peripheral corneodesmosomes distributed at the lateral regions is 
initiated, resulting in a weaker cell cohesion that ultimately leads to the shedding of 
the outermost superficial corneocytes (Haftek et al., 2006).  
The process of desquamation involves the proteolytic degradation of 
corneodesmosomal proteins. Several proteases have been implicated in this 
process, mainly proteins of the kallikrein family (KLK7 and KLK5) and the cathepsin 
family (CTSL2, CTSL-like, CTSD and CTSE-like). Protease inhibitors have also been 
implicated in the regulation of corneocyte exfoliation, among them elafin, 
antileukoproteinase and SPINK-5 are the most prominent. Additionally, several other 
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factors have been shown to influence cell cohesion at the SC, such as water content, 
SC pH and depletion of extracellular calcium (Haftek et al., 2006). Deregulations and 
alterations of the desquamation process can lead to several pathological conditions, 
e.g. Netherton syndrome (Schmuth et al., 2007).  
Whereas adherens junctions and desmosomes mechanically couple the 
intracellular cytoskeleton of neighboring cells and thereby regulate cell adhesion, 
tight junctions are primarily responsible for sealing adjacent cells and controlling the 
paracellular transport. Tight junctions (zonulae occludentes) from two adjacent cells 
form paired strands or fibrils, which contain aqueous pores, thus enabling the 
diffusion of selected ions and small molecules (Figure 11). In addition, tight junctions 
(TJs) separate the apical and the basal plasma membrane domains thereby blocking 
the lateral diffusion of proteins and lipids (Morita et al., 2002).  
The debate regarding the occurrence of typical TJ structures in mammalian 
epidermis has been ongoing for several decades. This controversy reached its end 
with the recent reports from the Tsukita and Franke groups describing TJs and 
TJ-related structures in stratified mammalian epithelia (Langbein et al., 2002; Morita 
et al., 2002). In addition to typical TJ structures (zonulae occludentes), characterized 
by their “kissing points” at the electron microscopical level, they identified “lamellated 
TJs” (coniunctiones laminosae), “sandwhich junctions” (iuncturae structae), extended 
close-contact junctions (occludens junctions), among other structures. These 
junctional complexes were often found interspersed between desmosomal junctions 
(Langbein et al., 2002).  
At the molecular level, tight junctional complexes are comprised of transmembrane 
and plaque proteins. Occludin, claudins and junctional adhesion molecules (JAMs) 
have been reported among the transmembrane proteins found in epidermal tight 
junctions. These intercellular proteins are associated with scaffolding plaque proteins 
such as cingulin, symplekin, zonula occludens proteins (ZO-1, ZO-2, ZO-3), etc. The 
latter zonula occludens-associated proteins have been demonstrated to directly bind 
to the F-actin cytoskeleton (Brandner and Proksch, 2006). The molecular 
composition of the tight junctional transmembrane and plaque proteins is widely 
diverse and varies according to cell types, as well as their degree of differentiation. In 
particular, the expression pattern of the extensive claudin protein family has been 
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reported to be highly tissue specific (Tsukita et al., 2001). Their composition and ratio 
of expression have been shown to modulate TJ permeability and ion selectivity 
(Furuse et al., 2001). However, the essential role of TJ in the epidermal permeability 
barrier was not established until it could be demonstrated that claudin-1 deficiency 
resulted in rapid postnatal lethality due to a tremendous transepidermal water loss 
(TEWL) in mice (Furuse et al., 2002).  
Differing from the wide distribution of adherens junctions within the living layers of 
the epidermis, the expression of zonulae-TJs is restricted to the SG layer. Typical 
zonulae-TJ structures are distributed continuously around the cell-cell borders of 
granular keratinocytes (Furuse et al., 2002). In addition, less developed TJ 
complexes known as maculae occludentes have also been reported at the SG layer. 
Their distribution was focussed in a series of discrete sites around the cell-cell 
borders of granular keratinocytes (Morita et al., 1998). 
In diseased skin, TJ expression exhibits a broadened distribution that included 
keratinocytes of the SS layer. Altered expression of TJ proteins have been 
demonstrated in psoriasis, ichthyosis vulgaris, various eczema, but also in tumors 
and in regenerating skin after wounding (Brandner and Proksch, 2006; Kirschner et 
al., 2010a). 
 
1.4.2.5. Epidermal permeability barrier 
The primary function of the epidermis is to provide a defensive barrier against 
pathogenic microbes, mechanical and chemical insults, and most importantly to 
provide terrestrial vertebrates with a barrier against desiccation. This essential 
permeability barrier primarily resides in the SC, where corneocytes are embedded in 
lipid lamellar sheets that form the corneocyte-lipid envelope. These highly 
hydrophobic lamellae are mostly composed of ceramides (Cer), cholesterol (Chol) 
and free fatty acids (FFA), estimated to contain 50%, 25% and 10% of the total lipid 
mass, respectively (Werzt, 2006). The near equimolar ratio of these major 
components of the CLE is critical for the proper maintenance of the epidermal 
permeability barrier (Holleran and Takagi, 2006). Alterations of this ratio, as well as 
the variation within their species, have been linked to a multitude of skin diseases 
such as atopic dermatitis and psoriasis (Imokawa et al., 1991; Motta et al., 1993). 
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Minor components of the lipid lamellae include cholesterol sulfate, which is required 
for proper desquamation (Elias et al., 1984), and free long chain bases, resulting 
from the degradation of ceramide, which might be necessary for inhibiting pathogenic 
microbial growth (Bibel et al., 1992; Veerman et al., 2010). 
 The formation of the epidermal permeability barrier is initiated with the synthesis of 
lipids required for the formation of the CLE and their precursors, which take place at 
the ER and the Golgi compartments of mostly keratinocytes of the upper SS and SG 
(Figure 12). These secretory lipids and their precursors are packed in disk-like form 
lipid layers, together with hydrolytic enzymes (e.g. glycosidases, proteases), and 
other proteins into lamellar bodies. These stacks of lipids mostly consist of 
cholesterol and the precursor species of glucosylceramides, sphingomyelins, and 
glycerophospholipids, required for the formation of intercellular ceramides and FFAs 
(Freinkel and Traczyk, 1985). Analysis on the composition of these precursor lipid 
species revealed that glucosylceramides are specially enriched of a unique ULC-ω-
hydroxy fatty acid moiety esterified with linoleic acid at the ω-position (Abraham et al., 
1985). In contrast, the acyl moieties of sphingomyelins have non-hydroxy fatty acids 
up to 26 carbon atoms, or α-hydroxy-LC-FA residues (Uchida et al., 2000). 
 Following the synthesis and recruitment of lipids and proteins into LB, these 
organelles translocate apically towards the plasma membrane of the uppermost 
keratinocytes of the SG. A deficiency or malfunction of this multifunctional organelle 
has severe consequences. Mutations in the ATP-binding cassette transporter A12 
protein, ABCA12, required for the proper lipid transport in LB, leads to the fatal 
human disorder of Harlequin ichthyosis causing a defective barrier function and 
neonatal death (Akiyama et al., 2005; Kelsell et al., 2005).  
At the interface, LB fuse with the PM and secrete their content in the extracellular 
space (Madison, 2003). There, LB-derived lamellar sheets are organized parallel to 
the PM, where conventional plasma membrane lipids are successively replaced by 
the lamellar sheets of the CLE. The formation of the mature CLE requires the 
attachment of ω-hydroxy-ULC-glucosylceramides to the carboxy residues of proteins 
in the outer surface of the CE (Holleran and Takagi, 2006). Previous ω-esterification 
to fatty acids like linoleic acid appears to be crucial for this process, as lack of 
sphingolipids containing these ω-esterified FAs in CGI-58 deficient mice also leads to 
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a strong decrease in protein bound sphingolipids (Radner et al., 2009). In vitro, the 
transesterification of ω-hydroxy-ULC-ceramides from their linoleic esters onto 
glutamine residues of involucrin has been demonstrated for transglutaminase 1 
(TG1) (Nemes et al., 1999). However, patients with TG1 deficiency exhibit sporadic 
normal CLE structures, therefore this enzyme might not be solely responsible for the 
attachment of ω-hydroxy-ULC-sphingolipids to the CE (Elias et al., 2002). 
 The CE proteins involved in the covalent attachment of ω-hydroxy-ULC-
sphingolipids in vivo remain elusive. Although involucrin, envoplakin and periplakin 
have been suggested substrates for ceramide attachment, other structural proteins 
have not been discarded as possible substrates (Marekov and Steinert, 1998). In 
mice, the in vivo depletion of involucrin develop normal CE (Djian et al., 2000), 
therefore other additional proteins might be responsible for the linkage to the CLE. 
At the extracellular space, the lipid lamellae are elongated and fuse resulting in the 
formation of uninterrupted lipid sheets. This fusion of short lipid stacks has been 
suggested to occur edge-to-edge (Landmann, 1986), and might be mediated by the 
extracellular processing of precursor polar lipids (mainly glucosylceramide and 
phospholipids) that generate the highly hydrophobic constituents of the CLE 
(Coderch et al., 2003).  
The final step for barrier formation requires the hydrolysis of precursor lipids by 
secreted acid hydrolyses. In particular, glucosylceramides are converted into 
ceramides by β-glucocerebrosidase (Holleran et al., 1994b). The formation and 
processing of glucosylceramide is an imperative for a functional epidermal barrier, as 
has been demonstrated in the keratinocyte specific deletion of glucosylceramide 
synthase (Jennemann et al., 2007) and in a mouse model for Gaucher disease with a 
defective β-glucocerebrosidase (Doering et al., 1999b; Holleran et al., 1994a). The 
hydrolysis of GlcCers appears to require the activation of β-glucocerebrosidase by 
saposins. The in vivo deficiency of prosaposin, common precursor of these small 
glycoproteins, exhibits abnormal lamellar membrane maturation (Doering et al., 
1999a). 
The processing of protein bound ω-hydroxy-ULC-glucosylceramides leads to the 
maturation of the CLE. However, the processing of sphingomyelin by acid 
sphingomyelinase, as well as the breakdown of phospholipids by phospholipase A2 
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to generate FFAs, has been shown to be critical for epidermal barrier homeostasis. 
The hydrolysis of precursor lipids has an optimum acidic pH, exhibiting extremely 
reduced enzymatic activities at neutral pH (Holleran and Takagi, 2006). 
 
 
 
Figure 12. Establishment of the epidermal permeability barrier. 
The epidermal permeability barrier is primarily localized at the SC. The highly 
hydrophobic lipid lamellae together with the CLE are required for the proper function 
of the epidermal barrier against desiccation. The lamellar bodies have an essential 
function involving the transport and secretion of precursor lipids to the interface, 
which are further processed to generate the CLE, i.e. the lipid sheets within the 
interstices. Modified from (Sandhoff, 2009). 
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Although a significant progress has been achieved in the last decades to elucidate 
the metabolic requirements for the formation of the CLE, the precise steps for ULC-
FA elongation, ω-hydroxylation and ω-O-esterification are still unresolved, regarding 
the enzymes and their intracellular localization. The specific regulation of these 
processes, as well as the precise biogenesis, transport and secretion of LB is a 
prerequisite for understanding the pathogenesis of a multitude of skin diseases. 
 
1.4.2.6. Epidermal ultra long chain sphingolipids 
Ceramides are the main class of sphingolipids expressed in the mature CLE, as well 
as in the lipid lamellae of the SC. Although at least twelve major classes of ceramide 
species have been identified (Uchida and Hamanaka, 2006), the characterization of 
human SC ceramides by LC-ESI-MS/MS resulted in the identification of 342 
ceramide species (Masukawa et al., 2008).  
SC ceramides derived from sphingosine can be classified according to their acyl 
residue: NS for non-hydroxy-FA, AS for α-hydroxy-FA, OS for ω-hydroxy-FA, POS for 
ω-hydroxy-FA bound to protein and EOS for ω-hydroxy-FA esterified primarily to 
linoleic acid (Figure 13).  
Sphingosine is not the exclusive LCB expressed in epidermal ceramides. In 
addition, phytosphingosine and 6-hydroxy-sphingosine are common LCBs found in 
human epidermis. The molecular diversity generated by the presence of various 
LCBs is further enhanced by mostly variations within the chain length of the acyl 
moieties and the hydroxylation of the sphingoid base and the acyl residue.  
The ω-hydroxy-ceramides esterified with linoleate (EOS) are the most common SC 
ceramides. They contain primarily saturated or monounsaturated ULC-acyl moieties 
of 30 to 36 carbon atoms. In humans, the linoleate residue (18:2, ω-6) is the major 
FA linked to EOS, which contributes with 95% of total EOS. In contrast, mice 
epidermis contains 45% of linoleate esters linked to the ω-hydroxyl group (Uchida 
and Hamanaka, 2006). In essential fatty acid deficiency (EFAD) oleate (18:1, ω-9) 
residues have been shown to replace linoleate, with a consequent decrease in the 
epidermal permeability barrier (Melton et al., 1987).  
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Figure 13. Major classes of epidermal ceramides.  
Non-hydroxy and α-hydroxy-ceramides mainly contain acyl moieties with a carbon 
chain length up to 26 carbon atoms. The majority of ω-hydroxy-ceramides 
incorporate saturated or monounsaturated ULC-acyl residues ranging from 30 to 36 
carbon atoms. 
 
 
The biosynthesis of ω-hydroxy-ceramides esterified to carboxy residues of CE 
proteins (POS) is essential for epidermal barrier homeostasis. Likewise to EOS, 
these ceramide species mainly contain saturated or monounsaturated ULC-acyl 
moieties (Coderch et al., 2003). The precursor of both ceramide classes has been 
shown to be exclusively glucosylceramide (Uchida and Hamanaka, 2006). In 
contrast, non-hydroxy and α-hydroxy epidermal ceramides appear to be derived from 
SM species (Uchida et al., 2000). The acyl residues incorporated into NS and AS 
ceramides are mostly saturated and contain 16, 18, 24 or 26 carbon atoms in their 
acyl chains (Coderch et al., 2003), however they do not contain ULC-acyl moieties. 
Although hydroxy fatty acids account for about 40% of SC ceramides, the 
enzyme(s) involved in the synthesis of α-hydroxy-Cers are not yet resolved. In vitro 
studies demonstrated that FA2H increased α-hydroxy-Cers levels upon keratinocyte 
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differentiation, however in vivo deletion of this gene did not exhibit obvious alterations 
of the permeability barrier suggesting another enzyme being involved in the 
biosynthesis of α-hydroxy-Cers (Hama, 2009; Meixner, 2009). 
The multiple regulatory functions of ceramides in cell cycle, apoptosis and cellular 
differentiation have been demonstrated for various cell types, including keratinocytes 
(Geilen et al., 1997). In the epidermis, the essential role of ceramides in the formation 
and maintenance of the permeability barrier is currently being established. However, 
whether epidermal ceramides have a functional role in regulating keratinocyte 
differentiation and/or apoptosis is yet undetermined.  
 
1.5. Hypothesis and aims 
 
Complex glycosphingolipids and ceramides containing ULC-PUFA moieties were first 
described in mature mouse testis by Sandhoff et al. Interestingly, the neutral subset 
of this class of GSLs correlates with male fertility in mice. The functional role of these 
unconventional testicular sphingolipids has not been yet elucidated, however 
understanding the biosynthetic requirements of ULC-sphingolipids is a prerequisite in 
order to gain a deeper insight into their role in cellular functions.  
ULC-acyl moieties are incorporated to sphingoid bases by a yet unidentified 
ceramide synthase homologue. Preliminary work demonstrated that CerS3 is 
strongly expressed in testis and skin, both being the only mammalian tissues 
containing ULC-sphingolipids (Sandhoff et al., unpublished data). Hence, we 
hypothesized that CerS3 might be involved in the synthesis of these ULC-ceramides, 
which are the common precursor for all complex ULC-glycosphingolipids.  
To confirm the role of CerS3 or any other CerSs in the biosynthesis of ULC-
sphingolipids, transcriptional analysis of the individual members of the CerS family 
will be performed to determine whether CerS3 or another CerS is coexpressed with 
testicular ULC-PUFA sphingolipids. For these studies, germ cell-stage specific and 
“germ cell-free” mice testes will be analyzed.  
The identified CerS(s) responsible for catalyzing ULC-sphingolipid formation will 
be further characterized regarding their genetic structure, topology and subcellular 
localization. 
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To demonstrate the in vitro capacity for ULC-ceramide biosynthesis, the identified 
CerS(s) will be subjected to enzymatic assays. The substrate specificity of the 
corresponding CerS(s) towards ULC-CoAs in favor of LC- and VLC-CoAs will be 
determined. To carry out these enzymatic assays, living mammalian cells expressing 
CerS(s) with recombinant GFP proteins will be generated and supplemented with 
various acyl-CoAs including ULC-CoAs.  
In parallel, the in vivo depletion of CerS3 is being established in our department. 
Mice carrying a genetic alteration of the CerS3 gene will provide a valuable tool to 
clarify the role of this enzyme in ULC-ceramide biosynthesis. In addition, this 
dysfunctional CerS3 mouse model will unveil new insights into the biological 
functions of its specific ceramide species in the skin and the testis.  
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2.1. Materials 
 
2.1.1. Chemicals 
All reagents used in this study for routine analysis were obtained from the following 
commercial sources: Sigma, Carl Roth, Fluka, AppiChem, Gerbu and Merck. The 
grade of these chemicals were pure for analysis.  
For cloning, restriction enzymes were obtained from Invitrogen and New England 
Biolabs (NEB). For synthesis of organic compounds, solvents and reagents were 
purchased from Fluka, except for coenzyme A obtained from American Radiolabelled 
Chemicals, dimethylketene methyl trimethylsilyl acetal and triethylamine from Sigma, 
and sphingosine (d17:1), which was acquired from Avati Polar Lipids. For ceramide 
synthase assay, activated fatty acids with coenzyme A with an acyl moiety ranging 
from 16 to 26 carbon atoms were also acquired from Avanti Polar Lipids. For cell 
culture, supplements were purchased from Invitrogen. All other chemicals were used 
and purchased as indicated in the corresponding sections. 
 
2.1.2. Basic equipment 
General consumables for molecular biology and cell culture were purchased from 
Eppendorf, Gilson, Greiner and BD Biosciences.  
 
2.1.3. Buffers and solutions 
All stock buffers and solutions were prepared using either Aqua ad injectabilia Braun 
or  double distilled autoclaved water.  
 
Solutions for molecular biology - I 
TAE buffer (50x) 
2 M Tris/AcOH pH 8.0 
0.1 M EDTA 
EB buffer (1x) 
10 mM Tris/HCl pH 8.5 
Xylene cyanol loading buffer  (10x) 
0.001% xylene cyanol (w/v) 
50% glycerol (v/v)  
20mM Tris/HCl pH 7.5 
Crystal violet loading buffer (10x) 
0.02% crystal violet (w/v) 
50% glycerol (v/v) in H2O 
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Solutions for molecular biology - II 
TE buffer (1x) 
10 mM Tris/HCl pH 8.0 
1 mM EDTA 
Restriction digest buffer 1 (1x) 
50 mM Tris-HCl pH 8.0 
10 mM MgCl2 
100 mM NaCl 
Ligation buffer 1 (5x) 
250 mM Tris-HCl pH 7.6 
50 mM MgCl2 
5 mM ATP 
5 mM DTT 
25% polyethylene glycol-8000 (w/v) 
PCR buffer 1 (10x) 
200 mM Tris-HCl pH 8.8 
100 mM KCl 
100 mM (NH4)2SO4 
20 mM MgSO4 
1% Triton X-100 (w/v) 
1 mg/ml nuclease-free BSA 
 
Solutions for Western blot - I 
Hypotonic lysis buffer 1 (1x) 
50 mM HEPES-NaOH 
0.5 mM DTT 
1x protease inhibitors mixture 2 
 Digitonin lysis buffer 1 (1x) 
20 mM HEPES-NaOH pH 7.4 
25 mM KCl 
250 mM sucrose 
2 mM MgCl2 
0.5 mM DTT 
1x protease inhibitors mixture 2 
1% digitonin 2,3 (w/v) 
Resolving gel buffer  (8x) 
3 M Tris-HCl pH 8.8 
0.1% SDS (w/v) 
Stacking gel buffer (4x) 
0.5 M Tris-HCl pH 6.8 
0.1% SDS (w/v) 
Lämmli loading buffer 1 (4x) 
40% glycerol (v/v) 
0.02% bromophenol blue (w/v) 
250 mM Tris pH 6.8 
8% SDS (w/v) 
0.4 M DTT 
Running buffer (10x) 
250 mM Tris 
1.92 M glycine 
1% SDS (w/v) 
Transfer buffer (10x) 
250 mM Tris 
1.92 M glycine 
Transfer-MeOH buffer 4,5 (1x) 
1x transfer buffer 
20% CH3OH (v/v) 
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Solutions for Western blot - II 
PBS buffer (10x) 
1.4 M NaCl 
27 mM KCl 
0.1 M Na2HPO4 
18 mM KH2PO4 
pH 6.8 
PBS-Tween buffer (1x) 
1x PBS 
0.1% Tween 20 (v/v) 
Ponceau red  
0.5% Ponceau red (w/v) 
1% AcOH (v/v) 
Blocking buffer 4,5 (1x) 
5% skimmed milk (w/v) in PBS-T 
 
Solutions for affinity purification of an antibody 
Coupling buffer (1x) 
0.5 M NaCl 
0.2 M NaHCO3 
pH 8.3 
Acetate buffer (1x) 
0.1 M NaOAc  
0.5 M NaCl  
pH 4.0 
20 mM Natrium phoshate buffer (1x) 
0.2 M NaH2PO4 x H2O (stock A) 
0.2 M Na2HPO4 x 7 H2O (stock B) 
28 ml stock A + 72 ml stock B  
+ 900 ml H2O 
pH 7.2 
Eluate solution-1 (1x) 
 70 mM glycine pH 2.7 
0.6 mM phosphate buffer 
pH 2.7 
 
Eluate solution-2 (1x) 
100 mM glycine pH 2.0 
Eluate solution-3 (1x) 
30% glycerol (v/v) in 10x PBS pH 11.7 
 
Other buffers and solutions 
Thermolysin buffer 1 (500 µg/ml) 
10 mM HEPES pH 7.4 
142 mM NaCl 
6.7 mM KCl 
0.43 mM NaOH 
1 mM CaCl2 
 Lowry complex reagent 5  (1x) 
2% Na2CO3 (w/v) in 0.1 M NaOH 
+ 0.01% CuSO4 in H2O 
+ 0.02% Na,K tartrate in H2O 
 Citrate buffer (1x) 
25 mM sodium citrate  
0.5% N-laurylsacrosine (w/v) 
pH 7.5 
Guanidin thiocyanate buffer (10x) 
1x citrate buffer 6 
+ 4.23 M guanidin thiocyanate 
+ 0.2 M 2-mercaptoethanol 
Materials and methods 
 
   
 39 
1 Store at – 20 ºC. 
2 Add freshly. 
3 Digitonin solution (10%) was prepared by dissolving the powder in boiling water and 
keeping the solution at 95 ºC for 10 min. 
4 Store at + 4 ºC. 
5 Freshly prepared. 
6 Freshly sterile filtered. 
 
2.1.4. Plasmids 
 
Name Gene of interest Resistance Size (bp) Source 
pEGFP-N1 EGFP Kanr 4733 Clontech 
hElovl2-EGFP – 
pReceiver-M03 
human Elovl2 Ampr 7190 
Genecopoeia 
(EX-W1503-M03) 
hElovl4-tGFP – 
pCMV6-AC-GFP 
human Elovl4 Ampr 7502 
Origene 
(RG206248) 
hCerS3 – 
pReceiver-M02 
human CerS3 Ampr 6913 Genecopoeia 
(EX-T7111-M02) 
pRevTRE2-EGFP 
MoMuLV-derived 
retroviral vector 
encoding EGFP 
Ampr 7198 
Kindly provided 
by Prof. Dr. 
W. Nickel 
 
2.1.5. Restriction endonucleases 
 
Plasmid 
Restriction endonucleases 
Company 
5’ – prime 3’ – prime 
hCerS2-EGFP HindIII EcoRI Invitrogen 
hElovl2-EGFP EcoRI BamHI Invitrogen 
mCerS3-EGFP EcoRI BamHI Invitrogen 
pRevTRE2-mCerS3-EGFP BamHI AgeI Invitrogen, NEB 
pRevTRE2-hCerS3-EGFP BamHI AgeI Invitrogen, NEB 
 
 
 
 
Materials and methods 
 
   
 40 
2.1.6. DNA and protein ladders 
 
Type of ladder Range  Comapny 
1 kb DNA ladder 506–12216 bp Invitrogen 
100 bp DNA ladder 100–2072 bp Invitrogen 
PageRuler plus prestained 10–250 kDa Fermentas 
Precision plus protein  
all blue standards 
10–250 kDa Bio-Rad Laboratories 
 
2.1.7. Technical devices 
Basic instrumentation used regularly in this study included incubator, oven, 
centrifuge, microwave, water bath, pH meter, autoclave and horizontal shaker. Other 
technical devices used are summarized in the following table: 
 
Instrument Company 
Instruments used for molecular biology 
2720 Thermal cycler - PCR Applied Biosystems 
Avanti J-25 centrifuge Beckman 
GelDocTM 2000 Gel Documentation System Bio-Rad Laboratories 
SM-30 Control rotary shaker Neolab 
Ultrospec 2000 UV/Visible Spectrophotometer Pharmacia Biotech 
Instruments used for cell biology 
Centrifuge 5417R and 5415C Eppendorf 
FACS Calibur BD Biosciences 
FACS Vantage Diva and FACS Aria I  
cell sorters 
BD Biosciences 
Instruments used for immunoblotting 
Mini-PROTEAN 3 Cell electrophoresis system Bio-Rad 
Sonifier 250 Branson 
Sonorex Super RK 102H - Sonicator Bandelin 
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Instruments used for lipid analysis 
Alpha 1-2 - lyophilizer Christ 
Evaporator Liebisch 
Linomat IV Camag 
Scanning densitometer CS-9301 Shimadzu 
Varifuge 3.0 R Heraeus Sepatech 
VG micromass model Quattro II Waters 
Instruments used for RNA analysis 
2100 Bioanalyzer Agilent Technologies 
Glass-Col grinder Glass-Col 
Light Cycler 2.0 system Roche Diagnostics 
Ultra Turrax T25 basic  IKA Labortechnik 
Instruments used for microscopic analysis 
Biorevo BZ-9000 Keyence 
DTK 1000 DSK Microslicer 
Leica CM 3050S Leica 
Leica DM-RBE microscope Leica 
Leica TCS-SL confocal scanning system, with 
microscope DMRE and Leica 
confocal software, Version 2.61 
Leica 
Leica Ultracut UCT Leica 
Leica Ultracut UCT equipped with a Leica 
EMFCS 
Leica 
Microm HM 340E Thermo Scientific 
Microm HM 355S Microm 
Zeiss EM 906E Zeiss 
Other instruments 
Tewameter TM300 Courage-Khazaka Electronics 
Thermomixer comfort Eppendorf 
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2.1.8.  Cell lines 
2.1.8.1. Bacterial and fungal strains 
E. coli derived DH5α bacterial strain was used for most cloning procedures. 
Subcloning efficiency DH5α competent cells (Invitrogen, 18265-017) were used for 
regular subcloning experiments, whereas library efficiency DH5α competent cells 
(Invitrogen, 18263-012) were used for ligation reactions. Low copy number 
CopyCutter™ EPI400™ E. coli cells (Epicentre, C400CH10) were used exclusively 
to enable the amplification of hElovl4-tGFP plasmid DNA.  
To examine the vulnerability of CerS3d/d skin against microbial infections, Candida 
albicans (ATCC 90028) were used. 
 
2.1.8.2. Eukaryotic cell lines  
The following cell lines and clones were used in this study: 
- HEK-293T: Human embryonic kidney 293 cells expressing SV40 large T-antigen. 
Provided by Prof. Dr. Walter Nickel.  
- HeLa: Human cervix carcinoma derived cell line with epithelial-like morphology. 
- HeLamCAT1-rtTA2-M2: Clone originated from HeLa cells stably transfected with mCAT1 
(murine cationic aminoacid transporter 1), rtTA2-M2 (optimized reverse tetracycline-
controlled transactivator), and a truncated version of CD2 (cluster of differentiation 2). 
This clone was kindly provided by Prof. Dr. Walter Nickel. 
- HeLamCAT1-rtTA2-M2-hCerS3-eGFP: Clone originated from HeLamCAT1-rtTA2-M2 stably 
transfected with hCerS3-eGFP. 
- HeLamCAT1-rtTA2-M2-mCerS3-eGFP: Clone originated from HeLamCAT1-rtTA2-M2 stably 
transfected with mCerS3-eGFP. 
- HeLamCAT1-rtTA2-M2-eGFP: Clone originated from HeLamCAT1-rtTA2-M2 stably transfected 
with eGFP. 
- K9: Immortalized cell line derived from murine primary Leydig cells. 
 
 
 
 
 
Materials and methods 
 
   
 43 
2.1.9.  Mouse lines 
 
Mouse strain Tissue analyzed Source 
C57/BL6 
Brain, colon, liver,  
skin, testis 
Charles River 
CerS2gt/gt Skin Kindly provided by K. Willecke 
CerS3d/d Skin Generated by R. Jennemann 
GM2AP-/- Testis Kindly provided by R.L. Proia 
KitW-v/KitW Testis 
The Jackson Laboratory 
 (stock number 100410) 
 
2.1.10. Media  
2.1.10.1. Media for bacterial culture  
 
LB medium 
1% tryptone (w/v) 
0.5% yeast extract (w/v) 
1% NaCl (w/v) 
pH 7.0 
SOC medium 
2% tryptone (w/v) 
0.5% yeast extract (w/v) 
10 mM NaCl 
2.5 mM KCl 
10 mM MgCl2 
10 mM MgSO4 
20 mM glucose 
  
LB-agar medium for plates was prepared by adding 1.5% bacto-agar in LB medium. 
Growth media were autoclaved and supplemented with antibiotics for selective 
growth of bacteria carrying the plasmid with the adequate resistance. Antibiotics used 
in this study were ampicillin (100 µg/ml) or kanamycin (50 µg/ml).  
 
2.1.10.2. Media for cell culture 
 
RPMI growth medium 1,2 
1x RPMI 1640 
+ 10% FCS 3 (v/v) 
+ 2 mM L-glutamine 
+ 10 mM HEPES 
+ 50 U/ml penicillin 
+ 50 µg/ml streptomycin 
DMEM growth medium 1,4 
1x DMEM 
+ 10% FCS 3  (v/v) 
+ 2 mM L-glutamine 
+ 100 U/ml penicillin 
+ 100 µg/ml streptomycin 
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DMEM growth medium 1,5 
1x DMEM 
+ 15% FCS 3  (v/v) 
+ 4 mM L-glutamine 
+ 15 mM HEPES 
+ 100 U/ml penicillin 
+ 100 µg/ml streptomycin 
MBS-medium 1 
DMEM 
+ 7% modified bovine serum (w/v) 
+ 25 µM chloroquine in PBS 
  
1 Stored at 4 ºC. 
2 For culture of HeLa cells. 
3 FCS was heat inactivated for 30 min at 56 ºC prior to be used as a supplement.  
4 For culture of HEK-293T cells. 
5 For culture of K9 Leydig cells. 
 
Additional solutions used for cell culture were: 
RPMI 1640 (1x) Roswell Park Memorial Institute medium (Sigma, R0883) 
DMEM (1x)  Dulbecco’s modified Eagle's minimal essential medium (Lonza, 
BE12-604F) 
D-PBS (1x)   Duldecco’s phosphate buffered saline (Sigma, D8537) 
Trypsin (10x)  0.25% trypsin (Gentaur) + 0.5 mM EDTA 
Trypan blue (1x) 0.4% trypan blue + 0.81% NaCl + 0.06% KH2PO4  
 
2.1.11. Multi-component systems (“Kits”) 
 
Multi-component system Company 
Agilent RNA 6000 nano reagents  Agilent 
ECL Western blotting analysis system Amersham GE Healthcare 
Light Cycler FastStart DNA master SYBR green I Roche Diagnostics 
MBS mammalian transfection kit Stratagene 
pVPack vectors kit Stratagene 
Qiagen plasmid maxi kit Qiagen 
QIAprep spin miniprep kit Qiagen 
QIAquick gel extraction kit Qiagen 
QIAquick PCR purification kit Qiagen 
TURBO DNA-free kit Ambion 
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2.1.12. Primers 
2.1.12.1. Primers used for analytical polymerase chain reaction (PCR) 
The tissue distribution of Cers3 was analyzed with the following primers: 
 
Gene Primer sequence 
Ta 
(ºC) 
Product 
size (bp) 
CerS3 – cDNA 1 
F 5’ – TCT GGG AGG TTT GGA ATG AC – 3’ 
55 687  
R 5’ – CGC CAC ATT GTG CTT CAA – 3’ 
mGapdh 
F 5’ – ACT CCC ACT CTT CCA CCT TC – 3’ 
55 156 
R 5’ – GGT CCA GGG TTT CTT ACT CC – 3’ 
 
1 To analyze Cers3 expression 30 cycles of denaturation-annealing-elongation of the 
cDNA template were used.  
 
2.1.12.2. Primers used for preparative PCR 
The following primers were used to generate mammalian expression plasmids: 
 
Plasmid Primer sequence 
T1, T2 
(ºC) 1 
Product 
size (bp) 
mCerS3-
EGFP 
F 2 5’ – ATG TTT CAG ACG TTT AGA AAA TGG TT – 3’ 
56 1171 
R 2 5’ – CGC CAC ATT GTG CTT CAA – 3’ 
F 
5’ – TAT ATA GAA TTC GCC ACC ATG TTT CAG ACG 
TTT AGA AAA TGG TTC TGG – 3’ 
56, 62 1181 
R 
5’– TAT ATA GGA TCC GTA CGG CCA TGC TGA CCA 
TTG GCA ATG – 3’ 
hCerS2-
EGFP 
F 5' – CAG GAT GCT CCA GAC CTT GT – 3' 
53 1164 
R 5' – GCA GCT GGA ATA ATG GTT CA – 3' 
F 
5' – TAT ATA AAG CTT GCC ACC ATG CTC CAG ACC 
TTG TAT GAT TAC TT – 3' 
54, 62 1171 
R 
5' – TAT ATA GAA TTC GGT CAT TCT TAC GAT GGT 
TGT TAT TGA GGA TG – 3' 
hElovl2-
EGFP 
F 
5' – TAT ATA GAA TTC GCC ACC ATG GAA CAT CTA 
AAG GCC TTT GAT GAT G – 3' 
54, 63 920 
R 
5' – TAT ATA GGA TCC GTT TGT GCT TTC TTG TTC 
ATC ACT CCA TTT – 3' 
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Plasmid Primer sequence 
T1, T2 
(ºC) 1 
Product 
size (bp) 
pRevTRE2-
mCerS3-
EGFP 
F 
5' – TAT ATA GGA TCC GC CAC CAT GTT TCA GAC 
GTT TAG AAA ATG GTT CTG G – 3' 
56, 66 1181 
R 
5' – TAT ATA ACC GGT GTA CGG CCA TGC TGA 
CCA TTG GCA ATG – 3' 
pRevTRE2-
hCerS3-
EGFP 
F 
5' – TAT ATA GGA TCC GCC ACC ATG TTT TGG ACG 
TTT AAA GAA TGG TTC TGG – 3' 
56, 66 1181 
R 
5' – TAT ATA ACC GGT GTA TGG CCA TGC TGG 
CCA TTG GGA ATG – 3' 
 
1 T1 is the annealing temperature used for 10 cycles in order to bind the primer nucleotides 
complementary to the template cDNA. T2 corresponds to the annealing temperature of the 
full-length primers including the overhang nucleotides and was used for an additional 15 
cycles. 
2 F and R stands for forward and reverse primer, respectively.  
Restriction sites are shown underlined. 
 
2.1.12.3. Primers used for quantitative real time PCR (qRT-PCR) 
The expression of ceramide synthase genes in testicular RNA was determined using 
the following primers: 
 
Gene Primer sequence 
Ta 
(ºC) 
Product 
size (bp) 
mCers1 
F 5’ – TGA CTG GTC AGA TGC GTG A – 3’ 
55 93 
R 5’ – TCA GTG GCT TCT CGG CTT T – 3’ 
mCers2 
F 5’ – TCA TCA TCA CTC GGC TGG T – 3’ 
55 90 
R 5’ – AGC CAA AGA AGG CAG GGT A – 3’ 
mCers3 
F 5’ – ATC TCG AGC CCT TCT TCT CC – 3’ 
55 128 
R 5’ – CTG GAC GTT CTG CGT GAA T – 3’ 
mCers4 
F 5’ – TGC GCA TGC TCT ACA GTT TC – 3’ 
55 132 
R 5’ – CTC GAG CCA TCC CAT TCT T – 3’ 
mCers5 
F 5’ – TCC ATG CCA TCT GGT CCT A – 3’ 
55 147 
R 5’ – TGC TGC CAG AGA GGT TGT T – 3’ 
mCers6 
F 5’ – GGG TTG AAC TGC TTC TGG TC – 3’ 
55 138 
R 5’ – TTT CTT CCC TGG AGG CTC T – 3’ 
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To study the mRNA expression levels of the ceramide synthase family in the skin of 
CerS3-/-, the primers detailed above were used, with the exception of CerS3, where 
primers within exon 7 and 8 were used. 
 
Gene Primer sequence 
Ta 
(ºC) 
Product 
size (bp) 
mCers3∆7 
F 5’ – GGT CAC TGG TGT TTA GCC TGA – 3’ 
55 128 
R 5’ – GGT CCC ACT GCG AAT GTA AT – 3’ 
 
For the evaluation of expression levels of enzymes involved in fatty acid elongation 
and desaturation, the primers summarized as follows were used. 
 
Gene Primer sequence 
Ta 
(ºC) 
Product 
size (bp) 
mElovl1 
F 5’ – GGT GGG GGA TAA AAA TTG CT – 3’ 
56 106 
R 5’ – CCA AGG GCA GAC AAT CCA TA – 3’ 
mElovl2 
F 5’ – GAC GCT GGT CAT CCT GTT CT – 3’ 
56 105 
R 5’ – GCT TTG GGG AAA CCA TTC TT – 3’ 
mElovl3 
F 5’ – TTT GCC ATC TAC ACG GAT GA – 3’ 
56 84 
R 5’ – CGT GTC TCC CAG TTC AAC AA – 3’ 
mElovl4 
F 5’ – GGG ATC ATA CAA CGC AGG AT – 3’ 
56 118 
R 5’ – CTC AAC GCC TTT CGA TAC AA – 3’ 
mElovl5 
F 5’ – CTC TCG GGT GGC TGT TCT T – 3’ 
56 98 
R 5’ – AGA GGC CCC TTT CTT GTT GT – 3’ 
mElovl6 1 
F 5’ – ACA ATG GAC CTG TCA GCA AA – 3’ 
60 119 
R 5’ – GTA CCA GTG CAG GAA GAT CAG T – 3’ 
mElovl7 
F 5’ – ATC GAG GAC TGT GCG TTT TT – 3’ 
60 81 
R 5’ – GGC GAG GAC ATG AGG AGA TA – 3’ 
 
1 Primer sequence reported by (Wang et al., 2006). 
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The endogeneous Cers transcript levels of HeLamCAT1-rtTA2-M2 cells were examined 
with the following primers: 
 
Gene Primer sequence 
Ta 
(ºC) 
Product 
size (bp) 
hCers1 
F 5’ – TGC CTG ACA TCC CCT TCT AC – 3’ 
60 90 
R 5’ – ACG CCA CGA TGT ACA GGA AC – 3’ 
hCers2 
F 5’ – ACG CAG TGA CCG GGA AGA AAC AGA – 3’ 
64 150 
R 5’ – TGG GAG GCA GCT GGA GTA ATG GTT – 3’ 
hCers3 
F 5’ – TCT TGC AGG TCC TTC ACC TT – 3’ 
65 102 
R 5’ – CCT CGT CAT CAC TCC TCA CA – 3’ 
hCers4 
F 5’ – TTC AAC GGG CTT CTG ATG TT – 3’ 
60 97 
R 5’ – CCA TCT GGC CCT TCT TCA T – 3’ 
hCers5 
F 5’ – CCT AAT TGC ACG GAT TGC TT – 3’ 
63 109 
R 5’ – TGT GCA GGT GGT CAC ATC TT – 3’  
hCers6 
F 5’ – TCA GCT GAT GCT CTT CTG GA – 3’ 
63 91 
R 5’ – CCA CGG CAA ACA TAA CAA AC – 3’ 
 
Primers used for the expression analysis of antimicrobial peptides: 
 
Gene Primer sequence 
T 
(ºC) 
Product 
size (bp) 
mBD1 / 
Defb1 
F 5’ – GGT GTT GGC ATT CTC ACA AGT C – 3’ 
60 99 
R 5’ – GGT ATT AGA TGG GCA GCT GGA G – 3’ 
mBD2 / 
Defb2  
F 5’ – TGC TGC CTC CTT TTC TCA TAT ACC A – 3’ 
60 78 
R 5’ – GTG GTC AAG TTC TGC TTC GTA TC – 3’ 
mBD3 / 
Defb3 
F 5’ – ATG CTG GAA TCG GTG CAT TGG CA – 3’ 
64 138 
R 5’ – CTT CAT GGA GGA GCA AAT TCT GGT GT – 3’ 
mBD4 1 / 
Defb4 
F 5’ – CAC ATT TCT CCT GGT GCT GCT – 3’ 
64 52 
R 5’ – GAT AAT TTG GGT AAA GGC TGC AA – 3’ 
mCamp 
F 5’ – CTT CAA CCA GCA GTC CCT AGA CA – 3’ 
60 53 
R 5’ – GAT CCA GGT CCA GGA GAC GGT A – 3’ 
 
1 BD4 primer sequence reported by (Dorschner et al., 2003). 
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For all experiments Gapdh was used to normalize the relative values of the target 
genes under the following conditions:  
 
Gene Primer sequence 
T 
(ºC)b 
Product 
size (bp) 
mGapdh 
F 5’ – ACT CCC ACT CTT CCA CCT TC – 3’ 
55 156 
R 5’ – GGT CCA GGG TTT CTT ACT CC – 3’ 
hGapdh 
F 5’ – CAA CTA CAT GGT TTA CAT GTT C – 3’ 
60 181 
R 5’ – GCC AGT GGA CTC CAC GAC – 3’ 
 
2.1.12.4. Primers used for mouse genotyping 
 
Gene Primer sequence 
Ta 
(ºC) 
Product 
size (bp) 
CerS3 – wt 1 
F 5’ – ACA TAT CTC CCT TTG CCC TGA TG – 3’ 
58 315 
R 5’ – ATA ATT GCA AGA GAC GGC AAT GA – 3’ 
CerS3 – ko 1 
F 5’ – ACA TAT CTC CCT TTG CCC TGA TG – 3’ 
58 272 
R 5’ – GAC AGC CCT GAA ATG TAT CAT GC – 3’ 
CerS3 – cDNA 2 
F 5’ – TCT GGG AGG TTT GGA ATG AC – 3’ 
55 687 3, 594 4 
R 5’ – CGC CAC ATT GTG CTT CAA – 3’ 
 
1 Primers used for routine genotyping of CerS3-/- mice.  
2 Primers used for the analysis of CerS3 mutant transcript from skin cDNA.               
3 Product size for wild type CerS3 transcript. 
4 Product size for mutant CerS3 transcript lacking exon 7. 
 
2.1.13. Antibodies 
 
Primary Antibodies – I 
Antibody 
Host/ligand 
- Clonality1  
Application2 Dilution 
Supplier 
(Clone) 
Order num. 
β-Actin rabbit – p WB 1:1000 Santa Cruz sc-1616-R 
F-Actin 
TRITC-
Phalloidin 
Cryo SM 1:600 Sigma P1951 
Filaggrin rabbit – p 
WB 1:1000 
Covance PRB-417P 
Unfix. cryo 1:10 
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Primary Antibodies – II 
Cathepsin D rabbit – p 
WB 1:500 
DakoCytomation A0561 Cryo SM 1:100  
Paraffin 1:100-200 
CerS3 rabbit – p 
Cryo SM 1:500 PickCell 
Laboratories 
Custom-
made3 Paraffin 1:1000 
Cholesterol Filipin 
Cryo SM 10 µg/ml 
Sigma F9765 
Unfix. cryo 10 µg/ml 
Cingulin 
Guinea  
pig  – p  
Unfix. cryo 1:2000 
Provided by 
L.Langbein 
- 
Claudin-1 rabbit – p 
WB 1:100 
Thermo 
Scientific 
RB-9209 
Cryo SM 1:20 
Unfix. cryo 1:10 
Paraffin 1:20 
Dansyl4 rabbit – p Unfix. cryo 1:100 Invitrogen A6398 
Desmoglein 
1/2 
mouse – m 
WB 1:100 
Progen 
(DG3.10) 
61002 Cryo SM 1:5 
Paraffin 1:10 
Desmoplakin 
1/2 
mouse – m 
WB 1:50 
Progen (DP447) 651155 Cryo SM 
Undil. 
Paraffin 
GFP rabbit – p WB 1:1000 Genetex GTX26556 
Golgin-97 mouse – m  ICC 1:200 
Molecular 
Probes 
A-21270 
Involucrin rabbit – p 
WB 1:100 
Thermo 
Scientific 
RB-10288 
Cryo SM 1:150 
Covance PRB-140C 
Paraffin 1:100 
Kalilkrein 5 rabbit – p WB 1:100 Abgent AP6324b 
Ki67 rat – m   Paraffin 1:200 Dako (TEC-3) M7249 
Lamp1 rabbit – p ICC 1:200 Acris SP5446P 
Loricrin rabbit – p 
WB 1:1000 
Covance PRB-145P Cryo SM 1:150 
Paraffin 1:100 
Lipids nile red Unfix. cryo 5 µg/ml MP Biomedicals 151744 
Ox-Phos 
Complex IV 
Subunit I 
mouse – m  ICC 1:400 
Molecular 
Probes 
A6403 
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Primary Antibodies – III 
PDI mouse – m  ICC 1:400 Acris SM5075 
Plakoglobin mouse – m WB 1:200 Progen (PG 5.1) 65105 
Transgluta-
minase 1 
rabbit – p WB 1:4000 Abcam ab86589 
 
1 m: monoclonal, p: polyclonal                                                                                                   
2 Cryo SM: cryo-semithin sections; ICC: immunocytochemistry; Unfix. cryo: unfixed cryo-
sections; WB: Western Blot. 
3: Custom-made against a peptide located at the C-terminus of the mouse CerS3. 
4: Against monodansylcadaverine for in situ transglutaminase 1 assay. 
 
 
Secondary Antibodies 
Antibody Host/ligand  Application1 Dilution Supplier Order num. 
Alexa 
Fluor 546 
anti-rabbit 
goat ICC 1:400 Molecular Pobes A11035 
Alexa Fluor 
488 anti-
guinea pig 
goat IHC 1:200 Molecular Pobes A11073 
Biotinylated 
anti-rat 
Rabbit Paraffin 1:200 
Vector 
Laboratories 
BA-4001 
Cy3- anti-
mouse 
donkey ICC / IHC 
1:200 / 
1:1000 
Jackson 
Dianova 
715-165-150 
Cy3- anti-
rabbit 
donkey IHC 1:1000 
Jackson 
Dianova 
711-165-152 
Mouse-HRP goat WB 1:1000 Santa Cruz sc-2005 
Rabbit-HRP goat WB 1:1000 Santa Cruz sc-2004 
 
1 ICC: immunocytochemistry; IHC: immunohistochemistry; WB: Western Blot 
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2.2. Methods 
 
2.2.1. Cloning and molecular biology 
2.2.1.1. Directional cloning 
For the generation of mammalian expression plasmids, cDNA from mouse or 
human biopsies (e.g. testis for CerS3 or kidney for CerS2) provided the DNA 
template used for the amplification of the gene of interest by means of PCR. Primers 
used for enhancing the target gene coincided with the beginning of the 5’ prime 
cDNA sequence (including the starting codon) as the forward primer, and the 3’ 
prime cDNA sequence (without terminal codon) as the reverse primer. Directional 
cloning of the amplified fragment DNA containing the gene of interest was achieved 
by inserting overhangs via a second PCR amplification that will be able to create 
cohesive ends upon restriction endonuclease digestion (Figure 14).  
 
 
 
 
Figure 14. Strategy design for cloning in frame.  
Forward primer included an additional overhang sequence, an adequate restriction 
site for the insertion into the target vector, the Kozak sequence, and the beginning of 
the 5’ prime cDNA sequence of the gene of interest. Contrarily, reverse primer lacked 
the Kozak consensus, and instead two additional nucleotides were inserted. These 
nucleotides were required for having the protein product in frame with its C-terminal 
tag. CerS3 overhang primers serve as an example for cloning in frame into an EGFP 
encoding vector. 
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Oligonucleotide linkers used for the generation of overhang termini primarily 
contained the specific recognition sites for endonucleases with some additional 
overhang nucleotides required for many restriction enzymes to efficiently cleave 
DNA. The Kozak consensus sequence was additionally inserted prior to the starting 
codon to favour translation of the engineered protein. For generating fusion proteins 
with tagged vectors (e.g. EGFP and HA), care was taken that the C-terminus of the 
protein of interest was in frame with the following tagged encoding sequence. 
Once the PCR product containing the restriction sites was generated and purified, 
enzymatic digestion with endonucleases was performed in parallel with vector DNA, 
thus generating unpaired nucleotide termini of both insert and vector DNA. The 
cohesive end termini of insert and vector DNA could then be ligated, and 
subsequently transformed into competent bacteria for DNA amplification. 
Afterwards, plasmid DNA was isolated and analyzed by agarose electrophoresis 
and nucleotide sequencing. One single clone carrying the gene of interest was then 
retransformed in bacteria, which was grown in a large volume of culture medium to 
obtain stocks of plasmid DNA. The complete cloning strategy is detailed in Figure 15.  
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Figure 15. Directional cloning of a DNA fragment into vector DNA. 
Generation of mCerS3-EGFP serves as an example for directional cloning. Mouse 
CerS3 flanked with EcoRI and BamHI sites was inserted into pEGFP-N1 vector, and 
transformed into competent bacteria. 
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Following this procedure, mCerS3-EGFP and hCerS2-EGFP were generated by 
inserting the corresponding cDNAs into the N-terminus of the pEGFP-N1 vector. For 
CerS3, EcoRI and BamHI sites were introduced to the amplified 1.2 kbp DNA 
template using overhang primers with these unique restriction sites. Similarly, full-
length CerS2 cDNA was cloned into pEGFP-N1 by HindIII/EcoRI sites. Additionally, 
hElovl2 encoding plasmid was subcloned into pEGFP-N1 via the EcoRI and BamHI 
sites. 
For retroviral transduction, mCerS3-EGFP and hCerS3 plasmids were further 
subcloned into pRevTRE2-EGFP. Both genes were inserted using primers flanked 
with BamHI and AgeI sites.  
The sequences of all constructs were verified by nucleotide sequencing. DNA 
sequencing was performed by the sequencing laboratory of the DKFZ.  
 
Figure 16. Plasmid map from generated mCerS3-EGFP. 
CerS3 was inserted at the N-terminus of an enhanced GFP tag plasmid via the 
EcoRI-BamHI restriction sites.  
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2.2.1.2. Polymerase chain reaction (PCR) 
PCR were performed to amplify specific DNA fragments containing the gene of 
interest from cDNA templates, as well as to introduce overhangs containing specific 
restriction sites that will generate “sticky ends” via endonuclease digestion, as 
described above. 
For cloning, four PCR reactions performed in a final volume of 50 µl were 
combined in order to obtain larger amounts of DNA. All PCR products were 
generated using proofreading Pfu DNA polymerase (Promega). The general protocol 
used for preparative PCR was the following: 
 
PCR reaction (50 µl):           PCR program     T (ºC)        time 
Buffer with 20 mM Mg2+(10x)  5 µl      1. Denaturation      95    2 min 
MgCl2 (25 mM)      0–3 µl     2. Denaturation      95      15–30 s 
dNTP mix (10 mM each)   1 µl      3. Annealing        T1,T2    30 s 
Forward primer (15 µM)   1 µl      4. Elongation       72   2min/1kbp 
Reverse primer (15 µM)   1 µl      (Steps 2 to 4 are repeated for 10  
cDNA template     10 pg–1 µg     cycles with T1 and 15 cycles with T2) 
Pfu DNA polymerase (3u/µl)  0.25 µl     5. Final elongation     72    5 min 
H2O         up to 50 µl     6. Cooling        4      ∞ 
 
The annealing temperature (Ta) was determined by the primer pair of each 
reaction, according to the length and the guanine/cytosine content of the 
oligonucleotides. For preparative PCR using overhang primers, two different 
annealing temperatures were used. The Ta used for the first 10 cycles (T1) allowed 
the binding of the nucleotides complementary to the template cDNA. T2 was used for 
an additional 15 cycles and corresponded to the annealing temperature of the full-
length primers including the overhang nucleotides. For analytical PCR using primers 
complementary to the DNA template, 35 cycles were run with an adequate Ta. 
The primer sequence and annealing temperatures used to generate DNA 
fragments by analytical and preparative PCRs are detailed in section 2.1.12.1. and 
2.1.12.2, respectively. 
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2.2.1.3. Purification of PCR products 
DNA fragments generated by PCR were purified using the QIAquick PCR purification 
kit following the manufacturer’s recommendations. This purification method is based 
on the adsorption of DNA to a silica membrane, which takes place in the presence of 
high salt concentrations, achieved by mixing the DNA with a binding buffer. 
Oligonucleotides (up to 40 bp), enzymes and other impurities do not bind to the 
membrane allowing the decontamination of the DNA. An additional washing step with 
an ethanol-based buffer is able to remove the additional salts. For all applications, 
DNA was eluted from the silica-based columns with 50 µl of provided EB buffer.  
 
2.2.1.4. Electrophoretic separation of DNA fragments by agarose gels 
DNA fragments were separated in agarose gels by electrophoresis using TAE buffer 
(1x). For small fragments (50 to 500 bp) agarose gels of 2% were used, while for the 
separation of larger fragments (0.5 to 10 kbp) lower percentage gels were preferred 
(0.8–1.5%). Gels were prepared by dissolving the agarose in TAE buffer with the help 
of a microwave oven. To visualize DNA fragments, ethidium bromide (final 
concentration 1 µg/ml) was added to the cooled solution, before being poured into 
the gel chamber. Xylene cyanol loading buffer (10x) with glycerol was added to the 
DNA samples before being electrophoresed at 80–120 V. In order to estimate the 
size of the DNA fragments, DNA ladder of either 100 bp or 1000 bp were loaded in 
parallel with DNA samples. Bands corresponding to the DNA fragments were 
visualized and documented with GelDocTM 2000 Gel Documentation System. 
 
2.2.1.5 Digestion of DNA by restriction endonucleases  
Plasmid DNA and fragment DNA containing the gene of interest (insert) were 
digested in parallel with sequence specific endonucleases in order to create “sticky 
ends”. The enzymatic reaction was performed overnight at 37 ºC (optimal 
temperature for all enzymes used) to assure the complete cleavage of the DNA. A 
control digestion with plasmid DNA lacking restriction enzyme was performed in 
order to distinguish between linearized and circular plasmid DNA, and to confirm the 
complete linearization of the digested plasmid in further analysis with agarose gels.  
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The restriction digest was performed as follows: 
 
Restriction digest (70 µl): 
Assay buffer (10x)       7 µl 
Plasmid DNA / Insert DNA    ~ 3–5 µg / whole purified PCR product   
Restriction enzyme (5–10 U/µl)   5 µl 
H2O            up to 70 µl 
 
The cloning strategy was designed to insert the DNA encoding for the gene of 
interest into the plasmid with two different restriction sites, in order to have the 
insertion of the fragment in the correct direction. Therefore, two restriction enzymatic 
reactions were necessary. After the first digest, an aliquot was analyzed by agarose 
electrophoresis to assure the complete linearization of the plasmid DNA, and 
subsequently the DNA was purified with QIAquick PCR purification kit. Following, the 
second restriction digest was performed, and the plasmid and insert DNA containing 
the “sticky ends” were purified by extracting the bands from agarose gels (described 
below). Thus, traces of circular plasmid DNA that could still be present were removed 
due to the different mobility with the linear conformation during gel electrophoresis. 
The restriction endonucleases used for the generation of each expression plasmid 
are summarized in section 2.1.5.  
 
2.2.1.6. Extraction of DNA fragments from agarose gels 
For purification of DNA fragments carrying “sticky ends”, extraction of the DNA from 
agarose gels with crystal violet dye were preferred. Crystal violet  (final concentration 
1.5 µg/ml) in TAE buffer (1x) was used instead of ethidium bromide, thus DNA bands 
could be visualized without being exposed to ultraviolet light, which might produce 
DNA damage or release of the single stranded nucleotides of the “sticky ends”. After 
electrophoresis, DNA fragments were excised from the gels, and extraction was 
performed using QIAquick gel extraction kit according to the instructions of the 
manufacturer. This purification method shares the same principle as the QIAquick 
PCR purification kit (see section 2.2.1.3.). DNA was eluted with 50 µl EB buffer. 
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2.2.1.7. Ligation of DNA fragments 
Plasmid and insert DNA with complementary “sticky ends” were enzymatically ligated 
with T4 DNA ligase, which binds the 5’-phosphate end of one nucleotide (or DNA 
fragment) with the 3’-hydroxyl end of the other nucleotide (or the other DNA 
fragment) by a phosphodiester linkage. All ligation reactions were performed 
overnight at 16 ºC with a final volume of 20 µl and using 5 units of ligase. In general, 
the following protocol was used: 
 
Ligation reaction (20 µl): 
Ligation buffer (5x)       4 µl 
Plasmid DNA          3–30 fmol 
Insert DNA          9–90 fmol    
T4 DNA ligase (5 U/µl)      1 µl 
H2O            up to 20 µl 
 
For a successful ligation, a molar ratio of 3:1 insert to plasmid was used. Two 
control ligations were performed in parallel, one lacking DNA ligase and a second 
lacking insert DNA. The amount of bacterial colonies after transformation with these 
negative controls indicated the success of the cloning procedure. 
 
2.2.1.8. Bacteria culture and storage 
E. coli-DH5α competent bacteria (either subcloning or library efficiency) were used 
for cloning procedures. Transformed bacteria were grown in LB medium (Luria-
Bertani broth or Lysogeny broth) with constant shaking (225 rpm) or in LB plates, at 
37 ºC with the required antibiotics.  
Competent bacterial cells were frozen with a mixture of dry ice/ethanol and stored 
at – 80 ºC.  
 
2.2.1.9. Bacterial transformation with plasmid DNA 
For the transformation of E. coli with DNA from ligation reactions, library efficient 
DH5α competent cells were used. Cells were thawed on ice and a 100 µl aliquot of 
bacteria for each ligation was transferred into 14 ml snap-cap polypropylene tubes 
(Falcon 2059). Following manufacturer’s recommendations, ligated DNA was diluted 
1:5 with TE buffer, and 1 µl of the dilution was homogeneously dispensed in the 
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bacteria. Gentle tapping proceeded, and subsequently bacteria were incubated on 
ice for 30 min. Bacterial transformation was achieved by heat-shock for 45 s in a 
water bath kept at 42 ºC. After 2 min on ice, transformed bacteria were allowed to 
grow in 900 µl of SOC medium with a constant shaking of 225 rpm at 37 ºC for 1 h. 
Various dilutions (non, 1:10 and 1:100) of the bacterial culture were plated onto 
selective LB-agar plates and incubated overnight at 37 ºC.  
For subcloning of plasmid DNA, generally subcloning efficiency DH5α were used. 
However, the amplification of hElov4-tGFP plasmid DNA required the usage of low 
copy number CopyCutter™ EPI400™ E. coli due to DNA instability in DH5α cells. A 
slightly modified protocol was followed according to the instructions of the 
manufacturer. 
 
2.2.1.10. Extraction of plasmid DNA from bacteria – “Mini-preparation” 
To analyze which bacterial colonies grown in LB plates were successfully 
transformed with the plasmid encoding the gene of interest, DNA from ten colonies 
was extracted. Plasmid DNA was isolated using the QIAprep spin miniprep kit 
following the instructions of the manufacturer. Briefly, a single bacterial colony after 
overnight growth in selective LB-agar plates was inoculated in LB medium (4 ml) with 
the adequate antibiotic: ampicillin (100 µg/ml) or kanamycin (50 µg/ml). E. coli-DH5α 
cells were grown overnight at 37 ºC and 225 rpm in a rotary-shaker (SM-30 Control). 
Snap-cap polypropylene tubes (Falcon 2059) were used for the bacterial culture, 
allowing exchange of oxygen during the incubation time. Cells were harvested by 
centrifugation at 8000 rpm for 3 min using a table-top microcentrifuge. Subsequently, 
bacterial cells were resuspended and lysed using a modified alkaline lysis method. 
After neutralization with a high salt concentration buffer, plasmid DNA was cleared of 
genomic DNA, proteins, cell debris and others by centrifugation at 13,000 rpm. The 
lysate containing the plasmid DNA was then ready to bind to a silica-based 
membrane. Several washing steps proceeded to remove salts and other 
contaminants. Finally, purified plasmid DNA was eluted from the silica membrane 
column with 50 µl of EB buffer. All steps required for the extraction were performed at 
room temperature. 
Materials and methods 
 
   
 61 
To evaluate which of the colonies carried the plasmid with the correct insertion of 
the DNA fragment, analytical restriction digestions (1h, 37 ºC) were performed and 
analyzed by agarose gel electrophoresis. Plasmid DNA with the correct size of 
cleaved fragments after analytical restriction digest was analyzed by nucleotide 
sequencing in order to assure that no mutation occurred during the cloning process.  
 
2.2.1.11. Extraction of plasmid DNA from bacteria – “Maxi-preparation” 
For purification of larger amounts of plasmid DNA, the Qiagen plasmid maxi kit was 
used. This DNA preparation was performed once the accuracy of the plasmid 
sequence was confirmed. Generally, 1 µl of plasmid DNA (from mini-preparation) 
was retransformed into E. coli-DH5α cells, as described in section 2.2.1.9. After 
transformation, the approximately 1 ml SOC medium containing the transformed 
bacteria was diluted 1:200 with selective LB medium, and incubated overnight at 
37 ºC under constant shaking. Bacterial cells were then harvested by centrifugation 
at 6000 × g using an Avanti J-25 centrifuge (Beckman). DNA extraction proceeded 
following the instructions provided. In general, cells were resuspended, lysed 
according to a modified alkaline lysis method, and finally neutralized. Proteins, 
genomic DNA and other impurities were cleared by centrifugation at 20,000 × g. 
Differing from mini-preparation, plasmid DNA in low salt conditions was allowed to 
bind to an anion-exchange resin column. Sequentially, DNA was washed and eluted 
from the columns using a high-salt concentration buffer. Isopropanol precipitation of 
the DNA allowed the removal of the salts and concentration of DNA into a pellet, 
which was further washed and finally dissolved in a suitable volume of water or EB 
buffer. 
 
2.2.1.12. Determination of nucleic acid concentration (DNA and RNA) 
Nucleic acid concentration was determined according to the amount of light absorbed 
when exposed to ultraviolet light at a wavelength of 260 nm. The absorbance (A) of 
analyzed samples was measured with Ultrospec 2000 photometer (Pharmacia 
Biotech). Concentration could be calculated according to the Lambert-Beer’s law, 
taking into account that the extinction coefficients for double-stranded DNA and 
single-stranded DNA/RNA are 0.020 and 0.027 (µg/ml)-1cm-1, respectively. Integrity 
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assessment of analyzed samples was determined by the ratio of absorbance at 
A260nm vs A280nm, the latter corresponding to the wavelength at which proteins absorb 
light. The optimal A260/280 ratio for pure DNA is approximately 1.8, while for pure RNA 
is  ~ 2. 
 
2.2.2. Cell culture and transfection 
2.2.2.1. Culture of eukaryotic cells 
HeLa cells were grown in RPMI-1640 medium (Sigma, R0883) supplemented with 
10% inactivated fetal calf serum, 2 mM L-glutamine, 10 mM HEPES, with or without 
50 U/ml pencillin and 50 µg/ml streptomycin. Instead, HEK-293T and K9 Leydig cells 
were cultured in DMEM growth culture media with supplements (see 2.1.10.2.). Cells 
were maintained in monolayer cultures in a humidified atmosphere of 5% CO2 at 
37 °C, and were subcultured twice a week with trypsin-EDTA (0.25% in PBS). 
 
2.2.2.2. Freezing and thawing of eukaryotic cells 
To create stocks, cells in growth phase were trypsinized and harvested at 1000 × g 
for 5 min. Cells were then resuspended in freezing media consisting of 90% FCS and 
10% DMSO, transferred into cryotubes (Nalgene) and kept for long time storage at   
– 80 ºC.  
For the repropagation of frozen cellular stocks, cryotubes were placed in a water 
bath at 37 ºC until cells were thawed. Cells in freezing media were directly diluted 
1:12 with prewarmed growth medium in a 75 cm2 tissue culture flask. After cellular 
attachment, medium was exchanged to remove residual DMSO. Cells were 
passaged at least once before being used for experiments. 
 
2.2.2.3. Transfection of eukaryotic cells 
Transient transfection of plasmid DNA into HeLa cells was achieved by means of 
lipofection. HeLa cells were seeded in 6-well plates either 24 or 48 h prior to 
transfection. Highly confluent cells (90–95%) were then transfected with the optimal 
amount of plasmid DNA (previously tested for each plasmid) using Lipofectamine 
2000 reagent (Invitrogen) according to manufacturer’s recommendations. Thus, 
plasmid DNA (4 µg) was complexed with transfection reagent with a ratio optimized 
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for each transfection in order to minimize cytotoxicity. DNA-cationic lipid complexes 
in serum-free RPMI medium were administered drop-wise to the cells, which were 
then incubated at 37 ºC for 4 h. Subsequently, medium was exchanged by growth 
medium with FCS. Analyses were performed genrally after 24 h of overexpression. 
Transfection efficiencies were determined by flow cytometric analysis according to 
the fluorescence signals generated from the overexpression of EGFP fusion proteins. 
For subcellular localization studies, HeLa cells (2.5×105) were transfected 24 h 
after seeding with mCerS3-EGFP and control pEGFP-N1 using Lipofectamine at a 
1:2.5 ratio (µg DNA/µl Lipofectamine). Double transfections with mCerS3-EGFP 
and either hEovl2-EGFP or hElovl4-tGFP were performed with 3:0.75 and 4:2 ratios, 
respectively. For ceramide synthase assays, HeLamCAT1-rtTA2-M2 cells (1×105) were 
seeded 48 h prior to transfection with hCerS2-EGFP and control EGFP with a ratio of 
1:2. 
 
2.2.2.4. Generation of stable cell lines 
Stable cell lines expressing CerS3-EGFP (mouse and human), as well as EGFP 
(control), were generated by retroviral transduction using genetically modified HeLa 
cells (HeLamCAT1-rtTA2-M2). The infection of these cells in order to achieve inducible 
transgene expression of CerS3 required the production of viral particles in a 
packaging cell line, HEK-293T. These virions were generated via the triple 
transfection with 1) a MoMLV (Moloney murine leukemia virus) derived retroviral 
vector encoding the gene of interest from the doxycycline/transactivator responsive 
element (pRevTRE2-EGFP), together with 2) gag-pol (pVPack-GP) and 3) envelope 
(pVPack-Eco), the latter vectors are both responsible for the formation of the viral 
proteins. While the former encodes the gag and pol genes required for the synthesis 
of proteins of the core capsid and for the reverse transcriptase and integrase, the 
latter encodes the ecotropic viral envelope protein (limited to infection of murine 
hosts), which facilitates infection of the target HeLamCAT1-rtTA2-M2 cells by direct 
interaction with cell-type specific receptors (mCAT1). On the other hand, the non-
replicating retroviral vector contains all the cis regulatory elements necessary for the 
transcription of CerS3, as well as an extended version of the viral packaging signal 
required for the viral CerS3 RNA transcript to be packaged into infectious virions. 
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Previous integration of mCAT1 (murine cationic aminoacid transporter 1) and the 
doxycycline-sensitive transactivator rtTA2-M2 (optimized reverse tetracycline-
controlled transactivator) allowed the generation of inducible HeLa cells expressing 
the gene of interest, as already described (Engling et al., 2002). Thus, viral particles 
produced by HEK-293T cells enabled the infection of the modified HeLa cells 
expressing the murine receptor protein (mCAT1) required for the infection of the 
murine leukemia virus, and consequently enabled the stable integration of CerS3.  
The expression of the gene of interest takes place under induction with 
doxycycline (dox), making use of the Tet-On inducible expression system. In this 
system, doxycycline is required for binding to the tetracycline-controlled 
transactivator (rtTA2-M2), expressed by the modified HeLa cells. This transcription 
factor binds to the tetracycline-responsive element (TRE), encoded in the MLV-
retroviral vector and thereby activates the transcription of the downstream gene of 
interest, CerS3-EGFP. 
CerS3-EGFP expressing cells were isolated by fluorescence-activated cell sorting 
(FACS) selecting for the EGFP-derived fluorescence. These populations were 
cultured for 7 days in the absence of doxycycline and then selected for negative 
fluorescence signals. Following an additional 7 days induction with doxycyline, single 
cell clones were sorted by EGFP-derived fluorescence. Three stable cell lines were 
generated following this procedure: mCerS3 regarding HeLamCAT1-rtTA2-M2-mCerS3-eGFP, 
hCerS3 for HeLamCAT1-rtTA2-M2-hCerS3-eGFP, and control for HeLamCAT1-rtTA2-M2-eGFP 
expressing cells. 
 These cell lines were produced using the pVPack vectors and the transfection 
MBS mammalian transfection kit (Stratagene), following the instructions of the 
manufacturer.  
 
2.2.2.4.1. Production of viral particles 
Viral particles were produced by cotransfection of the plasmids encoding viral 
proteins together with the plasmid encoding the gene of interest. HEK-293T cells 
were used as a packaging cell line for producing the virions after transfection via the 
calcium phosphate method. 
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Plasmid DNA was prepared for transfection by mixing 1.5 µg of each of the 
required plasmids: the MLV plasmid encoding the gene of interest (pRevTRE2-
mCerS3-EGFP, pRevTRE2-hCerS3-EGFP, or control pRevTRE2-EGFP), the 
pVPack-GP and pVPack-Eco. To this mixture, 1 ml ethanol (100%) and 100 µl 
NaOAc (3 M) were added, following 30 min incubation at – 80 ºC. Vector DNA was 
pelleted at 13,000 rpm in a cooled table-top centrifuge for 10 min, the supernatant 
was discarded and the DNA was washed once more with ethanol (70%). The DNA 
was collected at 13,000 rpm for 5 min, and the pellets were kept overnight at 4 ºC. 
HEK-293T cells (~ 40% confluent) were seeded in growth medium 24 h prior to 
transfection. Shortly before transfection, growth medium was exchanged by MBS 
(modified bovine serum) containing DMEM medium. DNA was prepared for 
Ca3(PO4)2 transfection by resuspending the air-dried pellet in 225 µl water 
supplemented with 25 µl solution I and 250 µl solution II of the MBS transfection kit. 
After 10 min incubation at room temperature, the DNA solution was added drop-wise 
to the cells and homogeneously distributed. Cells were incubated for 3 h at 37 ºC 
until transfection medium was exchanged by growth medium supplemented with 
25 µM chloroquine. The use of chloroquine leads to reduced degradation of the DNA 
and thereby increasing the efficiency of the gene transfer. After an additional 
incubation for 6 h, medium was exchanged by growth medium without chloroquine 
and cells were incubated overnight. This medium was once more exchanged after 
24 h by 2 ml of fresh growth medium and cells were then incubated at 37 ºC and 5% 
CO2 for additional 48 h.  
 
2.2.2.4.2. Retroviral transduction 
HeLamCAT1-rtTA2-M2 cells expressing the murine surface receptor and the reverse 
tetracycline transactivator were seeded in 6-well plates 24 h before transduction. 
Viral particles produced by HEK-293T cells and released into the medium for 48 h 
were collected with a syringe. About 50% of the supernatants (1 ml) were directly 
added to the target HeLa cells (~ 40% confluent) through a sterile 0.45 µm filter. 
Sequentially, DEAE-dextran solution (final concentration 10 µg/ml) was added and 
the cells were then transferred into an incubator at 37 ºC for 3 h. Subsequently, the 
medium was exchanged by growth medium and cells were incubated for 72 h. 
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Reagents and buffers required for retroviral transduction were provided by 
Prof. Dr. Walter Nickel of the Biochemie Zentrum der Universität Heidelberg (BZH) of 
University of Heidelberg. 
 
2.2.2.4.2. Selection of clones by fluorescence-activated cell sorting (FACS) 
HeLamCAT1-rtTA2-M2 cells transduced with CerS3 encoding retroviral particles were 
splitted and induced with 2 µg/ml doxycycline. Following 40 h incubation at 37 ºC, 
fluorescence positive cells were isolated using FACSVantage Diva cell sorter.  
For sorting, cells were detached from the culture plates using a mild dissociation 
buffer consisting of PBS with 0.5 mM EDTA. Cells were then harvested, washed with 
chilled PBS, and resuspended in FACS buffer (PBS with 0.5 mM EDTA and 1.5% 
FCS). Prior to cell sorting, cell suspensions were directly filtered with a cell strainer 
placed in the cap of sterile polystyrene tubes (BD Falcon 352235). 
Three cell lines expressing mCerS3-EGFP, hCerS3-EGFP and EGFP were 
obtained. These populations were cultured for an additional 7 days in the absence of 
doxycycline to turn off the transcription of the transgene. Sequentially, populations 
were selected for negative fluorescence signals. Following an additional 7 days 
induction with doxycycline, single cell clones were sorted by EGFP-derived 
fluorescence with FACSAria I cell sorter. Single clones were propagated and 
analyzed according to doxycycline response by flow cytometry. 
Sorted cells were directly placed in growth medium containing antibiotics (50 U/mL 
penicillin, 50 µg/mL streptomycin and 50 µg/ml gentamycin), and immediately 
transferred into culture plates.  
Sorting of the cells was performed by Dr. Steffen Schmitt and Klaus Hexel from 
the Flow Cytometry Core Facility of DKFZ. 
 
2.2.2.5. Analysis of transfection rates by flow cytometry 
Transient expression rates of transfected cells, as well as induced transgene 
expression of stable cell lines were analyzed by flow cytometry using FACSCalibur. 
Taking advantage of the expression of the gene of interest as a fusion protein with 
EGFP tags, transfection rates could be measured according to the fluorescence 
signal.  
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For analysis, cells were harvested and pelleted at 1000 × g in facs tubes (BD 
Falcon 352054). Supernatant was discarded and cell pellets were resuspended in 
chilled PBS. Cell suspensions were kept from light at 4 ºC until transfection rates 
were determined. Acquisition and analysis were performed using BD CellQuest Pro 
software.   
 
2.2.3. Western blot  
2.2.3.1. Preparation of total protein lysates 
2.2.3.1.1. Eukaryotic cell culture lysates 
Cells in culture were trypsinized and harvested at 106 × g for 5 min at 4 ºC. Cell 
pellets were then washed with chilled PBS and resuspended in hypotonic lysis buffer. 
After 30 min incubation on ice, cells were lysed by sonication (Sonorex Super RK 
102H) at 35 Hz for 5 intervals of 30 s. Total protein lysates were cleared of both 
nuclei and cell debris by centrifugation at ∼ 21,000 × g for 15 min. Supernatants were 
then transferred into a clean tube, and kept at – 80 ºC until further use.  
 
2.2.3.1.2. Tissue biopsy lysates 
Skin biopsies were incubated at 58 ºC for 6 min in PBS containing 10 mM EDTA in 
order to separate dermis from epidermis. Skin was then transferred into ice cold 
PBS-EDTA solution and epidermis was obtained by peeling off the dermis. Epidermis 
in digitonin lysis buffer was homogenized by sonication (Branson sonifier 250) using 
5 pulses every 30 s for 5 min. Lysates containing epidermal proteins were cleared by 
centrifugation at ∼ 21,000 × g for 15 min. 
 
2.2.3.2. Determination of protein concentration by BRADFORD assay 
Protein concentration in total lysates were determined according to the Bradford 
method (Bradford, 1976). This method is based on the shift of absorption of 
coomassie brilliant blue G-250 upon binding to proteins. 
Briefly, protein-dye solutions were prepared by mixing either 2.5 or 5 µl of lysate 
with Bradford reagent up to 1 ml. To determine the protein concentration, a dilution 
series of BSA standards ranging from 0 to 10 µg/µl dissolved in Bradford reagent 
was prepared in parallel. The absorbance of protein-dye mixtures was measured at 
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the absorption maximum (595 nm), and the protein content was calculated by 
interpolating the absorbance measured from the BSA standard curve.  
 
2.2.3.3. SDS-polyacrylamide gel electrophoresis (SDS-PAGE)         
 Proteins were separated according to their molecular weight in 7–10% SDS-
polyacrylamide gels. To cast the discontinuous gels, the solutions for the resolving 
and the stacking gel were prepared as indicated below. The resolving gel was then 
poured between glass plates separated by 1.5 mm and was allowed to polymerize for 
about 30 min. On top a stacking gel of 3.45% polyacrylamide was poured, and a 
comb was placed to create wells. Polymerization of the stacking gel was terminated 
at 4 ºC. The composition of the stacking and resolving gels used in this study was the 
following: 
 
 
 
 
 
 
 
1 Rotiferase gel 30, 37.5:1 (Carl Roth)  
2 Ammonium persulfate (APS) is a radical initiator that triggers the polymerization of the gels, 
therefore it is added shortly before the gels are poured.  
 
Protein samples were denatured prior to electrophoresis by the addition of 4x 
Lämmli buffer containing 8% SDS and sequentially incubated at 95 ºC for 5 min. 
Equal amounts of protein (50 µg) were electrophoresed at ~ 35 mA during the 
separation in the stacking gel and at ~ 45 mA in the resolving gel. 
 
 
 
Stacking gel 
 3.45% 
4x Stacking gel buffer 1.875 ml 
30% Acrylamide/ 
bisacrylamide1 
862.5 µl 
10% APS2 56.25 µl 
TEMED 15 µl 
H2O 4.76 ml 
Resolving gel 
 7% 10% 
8x Resolving gel buffer 1.875 ml 1.875 ml 
30% Acrylamide/ 
bisacrylamide  
3.5 ml 5.0 ml 
10% APS 150 µl 150 µl 
TEMED 9.9 µl 9.9 µl 
H2O 9.47 ml 8.0 ml 
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2.2.3.4. Immunoblotting                               
After electrophoresis, proteins were transferred onto nitrocellulose membranes. For 
transfer, 0.45 µm membranes were placed on gels and covered with 3 pieces of 
Whatmann paper and a sponge on each side. These stacks were assembled in a 
bath of chilled transfer buffer (1x) containing methanol. Electrotransfer of proteins to 
the membranes were carried out at ~ 170 mA for 4 h on ice. Subsequently, 
membranes were stained with Ponceau red to assess the quality of the transfer, the 
equality of the loading of the SDS-PAGE and to indicate the position of the lanes in 
case that cutting the membranes was required. Following the transfer, membranes 
were blocked generally with 5% skimmed milk in PBS-Tween. Blocking was 
performed at room temperature for 1 h. Afterwards, membranes were incubated with 
primary antibodies in 3% skimmed milk-PBS-Tween. Binding of primary antibodies 
was carried out under constant rotation overnight at 4 ºC. On the following day, 
unbound antibodies were washed from the membranes 3 times with PBS-Tween for 
10 min. Coupling of HRP-conjugated secondary antibodies was performed at r.t. for 
45–60 min. Then, membranes were washed 3 more times for 10 min each with PBS-
Tween. The working dilutions of primary and secondary antibodies used in this 
study are listed in the table of section 2.1.13. Finally, proteins were detected by 
enhanced chemiluminescence using an ECL-detection kit (Amersham GE 
Healthcare) following the instructions of the manufacturer.  
 
2.2.3.5. Purification of antibodies by affinity column chromatography 
Polyclonal CerS3 antibody against the mouse protein was generated by PickCell 
Laboratories. Thus, a synthethic peptide against our self-designed epitope 
(CGGKETEYLKNGLGTNRHLIANGQHGR) located at the C-terminus was used to 
immunize rabbits. Serum containing the polyclonal antibody was purified by affinity 
chromatography using the peptide coupled to N-hydroxysuccinimide (NHS)-activated 
sepharose. 
 For the coupling, 500 µl of sepharose beads preactivated with NHS were loaded 
into a polypropylene column (Thermo Scientific, 29922), where solvent was drained 
and beads were washed with 10 ml of 1 mM HCl. Subsequently, sepharose beads 
were preconditioned with 5 ml coupling buffer (0.2 M NaHCO3, 0.5 M NaCl, pH 8.3), 
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prior to be transferred with 1 ml of coupling buffer into an eppendorf tube. Beads 
were then pelleted and mixed with the peptide (3.7 mg) freshly dissolved in 500 µl 
coupling buffer. The coupling reaction was performed overnight at 4 ºC with constant 
rotation. After completion of the coupling, non-reacted groups were blocked with 
0.2 M glycine pH 8.0 for 2–3 h at 4 ºC. Afterwards, the sepharose beads were 
transferred back into the column and washed first with 3 ml of 0.1 M Tris-HCl buffer 
(pH 9.0), followed by washing with 3 ml of 0.1 M NaOAc with 0.5 M NaCl buffer 
(pH 4.0). These buffers were alternated to wash two more times the sepharose 
beads. The column containing the peptide-sepharose beads was stored at 4 ºC until 
further used in 2 ml PBS containing 0.05% NaN3 to prevent microbial contamination. 
 To affinity purify the serum containing polyclonal antibodies, serum was diluted 1:2 
with PBS and pelleted down to remove unsoluble particles. Subsequently, peptide-
sepharose beads were incubated with the serum in a 50 ml Falcon tube maintaining 
constant rotation overnight at 4 ºC. Afterwards, the beads were transferred into a 
polypropyene column where the solvent was eluted. Sepharose beads were washed 
with 20 mM natrium phosphate buffer (10 ml), and the purified antibody was eluted 
with a low pH glycine buffer in phosphate buffer (pH 2.7) directly into 175 µl of 1.5 M 
Tris-HCl (pH 8.8). Sequentially, the beads were washed with another 10 ml of 
phosphate buffer. The “washing-eluates” were collected, pooled and incubated 
overnight at 4 ºC with the peptide-sepharose beads. Afterwards, beads were 
transferred once more into the column, washed with phosphate buffer and eluted with 
glycine buffer. Both glycine eluates were collected, pooled and concentrated using an 
Amicon Ultra 15 centrifugal device (Millipore, UFC 9 030 08) at 4000 × g for 20 min.  
 In addition, CerS3 antibody was eluted from the column with a pH 2.0 glycine 
buffer directly into 700 µl of 1.5 M Tris-HCl pH 8.8. Following the washing of the 
column with 10 ml of phosphate buffer, the rest of the CerS3 antibody was eluted 
with 30% glycerol in 10x PBS into 700 µl of 1.5 M Tris-HCl pH 6.8. 
 Each of the three eluates were concentrated and washed twice with PBS. The 
purified antibody concentration was determined by absorbance at 320 nm. If the 
concentration was lower than 1 mg/ml, BSA was used to stabilize the solution. The 
eluate corresponding to the glycine buffer pH 2.7 exhibited the highest 
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concentrations. Aliquots were prepared from the purified CerS3 antibody solutions 
and stored at – 20 ºC and at 4 ºC. The latter aliquots contained 0.05% NaN3.  
 All solutions used during this procedure were used chilled at 0–4 ºC and were 
sterile filtered. 
 
2.2.4. Chemical synthesis of organic compounds 
2.2.4.1. Synthesis of ultra long chain acyl-CoAs (ULC-Acyl-CoAs) 
For the synthesis of montanoyl-CoA (28:0) and melissoyl-CoA (30:0), fatty acids 
(100 µmol) were dissolved in dry tetrahydrofuran (THF, 4 ml). Equimolar amounts of 
N-hydroxysuccinimide and dicyclohexylcarbodiimide were added at room 
temperature and the reaction was kept under nitrogen for 12 h. 
The activated fatty acids were coupled to the polysilylated form of coenzyme A, 
which was generated in situ as described (Lucet-Levannier et al., 1995). Thus, the 
trilithium salt of coenzyme A was passed through a Dowex-50 ion exchange column 
acidified with 1 M HCl and subsequently lyophilized. The resulting free CoA (26 µmol) 
was dissolved in dry acetonitrile (2 ml). Dimethylketene methyl trimethylsilyl acetal 
(650 µmol) was added and the resulting solution was stirred for 16 h under nitrogen. 
After removal of all volatiles using a nitrogen stream, the polysilylated coenzyme A 
was dissolved in 1 ml dry THF.  
To a stirred solution of activated fatty acid (39 µmol) in THF containing CsF 
(1.3 mmol) and dicyclohexano-18-crown-6 (0.13 mmol), the coenzyme A solution 
was added dropwise and the reaction mixture was stirred for 4 h at room 
temperature. The crude mixture was acidified with an equal volume of 10 mM 
KH2PO4 (pH 5.5), and the organic solvent was removed using a nitrogen stream. 
Afterwards, the aqueous phase was desalted using a reverse phase C18 column 
(see 2.2.6.4.) and the final product was eluted with methanol. For quantification, 
mass spectrometric analyses with acyl-CoAs of known concentrations were 
performed (see 2.2.6.8.).    
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2.2.4.2. Synthesis of internal standards for ESI-MS/MS 
2.2.4.2.1. Synthesis of ceramides(d17:1) standards 
Fatty acids were activated by converting them into their respective 
N-hydroxysuccinimide esters as described above (see 2.2.4.1.). The activated fatty 
acids (40 µmol) were then condensed with d17:1-sphingosine (10.5 mmol) in a final 
volume of 4 ml dry THF. The reaction was catalyzed by triethylamine (4 µl) for         
1–2 days at r.t. under an inert atmosphere.  
 
2.2.4.2.2. Purification of internal standards by flash-column chromatography 
The crude ceramide products were purified by silica gel flash-column 
chromatography using mixtures of hexane/isopropanol/water of increasing polarity as 
a solvent system.  
For preparative chromatography, a column of 20 mm in diameter with a fritted 
glass filter was used. A layer of sea sand was placed on top of the glass filter, 
following by 12 g of silica gel (LiChroprep Si 60, 40–43 µm, Merck) used as a 
stationary phase. The column was tightly packed by the application of vacuum, and a 
second layer of sea sand and glass wool were mounted on top of the stationary 
phase. Afterwards, the column was flushed with elution solvent using vacuum to 
force the solvent through the silica, and therefore solvate the column. Subsequently, 
the crude products dissolved in the minimum amount of elution buffer were loaded 
onto the column. Hexane/isopropanol/water (90/9.5/0.5 or 93/7/0.1) mixture was 
used as starting elution solvent system. Fractions of ~ 4–6 ml of eluate were 
sequentially collected into separate glass tubes until 100 ml for each of the 4 solvents 
mixtures with increasing polarity were used. The final elution mixture was 
hexane/isopropanol/water 83/15/1. 
In order to locate the fractions containing the purified products, an aliquot of every 
third fraction were loaded onto a thin layer chromatography (TLC) plate (see 
2.2.6.9.). Fractions containing the purified ceramides were pooled and dried under a 
nitrogen stream. To quantify the synthesized ceramides, a dilution series of the 
purified products were separated on a TLC plate and bands were analyzed by 
densitometry as described below. 
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2.2.5. Ceramide synthase enzymatic assay 
A non-radioactive enzymatic assay in living mammalian cells was established in 
order to evaluate the substrate specificity of CerS3 (and CerS2) towards acyl-CoAs. 
Therefore, HeLa cells stably transfected with mouse and human CerS3, EGFP-
control, as well as untreated cells (HeLamCAT1-rtTA2-M2) were seeded onto 6-well plates 
with a density of 1×105 cells/well with or without induction with 2 µg/ml doxycycline. 
These inducible cell lines were generated by retroviral transduction as described in 
section 2.2.2.4.  
Forty-eight hours after seeding, untreated cells were transfected with hCerS2-
EGFP and incubated for 4 h at 37 ºC (for transfection see 2.2.2.3.). The assay was 
started by exposing the cells to media containing a mixture of saturated acyl-CoAs, 
namely 16:0, 18:0, 24:0, 26:0 and 28:0 (10 µM each) and d17:1-sphingosine (6 µM).  
The latter was stored in an organic solvent mixture of CHCl3/CH3OH/H2O 
(10/10/1) at – 20 ºC, therefore the solvent had to be removed prior addition to the 
cells. To assure the complete solution of the relative lipophilic reagents in the 
aqueous medium, the dried solvents were dissolved in growth medium and 
sonication was applied for 5 min at r.t. (Sonorex Super RK 102H, Bandelin). 
The assay was finalized upon 20 h of reaction by harvesting the cells. Afterwards, 
lipids were extracted and quantified as described in section 2.2.6. 
 
2.2.6. Lipid analysis 
2.2.6.1. Sample preparation 
Cells grown in tissue culture plates were trypsinized and harvested at 106 × g for 
5 min at 4 ºC. Cell pellets were then washed with chilled PBS and dried with 
1-propanol under nitrogen flow. 
For the extraction of epidermal lipids, skin biopsies from the back of CerS3 
deficient mice and control littermates were rapidly dissected and snap-frozen in liquid 
nitrogen before being stored at – 80 ºC. Skins were thawed and epidermis were 
isolated by treating the biopsies with 500 µg/ml thermolysin buffer for 2 h at 37 °C 
(Germain et al., 1993). Afterwards, epidermis was separated from dermis, cut into 
small pieces, and lyophilized (Alpha 1-2, Christ). 
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2.2.6.2. Lipid extraction by modified BLIGH and DYER method  
Sphingolipids were extracted according to Doering et al. with slight modifications 
(Doering et al., 1999a; Jennemann et al., 2007). In general, lipids were isolated using 
mixtures of CHCl3/CH3OH/H2O. 
 In particular, dried pellets from cultured cells were extracted with 2 ml 
10/10/1 (v/v/v) solvent mixture at 37 ºC for 15 min with occasional sonication. After 
centrifugation at ~ 2000 × g for 10 min, supernatants were collected and pellets were 
then reextracted once more with 10/10/1 solvent mixture, and finally with a 
30/60/8 (v/v/v) solvent mixture.  
For the extraction of epidermal free lipids, ~ 3 mg of dried weight epidermis cut in 
small pieces was extracted once with CHCl3/CH3OH/H2O 30/60/8, then with 10/10/1 
and finally with CHCl3/CH3OH 2/1 (v/v/v) as described. Each extraction step was 
performed at 50 ºC for 15 min under sonication. 
Supernatants were combined and dried under a nitrogen flow at 37 ºC. In parallel, 
pellets were dried and kept at 4 ºC for further analysis.  
 
2.2.6.3. Removal of phospholipids by mild alkaline methanolysis 
Combined lipid extracts were subjected to methanolic mild alkaline hydrolysis (0.1 M 
KOH in CH3OH) for the removal of phospholipids. The saponification of cell culture 
extracts was performed at 37 ºC for 2 h, while epidermal extracts required 4 h at 
50 ºC for complete hydrolysis. Sequentially, saponified lipid extracts were neutralized 
with glacial AcOH and solvent was removed under a mild nitrogen flow.  
 
2.2.6.4. Desalinization by reverse-phase chromatography (RP-18) 
Saponified lipid extracts were desalted by reverse phase chromatography prior to 
being analyzed either by TLC or ESI-MS/MS. Thus, columns packed with C18 
material (Porasil silica 125Å 55–105 µm) were preconditioned consecutively with 
3 times CH3OH and 2 times with 0.1 M KCl. Salt-containing samples were dissolved 
in ddH2O to a final concentration of 0.1–0.2 M KCl by brief sonication before being 
loaded into the columns. Following the loading of the samples, vials were washed 
twice with 0.1 M KCl, sonicated and loaded as well into the columns. Lipids bound to 
the column were then washed 3 times with ddH2O. Finally, sphingolipids were eluted 
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with CH3OH and dried under a nitrogen flow. In case of desalinization of epidermal 
ceramides, an additional washing step with ddH2O was performed prior to elute the 
lipids with CH3OH into the original sample tubes, and subsequently dried under a 
nitrogen flow. 
 Desalting of saponified lipids from cultured cells was performed using freshly 
prepared Pasteur pipettes. For tissue extracts, 100 mg of packing material was 
loaded into 5 ml polypropylene reusable columns. To assure complete removal of 
previous lipid extracts, polypropylene columns were carefully washed with 2 x 4 ml 
CHCl3, 1 x 4 ml CHCl3/CH3OH 1:1, 1 x 4 ml CH3OH, 1 x 4 ml CH3OH /H2O 1:1, and 
finally equilibrated with 2 ml 0.1 M KCl.  
 
2.2.6.5. Extraction of protein-bound sphingolipids  
Protein-bound sphingolipids from epidermal biopsies were extracted from the pellets 
obtained after extraction of free lipids. Pellets were “washed” 3 times with 2 ml of 
100% CH3OH for 5 min and 2 times with 2 ml of 95% CH3OH at 60 °C for 2 h to 
remove residual free lipids. Treatment of the residual pellets with 1 ml of 1 M KOH in 
95% methanol at 60 °C for 2 h cleaved ester linkages and released protein-bound 
sphingolipids. Supernatants were neutralized with AcOH and desalted using RP-18 
columns as described above.  
 
2.2.6.6. Extraction of fatty acids 
Fatty acids rich in ULC-acyl moieties were isolated from GM2AP-/- mice testes by 
acid hydrolysis, as previously described (Valianpour et al., 2003). Following 
homogenization and lyophilization of the biopsies, fatty acids were hydrolyzed at 
90 ºC for 2 h with 10 ml of CH3CN/HClconc. 4/1 (v/v). Testicular fatty acids were then 
extracted with the double amount of n-hexane. The upper organic phase was 
separated and dried under a nitrogen flow. For cell culture experiments, isolated fatty 
acids corresponding to 2 mg of wet weight were dissolved first in ethanol (1 mg wet 
weight / 1 µl ethanol), following intensive vortexing and finally dissolved in 2 ml of 
culture media.  
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2.2.6.7. Protein determination according to LOWRY 
Pellets obtained after lipid extraction were used for determination of their protein 
content according to the method of Lowry (Lowry et al., 1951).  
This colorimetric assay is based on the redox-reaction of peptide bonds with 
CuSO4 under basic conditions and the subsequent reduction of Folin-Ciocalteu 
reagent by Cu+. First, proteins dissolved in alkaline conditions react with Cu2+ forming 
a tetradentate Cu2+ complex with the amino groups of peptide bonds. Subsequently, 
Cu2+ is reduced by certain peptide side chains. This reaction is stabilized by tartrate. 
Upon addition of the Folin-Ciocalteu reagent containing a mixture of 
phosphomolybdate and phosphotungstate (Mo6+/W6+), reduction to 
heteropolymolybdenum blue (Mo5+ and Mo6+) takes place, which is detectable at a 
maximum of 750 nm. 
Therefore, pellets were dissolved in 1 M NaOH at 50 ºC for 4 h with occasional 
sonication. To determine the protein concentration, a standard curve was prepared 
with BSA (0–20 µg) in 0.1 M NaOH. Sample aliquots and BSA standards were 
dissolved in 0.1 M NaOH to a final volume of 300 µl. Complex reagent (1.5 ml) 
containing Na2CO3, CuSO4, and tartrate was added to each sample. Copper 
complexes were allowed to form by incubating the samples 10 min at room 
temperature. Subsequently, 150 µl of Folin-Ciocalteu reagent were added, followed 
by a brief vortexing. Protein complexes were then incubated 45 min at r.t. in the dark, 
and protein content was measured by spectrophotometry at 750 nm. 
 
2.2.6.8. Quantification by electrospray ionization tandem mass spectrometry 
(ESI-MS/MS) 
Sphingolipid quantification was performed by tandem mass spectrometry using a 
triple quadrupole instrument (VG micromass model Quattro II, Waters) equipped with 
a nano electrospray source, as previously described (Jennemann et al., 2007; 
Sandhoff et al., 2005). Equivalent lipid samples regarding the protein content were 
dissolved in 5 mM NH4OAc in CH3OH. Prior to being analyzed, internal standards 
were added to the aliquots. 
Synthesized montanoyl- and melissoyl-CoA were also quantified by mass 
spectrometry. An equimolar mixture of 16:0, 18:0, 20:0, 24:0 and 26:0-CoA of known 
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concentration were used as internal standards to determine the concentration of the 
acyl-CoAs. 
Sphingolipids, as well as fatty acids and acyl-CoAs were detected with precursor 
ion scans and neutral loss modus, respectively. The acquisition parameters and the 
internal standards used for quantification are compiled in the following table: 
 
Lipid 
Scan 
modus 
m/z 
Specific  
scan for 
Collision  
energy (eV) 
Internal standards 
Acyl-CoA 
Neutral 
loss 
507 
Phosphato-
ADP 
37 
16:0-CoA,18:0-CoA 
20:0-CoA,24:0-CoA 
26:0-CoA 
Cer (d17:1) 
Precursor 
ion 
250 
Sphingoid 
base (d17:1) 
44 
Cer (d17:1,19:0) 
Cer (d17:1,25:0) 
Cer (d18:1) 
Precursor 
ion 
264 
Sphingoid 
base (d18:1) 
50 
Cer (d18:1,14:0) 
Cer (d18:1,19:0) 
Cer (d18:1,25:0) 
Cer (d18:1,31:0) 
GlcCer (d18:1) 
Precursor 
ion 
264 
Sphingoid 
base (d18:1) 
50 
GlcCer (d18:1,14:0) 
GlcCer (d18:1,19:0) 
GlcCer (d18:1,25:0) 
GlcCer (d18:1,31:0) 
α-Hydroxy-fatty 
acids 
Neutral 
loss 
46 Carbonyl 30 Not quantified 
SM 
Precursor 
ion 
184 
Phosphoryl-
choline 
35 
SM (d18:1,14:0) 
SM (d18:1,19:0) 
SM (d18:1,25:0) 
SM (d18:1,31:0) 
 
All ESI-MS/MS measurements were performed by Prof. Dr. Roger Sandhoff from 
DKFZ in Heidelberg.  
 
2.2.6.9. Thin layer chromatography (TLC) 
Ceramide internal standards were analyzed and quantified by thin layer 
chromatography. After purification of internal standards with column chromatography, 
20 µl of every third fraction of the eluate were spotted on double-sided HP-TLC silica 
plates (Silicagel 60 F254, Merck) using a Linomat IV (Camag). Separation was carried 
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out by running the TLC from both sides with CHCl3/CH3OH/glacial AcOH (188/11/1) 
in a horizontal chamber. Bands were then made visible by developing the TLC plate 
in 10% CuSO4 in 8% H3PO4 (10 min at 180 ºC). The fractions containing the purified 
ceramides were pooled and dried under a nitrogen stream. 
For quantification, a dilution series of the purified products were spotted on a 
HP-TLC together with standards of known concentration and separated with 
CHCl3/CH3OH/glacial AcOH (188/11/1). After development with CuSO4 reagent, 
quantification of the bands was performed by densitometric scanning using a TLC 
scanner (Shimadzu CS-9301).  
For epidermal extracts, lipids corresponding to 0.5 mg dry weight were spotted on 
a TLC plate and separated using a complex solvent system that included four 
different solvent mixtures. First, CHCl3/(CH3)2CO (1/1) was used to run the plate up 
to 4 cm of a 20 cm TLC plate, followed by CHCl3/CH3OH/glacial AcOH (60/35/8) run 
up to 7 cm, CHCl3/CH3OH/glacial AcOH (190/9/1) to 12 cm and finally 
n-hexane/methyl t-buthyl ether/glacial AcOH (90/10/1) up to the top. Lipids were then 
visualized using CuSO4 reagent. 
 
 Total mRNA expression analysis 
2.2.7.1. Isolation of total RNA from tissue and eukaryotic cells 
Total RNA was extracted with phenol, guanidinium thiocynate and chloroform 
according to Chomczynski and Sacchi, either with the ready-to-use Tryzol reagent 
or with a modified Chomczynski and Sacchi method (Chomczynski and Sacchi, 
1987).  
 
2.2.7.1.1. RNA isolation by modified CHOMCZYNSKI and SACCHI method 
Juvenile mice testes (PN 5–25) were homogenized on ice in 3 ml of freshly prepared 
guanidinium thiocyanate buffer. Total RNA was then extracted with 300 µl of NaOAc 
(2 M, pH 4), 3 ml of Roti-Aqua-Phenol (Carl Roth), and 600 µl of CHCl3/isoamyl 
alcohol 24/1 (Sigma), with thorough mixing by inversion after the addition of every 
reagent. The suspension was incubated 15 min on ice, following by a centrifugation 
step at 15,000 × g for 30 min at 4 ºC. The upper aqueous phase containing the RNA 
was then transferred into a fresh tube, separated from the DNA and proteins present 
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in the lower phenol phase. Subsequently, 3 ml of isopropanol (100%) were added 
and RNA was precipitated overnight at – 20 ºC. A second precipitation step was 
performed by collecting the RNA pellet at 15,000 × g for 20 min, following the 
addition of 2 ml guanidinium thiocyanate buffer and 2 ml isopropanol, and overnight 
precipitation at – 20 ºC. After collection of RNA at 15,000 × g for 20 min, a washing 
step with 600 µl of 70% ethanol (– 20 ºC) was performed. Finally RNA was collected 
once more with 20 min centrifugation at 18,000 × g, and the pellet was then 
solubilized in ddH2O. Isolated RNA was flash frozen in liquid nitrogen and kept at      
– 80 ºC.  
 
2.2.7.1.2. RNA isolation by Tryzol reagent 
Tryzol reagent (Invitrogen), a ready-to-use monophasic solution of phenol and 
guanidinium thiocyanate, was used to isolate total RNA from cultured cells as well as 
from tissue biopsies (e.g. testes, skin), according to manufacturer’s instructions.  
 Cultured cells grown in monolayer in a 6-well plate were directly lysed with 1 ml of 
Tryzol reagent. For the isolation of RNA from tissue, biopsies were homogenized in 
1 ml Tryzol per 50–100 mg of tissue. Skin biopsies were disrupted using a glass-
teflon grinder (Glass-Cool), while disruption of testes was performed using a power 
homogenizer (Ultra Turrax T25 basic).  Sequentially, homogenates were incubated 
for 5 min at r.t. to enable complete cell lysis. RNA was extracted with the addition of 
0.2 ml CHCl3 (per 1 ml of Tryzol), followed by a thorough mixing, and an incubation 
step of 3 min at r.t. Following, phase separation was performed at 12,000 × g for 
15 min, and the upper aqueous phase containing RNA was collected into a fresh 
tube. RNA precipitation was performed with 0.5 ml isopropanol, and RNA was 
pelleted at 12,000 × g for 10 min. To wash the RNA pellet, 1 ml ethanol (75%) was 
used, and RNA was finally collected at 7,500 × g for 5 min, and solubilized in DEPC 
or Braun water. All centrifugation steps were performed at 4 ºC. 
 
2.2.7.2. DNAse digestion 
Contaminating DNA was removed from RNA isolates using TURBO DNA-free Kit 
(Ambion). Thus, 10 µg of RNA dissolved in 15 µl of ddH2O were incubated for 30 min 
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at 37 ºC with 1 µl of DNase I and 1x DNase buffer. Following enzymatic treatment, 
2 µl of DNase inactivation reagent were added, and after 2 min incubation at r.t., 
contaminants were pelleted at 10,000 × g for 2 min. Finally, purified RNA was 
transferred into a fresh tube. 
 
2.2.7.3. RNA integrity assessment with RNA6000 nanochip 
RNA integrity was analyzed by electrophoresis using an Agilent RNA 6000 nanochip 
according to the description of the manufacturer. The nanochip was evaluated with 
2100 Bioanalyzer (Agilent Technologies) using the eukaryote total RNA assay. The 
RNA integrity number (RIN) was used to determine the quality of the isolated RNA. 
RIN is an algorithm calculated by the software according to the complete 
electrophoretic trace of the RNA sample. Maximum RNA quality is defined by RIN 
values equal to 10, and ratios between 28S/18S of rRNA equal to 2. 
 
2.2.7.4. Synthesis of double stranded cDNA 
Reverse transcription of RNA into single stranded (ss) cDNA was performed with 
Superscript II. Briefly, 3 µg of isolated RNA diluted in 14 µl of ddH2O were mixed 
with 1 µl of oligo-dT12-18 primer (0.5 µg/µl) and 1 µl of dNTP mixture (10 mM). The 
samples were heated to 65 ºC for 5 min prior the addition of 4 µl of first strand buffer 
(5x) and 2 µl of DTT (100 mM). After incubating the samples for 2 min at 42 ºC, 
1 µl of Superscript II (200 u/µl) was added, and reverse transcription was performed 
for 1 h at 42 ºC. 
Sequentially, double stranded (ds) cDNA was synthesized from freshly prepared 
single stranded cDNA. To the ss cDNA was added 30 µl of second strand buffer (5x), 
3 µl of dNTP mixture (10 mM), 4 µl DNA Polymerase I (10 u/µl), 1 µl of DNA ligase 
(10 u/µl), and 1 µl of RNAse H (2 u/µl) to a final volume of 153 µl with ddH2O. The 
reaction mixture was incubated for 2 h at 16 ºC. To assure blunt end of the ds cDNA 
termini, 2 µl of T4 DNA polymerase were added to the newly synthesized ds cDNA. 
Afterwards, samples were incubated for 10 more min at 16 ºC in order to allow the 
enzymatic reaction of the polymerase. Finally, ds cDNA was purified using the 
QIAquick PCR purification kit (see 2.2.1.3) and eluted from the silica-based 
membrane with 50 µl of ddH2O.  
Materials and methods 
 
   
 81 
All enzymes used for reverse transcription were purchased from Invitrogen. 
2.2.7.5. Quantitative real time PCR (qRT-PCR)  
Quantification of gene expression by real time PCR was performed using the 
LightCycler 2.0 system (Roche Diagnostics). For the amplification and detection of 
the gene of interest, the LightCycler FastStart DNA Master SYBR Green I was used 
in combination with specific primers for the target genes and 1:10 dilution of the 
synthesized cDNA. Generally, optimal amplification of target genes required divalent 
cations in a final concentration of 2.5 mM. The real time PCR reactions were set as 
follows: 
 
Real time PCR reaction (20 µl):       Program      T (ºC)     time 
H2O         12.8 µl     1. Denaturation     95   10 min 
MgCl2 (25 mM)     1.2 µl      2. Denaturation  95      15 s 
Primers (5 µM each)   2 µl      3. Annealing       Ta   5 s 
cDNA template (1:10)   2 µl      4. Elongation   72   10 s 
LightCycler SYBR Green  2 µl      (Steps 2 to 4 are repeated for 45 cycles) 
                 5. Denaturation  95   0 s 
                 6. Annealing   65   15 s    
                 7. Melting    95   0 s 
                 8. Cooling     40   30 s 
 
The PCR reaction mixtures were loaded in LightCycler glass capillaries, and the 
qRT-PCR was performed immediately. A negative control was loaded in each PCR to 
assure no contamination of the samples. Amplicons of the target gene were 
generated during the 45 denaturation-annealing-elongation cycles (programs 2–4). 
Following, melting curves of the amplified fragments were generated (programs 5–8) 
in order to evaluate the integrity of the products. Reactions were performed with 
biological triplicates and technical duplicates. 
Primers were designed exon-spanning and localized at the 3’-prime region using 
Primer3 (v 0.4.0). Generally, amplicon size was between 50 and 200 bp, and the GC 
content was set to 45–55%. To exclusively enhance the target homologue gene, 
blast analysis and multiple sequence alignment (ClustalW, v 1.83) were performed to 
evaluate the homology of the primer with the other homologue family members. The 
sequence and annealing temperatures of the primers used in this study are listed in 
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section 2.1.12.3. Amplicons were further analyzed by agarose electrophoresis to 
assure the amplification of the appropriate products. 
Quantification of the gene expression was calculated using the ∆∆CT method 
(Livak and Schmittgen, 2001), normalizing relative CT values to the expression of the 
housekeeping gene, Gapdh. 
 
2.2.8. Animal experiments 
2.2.8.1. Animal care 
Animals were kept under specific pathogen-free conditions in barrier facilities, where 
a 12 h light / 12 h dark cycle was maintained. Mice were housed in groups up to five 
animals at a controlled temperature of 22 ºC. They were fed regular laboratory chow 
diet and water, supplied ad libitum.  
 
2.2.8.2. Genotyping  
CerS3-/- mice were genotyped by PCR using genomic DNA isolated from tail 
biopsies. For routine extraction of genomic DNA, about 0.3 cm tails were digested 
overnight at 56 ºC with 100 µl of DirectPCR Lysis Reagent (PeqLab) supplemented 
with 2.5 µl of proteinase K (Sigma). Heat inactivation of the enzyme was performed 
at 85 ºC for 45 min prior to the PCR. Reactions were performed using 1 µl of DNA 
from tail digestion in a final volume of 50 µl, as described in section 2.2.1.2. 
Amplification of specific products corresponding to wild type and mutant allele were 
performed with primers listed in section 2.1.12.4., and using Taq DNA polymerase (5 
Prime). Agarose gel electrophoresis was performed to analyze the fragments 
obtained from PCR, as described in section 2.2.1.4. 
To corroborate the generation of a truncated CerS3 transcript lacking exon 7, 
isolated cDNA from skin of mutant and wild type animals (for methods see 2.2.7.1-4.) 
was used to specifically amplify a PCR product between exon 6 and the immediate 
3’UTR (primers listed in 2.1.12.4.).  
 
2.2.8.3. Skin permeability assay 
Permeability of skin was tested by hematoxylin diffusion essentially as described 
(Vasireddy et al., 2007). In brief, euthanized embryos and newborn animals were 
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fixed in CH3OH for 5 min, washed with PBS and incubated in hemalaun solution 
(Roth, T865.3, according to Mayer) for 40 min at room temperature. Excess 
hemalaun was removed by several thorough washes with PBS. After hematoxylin 
staining, images of the animals were taken using a digital camera. 
 
2.2.8.4. Determination of transepidermal water loss (TEWL) 
Transepidermal water loss was measured using a Tewameter TM300 (Courage-
Khazaka Electronics) as described (Herrmann et al., 2003).  
 
2.2.8.5. Epidermal pH 
Epidermal pH was determined by direct contact of humidified pH-indicator strips (pH 
5.2–7.2, Merck) to the skin of mice. 
 
2.2.9. Pathogenic infection experiments 
2.2.9.1. Culture of mouse skin 
Skin biopsies from the back of newborn animals were maintained viable on collagen 
gels partially submerged in DMEM medium (Lonza, BE12-604F) supplemented with 
50 U/ml penicillin and 50 µg/ml streptomycin (Gibco). Collagen gels were prepared 
as previously described (Stark et al., 2006). Thus, type I collagen was isolated from 
tail tendons of young rats and lyophilised. To a 4 mg/ml solution of collagen in 0.1% 
AcOH was added 10% of 10x Hank’s balanced salt solution (Gibco) titrated with 5 M 
NaOH and 10% of DMEM medium. The mixture was allowed to jellify in 
PET-membrane filter inserts (Falcon) for 1 h at 37 ºC, following the addition of 12 ml 
DMEM medium in each of the deep-wells (BD Biosciences, BD 355467).  
 
2.2.9.2. Pathogenic infection 
Candida albicans (ATCC 90028) was grown overnight in LB medium. Prior to 
infection, yeast concentration was determined by cell counting using a Neubauer 
chamber. Afterwards, cells were pelleted by centrifugation and resuspended in PBS 
to a concentration of 109 cells/ml. C. albicans (1 µl, 1×106 cells) was inoculated to the 
center of the skin biopsy and incubated at 30 ºC for the specified time.  
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2.2.9.3. Determination of pathogenic growth 
Infected skin biopsies were flushed with 10 ml PBS. An aliquot of these suspensions 
(100 µl) were plated in two different dilutions on Sabouroud agar plates (BioMérieux). 
Multiple serial dilutions had been previously performed to determine optimal 
conditions. After 24 h incubation at 37 °C, colonies were counted and concentrations 
were determined as CFU/ml. Technical triplicates from biopsies of four mice were 
analyzed.  
 Pathogenic infection and growth studies were performed by Rene Karayilan and 
Prof. Dr. Alexander Dalpke at the department of Medical Microbiology and Hygiene of 
University of Heidelberg. 
 
2.2.10. Microscopy 
2.2.10.1. Light and electron microscopy  
Specimens for ultrastructural analyses were prepared as previously described with 
slight modifications (Komljenovic et al., 2009). Embryonic and neonatal CerS3d/d and 
control mice were anesthetized and transcardially perfused for 15–30 min at r.t. The 
freshly prepared fixative solution contained 2.5–4% glutaraldehyde in 0.1 M sodium 
cacodylate buffer (pH 7.6) and saturated picric acid (300 µl per 100 ml fixative 
solution), in addition to 2% polyvinylpyrrolidone (PVP, Polyvidon 25, MW 25,000, 
Merck) and 0.05% CaCl2. Fixed skin from the interscapular region of the back was 
dissected and embedded in agar (extrapure, Merck) in order to preserve the 
periderm and the entire layers of the stratum corneum. Following, sections of 80 to 
150 µm thickness were prepared using a microslicer (DTK 1000).  
One series of samples were incubated in alkaline diaminobenzidine (DAB) for   
30–60 min for enhancement of membrane staining, and postfixed with 1% buffered 
OsO4 in sodium cacodylate buffer (pH 7.6) containing 1.5% potassium ferrocyanide 
for 20–30 min, followed by osmification without ferrocyanide for an additional         
40–60 min. 
A second series of specimens were treated, after one osmification step with 1% 
buffered OsO4 for 90 min, with 1% tannic acid (low molecular galloyl glucose, LMGG, 
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Mallinckrodt laboratories) in 0.1 M sodium cacodylate buffer (pH 7.0), as described 
(Simionescu and Simionescu, 1976).  
Fixed on superfrost, slides were immersed in freshly prepared HIO4 (5% aq. sol.) 
for oxidation at 60 ºC (2x 30 min), rinsed with ddH2O for 30 min and dried at 85 ºC. 
En-block staining with 1% uranyl actetate proceeded for 20–30 min prior to 
dehydration in graded ethanol and embedding in Epon 812. Subsequently, serial 
semithin Epon sections of 0.5–1 µm thickness were prepared (Leica Ultracut UCT).  
For light microscopical analysis, semithin sections were stained with periodic acid-
Schiff (PAS) (Schroeder et al., 1980) without counterstaining or followed by a 
modified Richardson solution containing methylene blue-Azur II. Briefly, Epon 
sections were immersed in a freshly prepared HIO4 solution (5% aq. sol.) at 60 ºC for 
2 × 30 min, rinsed in ddH2O for 30 min and dryed at 85 ºC. Sections were then 
incubated with Schiff solution for 90 min at 60 ºC, with an additional rinsing and 
drying step. Subsequently, samples were counterstained with 0.5% methylene 
blau/Azur II (1:1) in 0.5% aqueous borax solution for 3–5 min at r.t. Specimens were 
finally rinsed with ddH2O and dryed at 85 ºC. To visualize epidermal glycogen, 
specimens were exclusively stained with PAS without counter-staining. 
For ultrastructural analysis, series of ultrathin Epon sections were prepared and 
stained with lead citrate prior to be analyzed with an electron microscope (Zeiss EM 
906E).  
For pathogenic studies, infected skin biopsies from CerS3 deficient mice and 
controls were fixed together with collagen gels with 4% formalin for 24 h at r.t. and 
subsequently embedded in paraffin. Sections (Microm, HM 355S) of 1 µm thickness 
were prepared and deparaffinized by short sequential immersions in xylene, ethanol 
solutions (100%, 96%, 80% and 70%) and water. Sections were then immersed in 
0.75% HIO4 for 10 min, carefully rinsed with water and incubated in Schiff solution for 
5 min. Following rinsing and drying steps, biopsies were then counterstained with 
hemalaun solution (Roth, according to Mayer). Sections were dehydrated by 
subsequent immersions in ethanol solutions of increasing concentrations (70–100%), 
followed by immersion in xylene. Sections were then mounted with Vitro-Clud 
(Langenbrink) and analyzed using a Leica DMLB microscope. 
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Specimen preparation and ultrastructural analyses were performed in cooperation 
with Ingrid Kuhn-Krause and Prof. Dr. Karin Gorgas at the department of Anatomy 
and Cell Biology of University of Heidelberg. The PAS staining of infected skin 
biopsies was performed with the technical assistance of Gabriele Schmidt from DKFZ 
in Heidelberg. 
 
2.2.10.2. Immunohistochemistry of mouse newborn skin  
Neonatal mice were transcardially perfused with 3–4% paraformaldehyde (PFA) 
solution in 0.1 M PBS (pH 7) containing 2% PVP for 15–30 min at r.t. Skin samples 
were dissected, postfixed with fixative solution for additional 30–60 min at 4 ºC and 
rinsed with PBS containing 2% PVP. Sections were prepared as follows.  
 Ultracryosemithin sections. Microslicer sections of 600 µm thickness were cryo-
protected in sequential sucrose solutions (0.1 M PBS, pH 7.6 with 10% PVP) of 
increasing concentrations (10%, 20%, 30% and 2.3 M) prior to be frozen in precooled 
isopentane with liquid nitrogen. Subsequently, ultracryosemithin sections of          
0.6–0.8 µm thickness were prepared with a Leica Ultracut UCT equipped with a Leica 
EMFCS. F-actin, loricrin and involucrin were localized following this protocol. 
 Cryosections. After anesthesia, unfixed skin biopsies from the back of newborn 
animals were quickly placed onto an aluminium foil and frozen in pre-cooled 
isopentane with liquid nitrogen and embedded in tissue block. Cryosections of         
3–5 µm thickness were obtained with a Leica CM 3050S and subsequently fixed with 
acetone for 10 min at r.t. For the detection of claudin 1, sections were subjected to an 
antigen retrieval with 10 mM sodium citrate and 0.5% Tween-20 (pH 6.0) for 20 min 
at 96 ºC. Instead, cingulin and filaggrin were permeabilized with 1% Triton X-100 in 
PBS (v/v) for 5 min and then blocked for 30 min with 10% FCS. For nile red, filipin 
and transglutaminase detection of unfixed cryosections a modified protocol was used 
(vide infra).  
 Paraffin. Fixed specimens were dehydrated in a graded ethanol series and 
embedded in Paraplast Plus. Paraffin sections of 3–5 µm thickness were obtained 
with a Microm HM 340E, then deparaffinized and subjected to antigen retrieval as 
described (vide supra). Cathepsin D, desmoglein 1/2, desmoplakin, Ki67 (vide infra), 
loricrin, and CerS3 were detected with this protocol. 
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 In situ extraction of protein-bound sphingolipids on paraffin sections was 
performed to detect desmoglein, loricrin and involucrin antigens. Thus, sections were 
deparaffinized with xylene (2 x 30 min) and immersed in 100% ethanol (2 x              
10–15 min). Protein-bound epidermal sphingolipids were then extracted with mild 
alkaline methanolysis (0.1–1M KOH in 100% CH3OH) for 1–2 h at r.t., slightly 
modified as described in section 2.2.6.5. Afterwards, sections were washed in 
CH3OH (3 x 2 min) and finally immersed in 100% ethanol for 10 min. Subsequently, 
sections were dehydrated by immersion in sequential ethanol solutions of decreasing 
concentrations and water, prior to be subjected to an antigen retrieval. 
 
For detection of antigens, sections were incubated with primary antibodies for     
1–16h at 4 ºC or at r.t. Subsequently, sections were washed and incubated with 
secondary antibodies for 1 h at r.t. Following another washing step, nuclear staining 
was performed with DAPI (20 ng/ml, Sigma). Sections were then mounted in 
DakoCytomation fluorescent mounting medium.  
The in situ detection of transglutaminase activity in skin biopsies was performed as 
described with slight modifications (Yanagi et al., 2010). Shortly, unfixed cryosections 
of 3–5 µm thickness were air-dried for 30 min at r.t and washed with PBS (2 x 5 min) 
to remove the tissue block. Sections were blocked with 1% BSA in 100 mM Tris-HCl 
(pH 7.4) for 30 min, following 1 h incubation with 12 µM monodansylcadaverine 
(Sigma) in 100 mM Tris-HCl (pH 7.4) containing 5 mM CaCl2. For negative controls, 
EDTA was added into the substrate buffer to a final concentration of 20 mM. The 
enzymatic reaction was stopped by incubation of PBS containing 10 mM EDTA for 
5 min. Two additional washing steps were performed with PBS for 5 min, prior to 
incubation for 3 h with the primary antibody dissolved in 12% BSA-PBS. Sections 
were then washed with PBS (3 x 5 min) and incubated for 45 min with the secondary 
antibody in 12% BSA-PBS. Following nuclear staining, specimens were mounted in 
Fluoromount-G. All steps were performed at r.t.  
Lipids were detected with nile red and filipin using unfixed cryosections, as 
previously reported with slight modifications (Goritz et al., 2007; Greenspan et al., 
1985). For cholesterol staining using filipin, sections were left to air-dry and washed 
prior to be immersion-fixed in 4% phosphate-buffered formalin. Sections were then 
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washed with ddH2O and PBS, and subsequently incubated with freshly prepared 
filipin solution (10 µg/ml in PBS with 1% DMSO) for 2 h at r.t. Substrate was then 
washed with PBS and ddH2O, and finally mounted in Fluoromount-G. To visualize 
neutral and polar lipids using nile red, sections were air-dried and sequentially 
incubated with a freshly prepared solution containing 5 µg/ml of nile red in 75% 
glycerol. This solution was prepared from a 500 µg/ml stock solution of nile red 
dissolved in acetone. After 5 min incubation, sections were mounted and directly 
visualized. 
For immunofluorescence studies, sections were analyzed with the fluorescence 
microscope Biorevo BZ-9000 (Keyence). For negative controls, PBS was used 
instead of primary antibodies. 
Keratinocyte proliferation was assessed in paraffin sections with detection of Ki67 
antigen using a DakoAutostainer. Following permeabilisation, blocking and binding 
with primary antibody, sections were incubated with a biotinylated anti-rat antibody 
and detected with alkaline phosphatase-labelled streptavidin (1:200, Vector 
Laboratories, SA-5100).  
Terminal dUTP nick-end labeling (TUNEL) was performed on unfixed skin biopsies 
embedded in paraffin wax using the in situ cell death detection kit (Roche, 11 684 
817 910), following the recommendations provided by the manufacturer. Afterwards, 
biopsies were counter-stained with hematoxylin prior to being analyzed using a Leica 
DM-RBE microscope. 
Sample preparation and immunohistochemical stainings were performed with 
major help of Ingrid Kuhn-Krause, Claudia Schmidt and Prof. Dr. Karin Gorgas. 
 
2.2.10.3. Immunohistochemistry of cell cultures 
For subcellular localization of CerS3, HeLa cells were seeded and transfected on 
sterile 12 mm glass coverslips placed in 6-well plates. Following 24 h after 
transfection, cells were washed 3 times with chilled PBS. Cells were then fixed with 
3.5% PFA for 5 min on ice, following 10 min at r.t. Afterwards, cells were washed with 
chilled PBS (3x for 5 min), following permeabilization with CH3OH (– 20 ºC) for 6 min 
(Brock et al., 1999). Subsequently, cells were washed once more with PBS (3x for 
5 min), before blocking for 1 h with 3% BSA-PBS. Binding of primary antibodies was 
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performed for 1.5 h at r.t. After three washing steps, incubation of secondary 
antibodies for 45 min followed. Primary and secondary antibodies were diluted in 
1.5% BSA-PBS. Afterwards cells were washed once more and nuclear staining was 
performed with Draq5 (Biostatus) in PBS for 10 min. Finally, cells were washed 
with PBS (4x for 5 min) and mounted with Fluoromount-G. Immunofluorescence 
images were acquired with Leica TCS-SL microscope and analyzed with Leica 
Confocal software (version 2.61) by Tjeerd Sijmonsma from DKFZ in Heidelberg. 
 
2.2.11. Statistical analysis 
All data concerning animal experiments included a minimum of 3 mice per group. In 
vitro experiments were performed at least in 3 independent experiments. All 
statistical analyses were performed using Student t test, and differences among 
groups were considered significant for p < 0.5 (*), p < 0.1 (**) and p < 0.01 (***).
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3.1. Transcriptional analysis of the ceramide synthases in murine 
testis and skin 
 
Previous studies with fertile and infertile mouse models led to the finding of a novel 
class of fucosylated GSLs, whose expression of the neutral subset strictly correlates 
with fertility in mice. The acyl moieties of this main class of testicular GSLs are 
almost exclusively comprised of ultra long chain polyunsaturated fatty acids 
(ULC-PUFAs) (Sandhoff et al., 2005). To gain deeper insight into the function of 
these unusual GSLs, we aimed first to identify the ceramide synthase homologue/s 
responsible for the incorporation of these ULC-acyl residues into the ceramide 
backbone. 
 
3.1.1. Cers3 is exclusively expressed in tissues containing ULC-sphingolipids 
The mammalian ceramide synthase family is composed of six homologue genes 
(Cers1–6). Currently, five of these enzymes have been reported to incorporate 
specifically a subset of acyl-CoAs, which differ in the length of their hydrocarbon 
chain. The affinity for ULC-FAs has not been appointed to any of the investigated 
ceramide synthases. Yet neither the tissue, nor substrate specificity of CerS3 had 
been determined at the starting point of this study. However, it is CerS3 that was 
found in our department to be strongly expressed in mature mouse testis (Sandhoff 
et al., unpublished results). To confirm these preliminary results, and to investigate 
the Cers3 expression in other tissues, PCR analyses from mouse cDNA were 
performed (Figure 17). 
The highest Cers3 expression was found in testis, confirming previous results and 
succeeding studies (Laviad et al., 2008; Mizutani et al., 2006). To a lesser extent, 
Cers3 was additionally expressed in mouse skin. Interestingly, both testes and skin 
are the only mammalian tissues reported to contain major concentrations of ULC-
sphingolipids. Otherwise, Cers3 cDNA could not be amplified from either brain, liver 
or colon. 
 
Results 
 
    
 92 
 
 
Figure 17. Tissue distribution of Cers3 cDNA. 
Agarose gel electrophoresis of Cers3 DNA products obtained by PCR analyses from 
diverse mouse tissues. The expression of Gapdh was used as a loading control. 
 
 
The substrate specificity of the ceramide synthase homologues has been already 
characterized in several studies, including a recent study on the substrate preference 
of CerS3 (Mizutani et al., 2006). However the length of acyl-CoAs included in all 
previous studies ranged between 14 and 26 carbon atoms without including ULC-
acyl-CoAs. Nevertheless, the longer acyl-CoAs included in these studies, 24- and 26-
CoA, were best incorporated by CerS2 and CerS3. To elucidate whether CerS2 and 
CerS3 or any other CerS homologue plays the leading role in the synthesis of ULC-
sphingolipids, mRNA analyses of the ceramide synthase family in mice testis and 
skin were performed. 
In the testis, Cers3 was the ceramide synthase member with highest transcript 
levels (Figure 18A). The expression of Cers5 was the most abundant following Cers3 
with about 40% decrease in its transcript levels. Murine testicular mRNA additionally 
expressed Cers2 and Cers6, however their mRNA levels were about 7 and 10 fold 
downregulated in relation to Cers3, respectively. The mRNA expression of Cers1 and 
Cers4 could not be detected in mouse testis.   
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In murine neonatal skin, Cers2 and Cers3 mRNA transcripts were the most 
prominent, although the expression of Cers5 and Cers4 were fairly abundant (Figure 
18B). Here the relative gene expression levels of the ceramide synthases were 
determined in the combined endothelial and epithelial layers, and thus Cers levels 
reflect an average of their mRNA transcripts in the different cell types present in the 
skin.   
Sphingolipids with ULC-FA moieties are exclusively found in the epidermis, where 
they play an essential role in the formation and maintenance of the epidermal 
permeability barrier. Determining whether Cers3 or Cers2 is the major Cers mRNA 
expressed in the epidermis would still require further investigations. However, both 
enzymes could potentially be responsible for the transfer of ULC-acyl-CoAs to 
ceramides. 
Cers5 and Cers4 were additionally expressed in murine neonatal skin. Their 
relative expression levels were found over 2 and 3 fold times downreagulated, 
respectively, in relation to the mRNA concentration of Cers2. The transcript levels of 
Cers6 and Cers1 were barely detectable.   
 
 
 
Figure 18. Cers3 is highly expressed in murine testis and skin. 
Quantitative RT-PCR was performed to evaluate Cers transcript expression profile in 
mice testes (A) and skin (B). Isolated mRNA from juvenile (PN 25) testes and 
newborn (PN 0) skin were transcribed into cDNA and subsequently evaluated for 
relative gene expression using specific primers for each homologue. Cers expression 
levels were calculated according to the ∆∆Ct method normalizing values relative to 
the expression of a housekeeping gene, here Gapdh. Normalized ∆Ct values were 
compared to normalized ∆Ct of Cers5-mRNA of each tissue.  
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 Taking into account the expression levels of the ceramide synthase members in 
the primary tissues containing ULC-sphingolipids, and their reported preferences for 
acyl-CoA species, it was deducted that Cers2 and Cers3 are the only possible 
candidates that might be responsible for the biochemical transfer of ULC-acyl-CoAs 
into sphingoid bases (for detailed discussion see section 4.1). 
 
3.1.2. Cers3 and ULC-PUFA sphingolipid expression simultaneously increase 
during testicular maturation 
Detailed mass spectrometric analyses of testicular sphingolipids according to their 
acyl residues revealed the lack of ULC-PUFA during the earlier stages of the first 
spermatogenic cycle. ULC-PUFA moieties were first incorporated into sphingolipids 
at PN 15, with their levels increasing during the progress of spermatogenesis 
(Rabionet et al., 2008).  
To further investigate whether CerS2, CerS3 or any other CerS member could be 
responsible for the synthesis of ULC-sphingolipids in testis, stage specific mRNA 
analysis of the ceramide synthase family was performed. The aim was to correlate 
the expression of any of the Cers genes to the expression of ULC-sphingolipids 
during the progress of the first spermatogenic cycle in mice. Therefore, mRNA from 
mice testes of different stages of juvenile development were isolated, subsequently 
transcribed into cDNA and subjected to quantitative RT-PCR. 
The expression profile of the ceramide synthase gene family revealed Cers2, 
Cers3, Cers5 and Cers6 to be present in murine juvenile testes, whereas the levels 
of Cers4 and Cers1 were extremely low and almost undetectable, respectively. At the 
earlier stages of testicular development mRNA of Cers5, followed by Cers2 and 
Cers6, exhibit the most abundant transcript levels. Despite an initial increase from 
PN 5 to 10, their expression levels were kept roughly constant with no significant 
changes throughout testicular maturation. 
On the contrary, Cers3 exhibited a distinctive mRNA expression pattern during the 
progression of the first spermatogenic cycle. Whereas transcript levels prior to PN 10 
were low, mRNA was strongly and continuously upregulated from PN 14 onward. 
Cers3 mRNA analyses revealed a noteworthy 700 fold change increase during the 
first wave of spermatogenesis in mice. 
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Figure 19. Testicular Cers3 mRNA is strongly upregulated during the first wave 
of spermatogenesis in mice. 
Cers mRNA expression of isolated cDNA from mice testes at PN 5 to 25 was 
determined by quantitative RT-PCR. Relative fold expression was calculated using 
the ∆∆CT method. ∆CT represents the normalized threshold cycle (CT) value 
corresponding to the difference between CT of each Cers and the CT of the 
housekeeping gene, here Gapdh. Normalized ∆CT values were compared to 
normalized ∆CT of Cers5-mRNA at PN 5. Data represents isolated mRNA of 
minimum 3 animals per group with technical duplicates. Error bars represent the 
SEM. 
 
 
 Cers3 mRNA exhibited a tremendous upregulation of over 4.5-fold change during 
PN 14 to 15, which coincided shortly afterwards with the onset of ULC-sphingolipid 
expression. Subsequently, the levels of sphingolipids containing ULC-PUFA moieties 
remarkably increase simultaneously with the mRNA levels of Cers3. Contrarily, 
Cers2, Cers5 and Cers6 mRNA concentrations exhibited a moderate downregulation. 
 Collectively, these findings evidence a correlation between Cers3 transcriptional 
levels and the biosynthesis of ULC-sphingolipids. 
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3.1.3. Cers3 and ULC-PUFA sphingolipid expression are restricted to 
differentiated male germ cells 
Previous immunohistological studies by Sandhoff et al. localized fucosylated GSLs 
solely in testicular germ cells, excluding their localization in both Sertoli and 
interstitial cells (Sandhoff et al., 2005). Taking into consideration that FGSLs mainly 
contain ULC-PUFA residues, the enzyme responsible for the incorporation of these 
residues must be likewise localized in germ cells.  
In order to provide additional evidence supporting the requirement of CerS3 for the 
synthesis of ULC-sphingolipids, the ceramide synthase expression levels were 
determined in germ cells. In this regard, a mouse model lacking intact differentiated 
germ cells, i.e. preleptotene and leptotene spermatocytes, was used for these 
studies. KitW-v/KitW mutant mice lack the c-kit receptor, which is necessary for the 
stem cell factor ligand in order to regulate the proliferation and differentiation of stem 
cells. Consequently, Sertoli cells and only a few undifferentiated spermatogonia 
reside at the basal lamina, while further differentiated germ cells undergo apoptosis. 
Besides Sertoli cells, other cell types localized in the interstitium, e.g. Leydig cells, 
were unaffected by the lack of the c-kit receptor, as histological analysis of mutant 
seminiferous tubules revealed (Rabionet et al., 2008).  
Cers expression levels were determined in mRNA isolated from testes of             
KitW-v/KitW mutant and control mice, and further subjected to quantitative RT-PCR for 
transcriptional analysis. 
The mRNA profile of control murine testes revealed the expression of Cers2, 
Cers3, Cers5 and Cers6, corroborating previous findings. The transcripts of all four 
ceramide synthases were decreased in mutant testes, however significant amounts 
of Cers2, Cers5 and Cers6 could still be detected in KitW-v/KitW mutant testes. These 
results indicate that Cers2, Cers5 and Cers6 are not exclusively expressed in 
differentiated germ cells. Particularly, Cers5 mRNA was barely decreased in mutant 
testicular mRNA, which might indicate a major expression of this ceramide synthase 
homologue in testicular somatic cells. On the other hand, Cers2 and Cers6 were 
decreased to 20% and 45% of control values, respectively, suggesting their 
expression in either somatic cells and/or residual spermatogonia in addition to 
differentiated germ cells. 
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Figure 20. “Germ-cell free” testes of KitW-v/KitW mice are devoid of Cers3 mRNA 
expression.  
Quantitative RT-PCR analysis of Cers mRNA of isolated cDNA from mutant mice 
testes that lack differentiated germ cells. Relative fold expression was calculated 
using the comparative CT method. Normalized ∆CT values were compared to 
normalized ∆CT of control Cers5-mRNA. 
 
  
In contrast, mutant KitW-v/KitW testes were completely depleted of Cers3 mRNA, 
implying that Cers3 expression is restricted to differentiated germ cells. 
The testicular sphingolipid pattern of mutant mice determined by ESI-MS/MS 
revealed the complete lack of sphingolipids containing ULC-PUFA moieties, thus 
indicating their localization in differentiated germ cells (Rabionet et al., 2008). Hence, 
the complete loss of Cers3 mRNA expression correlates with the absence of ULC-
sphingolipids in testis. Taking all these results into account and the overall decrease 
of Cers mRNA in infertile mutant mice, the only significant decrease that could be 
responsible for the loss of ULC-sphingolipids is that of Cers3 transcript.   
 In summary, the transcriptional analysis of the ceramide synthases in combination 
with the ULC-SL expression in juvenile and mutant KitW-v/KitW mice testes strongly 
suggested a leading role of CerS3 in the synthesis of these unconventional 
sphingolipids. 
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3.2. Characterization of ceramide synthase 3 
 
Understanding the biosynthetic requirements of these unusual ULC-sphingolipids is a 
sine qua non condition to gain deeper insight into their functional role in 
spermatogenesis and the epidermal permeability barrier. In this regard, genetic, 
topological and enzymatic localization analyses, in conjunction with enzymatic 
assays were performed.  
 
3.2.1. The ceramide synthase 3 gene 
Ceramide synthase 3 (Cers3, officially denominated Lass3) mRNA was first isolated 
from mouse testis in our department (Sandhoff et al., unpublished results). The 
identified amino acid sequence could be corroborated by a succeeding study, which 
in addition identified 36 amino acid residues at the N-terminus (Mizutani et al., 2006).  
Phylogenetically, Cers3 is highly conserved in all vertebrates, exhibiting a 78% 
homology between the mouse and the human protein, as determined by sequence 
alignment (ClustalW v 1.83, Figure A1). The mouse Cers3 gene encodes for 
419 amino acids in 11 coding exons, with a predicted molecular weight of 50.0 kDa. 
The additional 5’-prime coding exon of the mouse genome is lacking in the 
homologous human protein. Therefore, the human Cers3 gene encodes for 
383 amino acids with a predicted molecular weight of 46.1 kDa.  
The ceramide synthase genes are characterized by the lag1 motif, a highly 
conserved stretch of 52 amino acids required for the catalytic activity of these 
enzymes (Spassieva et al., 2006). The lag domain in mouse is comprised of the 
totality of exon 8, spanning to the last 2 amino acids of exon 7 and the first seven of 
exon 9 (exons 6 to 8 in humans). In a broader manner, the lag1 motif has been 
described to reside in the Tram-Lag-CLN8 (TLC) domain, a region of 201 amino 
acids contained in 16 additional proteins besides Cers3 (Winter and Ponting, 2002). 
The TLC domain is flanked by exon 4 to 10 in the mouse protein, and exon 3 to 9 in 
the human Cers3. 
A shortened homeobox (or hox) domain is present in all ceramide synthases 
except for Cers1. In Cers3, the hox domain is composed of 44 residues (according to 
Prosite database) located between exon 3 and 4 (exon 2 and 3 for humans). 
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Figure 21. Genomic organization of mouse Cers3. 
Cers3 (Gene ID mouse: 545975 and human 204219) is composed of 11 exons in 
mice and 10 exons in humans. Likewise its family homologues, Cers3 is 
characterized by the lag1 domain included in the broader Tram-Lag-CLN8 (TLC) 
domain. Topology analysis predicted 6 transmembrane (TM) domains, with about 
half of the lag1 motif residing in TM4. Additionally, the homeobox domain is predicted 
to face the cytosolic side between TM1 and TM2. 
 
3.2.2. The transmembrane topology of ceramide synthase 3  
Hydrophobicity profile analysis was performed in order to predict the membrane-
spanning segments of CerS3. The topology of CerS3 as predicted by TopPred II 
(Claros and von Heijne, 1994) revealed 6 transmembrane spanning (TM) domains, 
as shown in the upper cutoff (red) of the following graph: 
 
 
 
Figure 22. Topology analysis and proposed model for CerS3.  
A) Hydrophobicity plot of murine Cers3 as predicted by TopPred. B) Membrane 
topology model of CerS3 indicating the predicted localization of the transmembrane 
domains, as well as the HOX and the LAG domain. The first and last amino acid 
positions are indicated for each domain. 
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Less restringent algorithms have suggested up to 8 TM for the yeast ceramide 
synthases and 7 TM for all mammalian CerSs (Kageyama-Yahara and Riezman, 
2006; Teufel et al., 2009). Accordingly, the hox domain might reside in the cytosolic 
loop between TM1 and TM2, and both N- and the C-termini are predicted to face the 
luminal side of the endoplasmic reticulum (ER).  
Presumably, the lag1 domain may be located in the entire TM4, and additionally 
exposed to both cytosolic and luminal sides of the ER. This model is partially in 
agreement with the model suggested by Mizutani and coworkers, however they 
proposed 5 transmembrane spanning domains to be present in CerS3 (Mizutani et 
al., 2006). 
 
3.2.3. CerS3 is an ER-resident protein 
The subcellular localization of CerS3 has not yet been reported. To address this 
issue, overexpression of CerS3 with a C-terminal EGFP tag was conducted in HeLa 
cells by means of lipofection. The fluorescence signals of mCerS3-EGFP were 
compared to those generated by the lysosomal, the golgi compartment and the ER 
protein-specific markers. 
CerS3-EGFP exhibited no colocalization with neither Lamp1 nor Golgin-97 
markers, the distribution of whose indicates the location of lysosomes and the Golgi 
apparatus, respectively. In contrast, CerS3-EGFP was found to colocalize with the 
protein disulfide isomerase (PDI), demonstrating that CerS3 is an ER-resident 
protein. Additionally, CerS3-EGFP fluoresecence signals appeared to be distributed 
in the nuclear envelope.  
These findings are in agreement with previous studies indicating the intracellular 
localization of the remaining ceramide synthases within the ER (Mizutani et al., 2005; 
Riebeling et al., 2003; Venkataraman et al., 2002) and the nuclear envelope 
(Mizutani et al., 2005). 
Despite the lack of an ER retrieval motif as determined by SignalIP, CerS3 resides 
at the site of the elongation of fatty acids and ceramide synthesis (Jakobsson et al., 
2006; Teufel et al., 2009).  
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Figure 23. mCerS3-EGFP colocalizes with the ER marker, anti-PDI. 
The fluorescence signals detected from the overproduction of CerS3-EGFP in HeLa 
cells were compared to those generated by the lysosomal marker (anti-Lamp1), the 
Golgi (anti-Golgin-97) and the ER marker (anti-PDI), shown in red. Nuclear staining 
with Draq5™dye is shown in blue, while GFP derived fluorescence is shown in 
green. 
 
3.2.4. CerS3 synthesizes ULC-sphingolipids in living mammalian cells 
In the past few years, significant efforts have been made to define the biosynthetic 
requirements of the ceramide synthases in vitro, in order to provide the basis for 
elucidating the role of specific ceramide species in vivo. As described above, each of 
the six mammalian ceramide synthases have been shown to have affinity for a 
restricted subset of acyl-CoAs, with the exception of CerS3. Mizutani and colleagues 
reported a relative broad substrate specificity of CerS3, with certain preference 
towards long and very long chain acyl-CoAs, namely 18:0-CoA and 24:0-CoA 
(Mizutani et al., 2006). However, the affinity of CerS3 for ultra long chain acyl 
residues, as those mainly expressed in skin and testis were not included in those 
studies. 
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 To address this issue, the in vitro specificity of CerS3 towards a wide range of 
acyl-CoAs including ULC-acyl-CoAs (16:0 to 28:0-CoA) was examined. From the 
remaining five CerS homologues, CerS2 has been described to best incorporate acyl 
residues with the longer carbon chain length (22:0 to 26:0-CoA) for the synthesis of 
the corresponding ceramides (Laviad et al., 2008). All other CerS homologues have 
been reported to produce ceramides with shorter acyl moieties (Lahiri et al., 2007). 
Additionally, CerS2 has the highest homology with CerS3, and likewise its mRNA 
was expressed in skin and testis. However, mRNA and sphingolipid expression 
analysis performed in testes lacking differentiated germ cells, as well as juvenile mice 
testes during the first wave of spermatogenesis suggested that CerS3 is the unique 
enzyme capable of producing ULC-ceramides. 
In order to corroborate these findings and to establish whether solely CerS3 
incorporates ULC-acyl-CoAs to sphingoid bases, the preference of CerS3 and CerS2 
towards acyl-CoAs was tested by means of ceramide synthase assays. 
 
3.2.4.1. CerS3 does not modify the ceramide profile in the absence of ULC-acyl-
CoAs 
The first approach to demonstrate that CerS3 is the enzyme responsible for the 
formation of ULC-(PU)FA sphingolipids included an activity study of the enzyme in 
transient transfected cells. As it has been shown for other ceramide synthase 
homologues, overexpression of a given CerS in either HEK-293T or HeLa cells 
produced a change in the ceramide pattern reflecting the specificity of the enzyme 
towards the fatty acid substrates (Riebeling et al., 2003). In this regard, HeLa cells 
were transfected with a plasmid encoding for mCers3 gene in the N-terminus of an 
EGFP tag. However, the sphingolipid profile upon 24 h post transfection exhibited no 
change in the fatty acid pattern for neither ceramide nor any of its direct metabolites, 
albeit the expression of the fusion protein in transfected cells was confirmed by 
immunoblot analysis (Figure 24A). We reasoned that overexpression of CerS3 had 
no effect in the sphingolipid pattern due to the lack of its fatty acid substrates in these 
cells, and not due to a lack of activity of the fusion protein. In order to circumvent this 
issue, we tried to expose the cells with the adequate substrates using different 
approaches.  
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First, we attempted to introduce the ULC-FA substrates by performing double 
transfections with CerS3 together with genes belonging to the elongation of very long 
chain fatty acid (Elovl) gene family. The Elovl genes are responsible for the synthesis 
of activated fatty acids with more than 16 carbons in length via the addition of 
2 carbon units from malonyl-CoA to a long chain acyl-CoA substrate. At the starting 
point of this work, reliable data on the substrate specificity of the seven elongases 
was limited, therefore we attempted to determine the potential elongase responsible 
for the synthesis of ULC-acyl-CoAs by means of transcriptional analysis (Figure 
24C). Elovl2 and Elovl5 mRNA were found to be the most prominent in testis, 
however Elovl5 transcript was linked by gene array data (available 
at www.germonline.org) to be localized in spermatogonia and somatic Sertoli cells 
(Chalmel et al., 2007). Taking into account that these cells do not contain ULC-
sphingolipids, and that its transcript levels were decreased at the onset of ULC-
sphingolipid expression (Shima et al., 2004), Elovl5 was rejected as a potential 
candidate, leaving Elovl2 as the most promising candidate. 
On the other hand, Elovl4 was additionally included as a possible enzyme for 
generating ULC-acyl-CoAs, despite the fact that its mRNA levels were not prominent 
in juvenile murine testes. The rationale behind relies on several studies on Elovl4 
deficient mice, where it was shown a complete depletion of epidermal ceramides with 
FA residues longer than 28 carbon atoms, as well as an accumulation of cerotoyl-
ceramide (26:0-Cer) (Li et al., 2007; McMahon et al., 2007b; Vasireddy et al., 2007). 
Taken together, these results point out Elovl4 as an additional candidate enzyme for 
the synthesis of ULC-acyl-CoAs, which we hypothesized to be the substrates for 
CerS3.  
 However, neither Elovl2 nor Elovl4 double transfections with CerS3 exhibited 
increased levels of montanoyl-ceramides (28:0-Cer) or any other sphingolipid 
species containing ULC-acyl moieties. Although overexpression of both fusion 
proteins could be confirmed by Western blot, as shown with Elovl2 and CerS3 co-
transfections (Figure 24B), the sphingolipid pattern of these cells did not exhibit any 
significant changes. In particular, no increase for m/z 692.7 or 854.7 corresponding 
to Cer(d17:1, 28:0) and GlcCer(d17:1, 28:0) could be detected.  
 
Results 
 
    
 104 
 
Figure 24. Coexpression of Elovl2/4 and CerS3 does not produce ULC-SLs. 
(A) Immunoblot analyses demonstrating overexpression of CerS3-EGFP and control 
EGFP, and (B) cotransfections with Elovl2-EGFP in HeLa cells. (C) Transcript 
analyses of the Elovl genes during murine testicular development, as determined by 
qRT-PCR. (D) Mass spectrometric analyses of ceramide, glucosylceramide and 
lactosylceramide species in HeLa overexpressing Elovl2/4 and CerS3. 
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These results provide evidence for the requirement of additional 
metabolites/enzymes being involved in the production and/or transport of ULC-acyl-
CoAs that might be necessary for the complete biosynthesis of ULC-sphingolipids, 
besides of Elovl2/4 and CerS3. Taking into consideration that with the current stage 
of knowledge many of the processes regarding the activation and transport of fatty 
acids, particularly of ULC-FA, are still elusive, we decided to establish the ceramide 
activity assay by a different approach. 
The major difficulty in establishing an adequate assay for CerS3 was the lack of 
availability of the fatty acid substrates. As stated above, ULC-FAs are restricted to 
testis, epidermis, and in lesser extent are expressed in the rod outer segments of the 
retina. The latter have been reported to be incorporated into membrane 
phospholipids, mainly phosphatidylcholine (Aveldano and Sprecher, 1987).  
Therefore, we attempted to overexpress CerS3 in an immortalized cell culture system 
originated from these tissues, expecting that their fatty acid pattern might contain the 
suitable substrates for CerS3. The immortalized testicular cell types TM4 (Sertoli 
cells) and K9 (Leydig cells) were studied upon transfection with a CerS3 encoding 
plasmid. In neither cell lines the concentration of ULC-FAs reached 1%, and thus this 
minimal amount of substrate was obviously not sufficient to detect an increment of 
montanoyl- and longer acyl chain ceramides due to the activity of CerS3 
overexpression. Retinoblastoma Y79 suspension cells were also subjected to 
transfection by means of magnetofection or liposome-based transfection, however 
the gene delivery rates achieved were not sufficient for a quantitative production of 
the enzyme. 
Additional efforts were made to obtain the ULC-FA substrates by means of fatty 
acid isolation from GM2 activator protein (GM2AP) deficient mice testis. This cofactor 
is required in conjunction with the lysosomal β-hexosaminidase isoenzymes for the 
degradation of GM2 and Gg3Cer, which are intermediate products of FGSL 
degradation in testis (Liu et al., 1997). Correspondingly, the testes from these mutant 
mice accumulate both GM2 and Gg3Cer containing mainly ULC-FA residues. 
Therefore, fatty acids were extracted from GM2AP-/- mice testes by acid hydrolysis, 
and subsequently exposed to K9 or HeLa cells overexpressing CerS3. However, the 
sphingolipid analysis from these cells revealed no incorporation of fatty acids longer 
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than 26 carbon atoms into ceramide or sphingomyelin (Figure 25). Presumably, the 
insolubility of these highly hydrophobic compounds in the aqueous culture medium, 
and/or the deficiency of an effective fatty acid transporter across the plasma 
membrane, caused the failure of this CerS3 transfection assay.  
Considering that ULC-acyl-CoAs are not commercially available, and that all 
attempts to obtain these substrates via biochemical methods led to failure, we aimed 
to synthesize ULC-acyl-CoAs chemically. 
 
 
Figure 25. CerS3 overexpressing K9/HeLa cells with media supplementation 
rich in ULC-FAs do not produce ULC-ceramides.  
(A) Mass spectrometric analyses of fatty acids isolated from GM2AP-/- mice testes. 
The base peak corresponded to hydroxylated fatty acid with 30 carbon atoms in 
length with 5 olefinic residues. Media supplementation of GM2AP-/- derived FAs into 
K9 (C) and HeLa cells (E) transfected with CerS3-EGFP did not alter the sphingolipid 
pattern in relation to control K9 (B) and HeLa (D) endogeneous sphingolipids. For 
MS, sphingomyelin was detected with parent scan at m/z +184 and fatty acids with 
neutral loss of m/z +46. 
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3.2.4.2. Synthesis of ULC-acyl-CoAs 
Epidermal and testicular ULC-sphingolipids exhibit a structural diversity, which might 
reflect their functional specialization. The majority of epidermal ceramides 
incorporate ω-hydroxylated ULC-acyl-CoAs, which are mainly saturated. Contrary, in 
testis, ceramide incorporates mostly polyenoic ULC-acyl resiudes, which to a great 
extent are α-hydroxylated. Regardless of this existent heterogeneity within testicular 
and epidermal ULC-sphingolipids, we assumed that the enzymatic specificity of the 
ceramide synthases relies primarily on the hydrocarbon length of the acyl donor, 
subjugating modifications by hydroxylation or saturation to negligible levels. The 
basis for this assumption is that: i) CerS2 have been reported to incorporate 
saturated and monosaturated acyl-CoA substrates with comparable CerS activities 
(Laviad et al., 2008), and that ii) all CerS homologues could produce α-hydroxy-
ceramides with similar chain length preferences as their respective non-hydroxy 
substrates (Mizutani et al., 2008). Taking this into consideration, saturated acyl-CoAs 
longer than 26 carbon atoms in length should be adequate substrates for CerS3.  
The synthesis of ULC-acyl-CoAs involved a three-step reaction. First, fatty acids 
were activated with N-hydroxysuccinimide in the presence of 
dicyclohexylcarbodiimide (DCC) to generate the N-hydroxysuccinimide esters of the 
fatty acids, which will be used as the acylating reagent. Subsequently, the activated 
fatty acids were coupled to coenzyme A (CoA) in two consecutive one-pot reactions 
to yield the acyl-CoAs. 
The coupling of CoA was performed via the in situ transformation of coenzyme A 
into its polysilylated form, which is non polar and thus especially suitable for the 
formation of highly lipophilic long chain acyl-CoAs, such as the ULC-acyl-CoAs. This 
method developed by Lucet-Levannier and coworkers (Lucet-Levannier et al., 1995) 
avoids the use of a water-organic solvent binary mixture that had been previously 
used as the classical synthetic methodology (Al-Arif and Blecher, 1969). The 
cosolubilization of the highly hydrophophic acylating reagent containing the ULC-acyl 
residue in the binary mixture is the limiting factor, which could be bypassed by the 
use of the lipophilic derivative of coenzyme A under anhydrous conditions. Fluoro-
desilylation of the polysilylated CoA under phase-transfer conditions with cesium 
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fluoride yielded the polyanionic form of CoA, which was subsequently coupled with 
the N-hydroxysuccinimide ester of the fatty acid to give the final acyl-CoAs.  
The synthetic strategy of the non-aqueous in comparison with the classical 
aqueous method is illustrated in the following scheme:   
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Figure 26. Synthetic scheme comparing classical aqueous and non-aqueous 
methods for the generation of acyl-CoAs.  
ULC-acyl-CoAs were synthesized according to the non-aqueous procedure. This 
scheme has been modified from (Lucet-Levannier et al., 1995).  
 
 
 
 The crude product was partially purified by reverse-phase column 
chromatography, prior to quantification by mass spectrometry analyses with an 
acyl-CoA mixture of known concentration. 
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Figure 27. Mass spectrometric characterization of montanoyl-CoA. 
Acyl-CoAs were detected with neutral loss of m/z +507. 
 
3.2.4.3. Synthesis of ceramide internal standards 
The substrate preference of CerS3 and CerS2 towards a wide range of acyl-CoAs, 
was established by means of a non-radioactive enzymatic assay in mammalian cells. 
Thus, the addition of a non-endogeneous sphingoid base (d17:1) enabled to 
distinguish the various ceramide species generated by CerS overexpression from 
those ceramides produced by the CerSs conventionally expressed in HeLa cells.   
For quantification of de novo ceramides by electrospray ionization tandem mass 
spectrometry (ESI-MS/MS), ceramide internal standards with an appropriate d17:1-
sphingoid base and appropriate acyl composition were synthesized. These internal 
standards were designed in a way that their m/z values could not interfere with those 
of the ceramide species to be analyzed.  
 Specifically, Cer(d17:1; 19:0) and Cer(d17:1; 25:0) were prepared via a two-step 
reaction. First, fatty acids were derivatized with N-hydroxysuccinimide (NHS) in order 
to activate the carboxylic acid by transforming into an ester with a good leaving 
group. Subsequently, sphingosine(d17:1) was coupled to the activated fatty acids, 
generating an amide bond through nucleophilic displacement of NHS.  
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Figure 28. Synthetic scheme describing the preparation of ceramide internal 
standards.  
Syntheses were performed as previously described with slight modifications 
(Sandhoff et al., 2002).  
 
 
 
Crude ceramide products required purification by flash-column chromatography in 
order to remove excess of fatty acids and other unreactive species (supplemental 
Figure A2A). Subsequently, final products were characterized by ESI-MS/MS with 
precursor ion scan corresponding to the d17:1 shingoid base, and their quantification 
was performed by densitometric analyses via thin layer chromatography 
(supplemental Figure A2B). For that, a series of dilutions of the synthesized 
standards were spotted in parallel with ceramide standards with a conventional 
sphingoid base (d18:1).  
For quantification of ceramide species produced by overexpression of specific 
CerSs, a 14 pmol mixture of each d17:1-ceramide internal standard was added into 
equivalent lipid aliquots corresponding to 80–100 mg of protein.  
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Figure 29. Mass spectrometric characterization of internal standards.  
Ceramides were detected with precursor ion scan of m/z +250 corresponding to the 
sphingoid base (d17:1). 
 
3.2.4.4. The ceramide synthase assay 
To definitely establish the role of CerS3 in the biosynthesis of ULC-ceramides, a non-
radioactive enzymatic assay in living mammalian cells was established. To 
accomplish this, stable HeLa cells expressing either the mouse or the human CerS3 
with a C-terminal EGFP tag were generated by retroviral transduction.  
Thus, virions were produced in the packaging cell line HEK-293T following a triple 
transfection with a vector encoding for the gene of interest (CerS3-EGFP or control 
EGFP), in addition to two vectors responsible for the formation of the viral proteins 
(pVPack-GP and pVPack-Eco). To enable the infection of HeLa cells, CerS3 or 
control EGFP cDNA were inserted into a murine leukemia derived retroviral vector. 
The assembled retroviral particles in the packaging cell line were collected and used 
for infecting genetically modified HeLaMCAT1-rtTA2-M2 cells. These HeLa cells were 
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previously modified to stably express the murine receptor protein (mCAT1), which is 
required to achieve the infection by the murine leukemia derived retroviral particles.  
In addition, HeLaMCAT1-rtTA2-M2 cells expressed the doxycycline-sensitive 
transactivator (rtTA2-M2). This transcription factor binds to the 
tetracycline-responsive element, which is encoded upstream of CerS3 (or control), 
and thereby enabling the expression of the gene of interest exclusively under 
doxycyline induction. HeLa cell lines expressing mCerS3-EGFP, hCerS3-EGFP and 
control EGFP were generated according to this procedure. For more details refer to 
the corresponding section in the material and methods (2.2.2.4.). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 30. Schematic representation of the generation of stable cell lines by 
retroviral transduction.  
pRevTRE plasmid map was acquired from Clonetech, whereas pVPackgag-pol and 
pVPackEco were obtained from Stratagene. 
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The inducible transgene expression of the recombinant mCerS3, hCerS3, and 
control EGFP, as well as hCerS2 were confirmed by flow cytometric analyses and 
immunoblotting (supplemental Figure A3 and Figure 31). Using Western blot 
analyses, fusion proteins were detected using an anti-GFP antibody. Although, both 
mouse and human CerS3 homologues were detected as one single band at about 
63 kDa (Figure 31A), the recombinantly expressed human CerS2 cells exhibited four 
specific bands that very likely arise from N-glycosylation heterogeneities (Figure 
31B). 
 
 
 
Figure 31. Confirmation of CerS3 and CerS2 recombinant protein expression in 
HeLa cells by immunoblotting. 
Total cell lysates of overexpressing HeLa cells were separated on a 10% 
SDS-PAGE, and transferred onto nitrocellulose membranes. Fusion proteins were 
detected using an anti-GFP antibody. 
 
 
 
The ceramide synthase activities of the CerS2 and CerS3 homologues were 
tested in living HeLa cells (Figure 32A). Following 52 h of transgene induction with 
doxycycline, HeLa cells expressing CerS2 or CerS3 were exposed to a mixture of a 
wide range of saturated acyl-CoAs, which included the ULC-acyl-CoA, montanoyl-
CoA (28:0-CoA). Simultaneously, the non-endogeneous d17:1-sphingosine substrate 
was supplemented into the culture medium for the duration of the assay in order to 
monitor newly synthesized ceramides (see above). 
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Figure 32. The ceramide synthase assay in living HeLa cells.  
 (A) Schematic respresentation of the experimental setup. Stable HeLa cell lines 
were induced for CerS3 (human and mouse) and EGFP expression by incubation 
with doxycycline, which binds to the tetracycline-controlled transactivator (rtTA2-M2), 
and ultimately activates transgene expression of the gene of interest downstream of 
the tetracycline-responsive element. Forty-eight hours after seeding untreated 
HeLamCAT1-rtTA2-M2 cells were transfected with an hCerS2-EGFP encoding plasmid. 
Ceramide synthase activity towards acyl-coA substrates was tested by addition of a 
saturated acyl-CoA mixture (16 to 28-CoA). Simultaneously, the addition of 
sphingosine (d17:1) enabled to monitor newly synthesized ceramides, which were 
extracted after 20 h of assay and quantified by ESI-MS/MS. (B) Transcript expression 
and (C) Cer/GlcCer profile of HeLamCAT1-rtTA2-M2 cells exposed to the acyl-CoA mixture 
and d17:1-sphingosine substrate.  
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 Uninduced HeLa cells expressed all Cers-mRNA except of Cers3, which 
expression levels were barely detectable. The major transcript levels corresponded 
to those of Cers2 (Figure 32B). Correspondingly, the main ceramide species 
expressed in HeLa cells were lignoceroyl- (24:0) and nervonyl-ceramide (24:1). 
Despite relatively low expression levels of Cers5 and Cers6, the amount of palmitoyl-
ceramide (16:0) was fairly high (Figure 32C). The levels of 18:0-Cer, 20:0-Cer, 22:0-
Cer and 26:0-Cer were below the 7% of the total ceramide concentration.    
Quantification of de novo ceramides produced by either the recombinantly 
expressed human or murine CerS3 upon incubation of the acyl-CoA mixture 
(16,18,20,24,26,28-CoA) to the cell culture media, demonstrated that both enzymes 
were able to synthesize ceramides using cerotoyl- (26:0) and montanoyl-CoA (28:0) 
as acyl donors (Figure 33B and 33D). Expression of CerS3 strongly induced the 
synthesis of ultra long chain acyl ceramides. Together the concentration of newly 
synthesized 26- and 28-ceramides accounted for over 25% of the total ceramides 
produced by the transgenic CerS3 (Figure 33A and 33C). Mass spectrometric 
analyses revealed that the absolute cerotoyl-ceramide concentration was increased 
by 5 fold, while montanoyl-ceramide was over 16 fold increased for the hCerS3 
(Figure 33B and 33D). These results indicate that CerS3 has a higher affinity for 
28:0- than for 26:0-acyl donors.  
Although stearoyl-ceramide (18:0-Cer) and lignoceroyl-ceramide (24:0-Cer) were 
reported to be the substrates with the highest CerS3 affinity in studies lacking of 
ULC-CoAs, neither of them exhibited a significant increase in their concentrations 
upon CerS3 expression with the current conditions. Our results provide evidences 
that the cell-specific ceramide pattern not only depends on the expression levels of 
the ceramide synthases, but importantly is also based on the availability of the 
corresponding substrates. In the presence of ULC-acyl donors, solely cerotoyl-CoA 
and montanoyl-CoA were preferentially incorporated, demonstrating that they are 
bona fide substrates of CerS3. 
In contrast, CerS2 or EGFP-control overexpressing cells generated significant  
amounts of ULC-ceramides upon induction of these proteins. The levels of 
lignoceroyl and cerotoyl-ceramides were neither significantly increased with CerS2 
expression. However, the relative Cers2 transcript levels account for over 90% of the 
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Cers-mRNA, and therefore an increased expression level did not differ significantly 
the concentration of its reported substrates. 
In conclusion, our findings indicate that CerS3 acylates sphingoid bases with acyl-
CoAs of 26 or longer carbon atom chains, exhibiting a preferential specificity for the 
longer acyl substrates in living mammalian cells.  
 
 
 
Figure 33. CerS3 synthesizes ULC-ceramides in living HeLa cells.  
(A) Relative de novo acyl-ceramide (d17:1) concentrations in non expressing (-), as 
well as expressing (+) human CerS2 and CerS3 HeLa cells, and (C) mouse CerS3 
and EGFP-control HeLa cells. Lipid isolation was performed after cells were 
incubated for 20 h with a saturated acyl-CoA mixture (16–28-CoA). Mass 
spectrometric quantification was performed using d17:1 long chain base internal 
standards. (B) Absolute cerotoyl-ceramide (d17:1, 26:0) and (D) montanoyl-ceramide 
(d17:1, 28:0) concentrations in CerS2, CerS3 and control cells. 
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3.3. Disturbed epidermal permeability barrier and keratinocyte 
differentiation facilitates microbial invasion in CerS3 deficient mice 
 
3.3.1. Characterization of CerS3 deficient mice with a targeted disruption of 
Cers3-exon 7. 
In order to confirm the in vitro findings and to elucidate the functional role of CerS3 
and ULC-sphingolipids in vivo, characterization of CerS3d/d mice were conducted. 
The constitutive depletion of Cers3 was achieved via the Cre-loxP-mediated 
recombination. In this regard, germline transmission CerS3-floxed mice with loxP 
sites flanking exon 7 were mated with Cre-deleter mice to generate a systemic 
deletion of exon 7 of the Cers3 gene.  
 To verify the appropriate homologous recombination of mutant Cers3, PCR 
analyses with mouse genomic DNA were performed. Wild type and mutant bands 
were detected at 315 and 272 bp, respectively, corroborating the deletion of exon 7 
in mutant mice (Figure 34A, bands 1 and 2).  
In skin, CerS3 deficient mice exhibited expression of Cers3 mRNA lacking exon 7, 
as analyzed by PCR. The targeted disruption of Cers3 was confirmed with the control 
and mutant bands at 686 and 593 bp, respectively, corresponding to the lack of 
93 bp of exon 7 in mutants (Figure 34B, bands 3 and 4). Consequently, the gene 
rearrangement led to complete loss of expression exclusively when amplifications 
were performed using primers within exon 7 (Figure 34C). The truncated CerS3 
transcript was finally confirmed by nucleotide sequencing. 
 
 
 
Figure 34. Targeted disruption of Cers3-exon 7 in CerS3 deficient mice.  
(A) PCR analysis from genomic tail DNA of newborn mice confirming the 
amplification of the corresponding allelic products of CerS3+/+ and CerS3d/d. (B) Skin 
cDNA analysis demonstrating the synthesis of a truncated CerS3 transcript lacking 
93 bp due to the targeted deletion of exon 7 in CerS3 deficient mice, as 
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demonstrated by PCR. (C) Quantitative RT-PCR verifying the complete loss of CerS3 
mRNA expression when amplifying a product within exon 7. Error bars represent the 
SEM. ** indicate p value < 0.01. 
 
3.3.2. Defective epidermal barrier function of CerS3d/d mice leads to premature 
neonatal death  
The offspring of CerS3+/d mice were born with Mendelian distribution, indicating that 
CerS3 might not be essential for embryonic development. Phenotypically, CerS3+/d 
could not be distinguished from wild type mice, however the skin of CerS3d/d 
appeared unwrinkled, shiny, sticky and intensively red colored (Figure 35A). Mutant 
offsprings were not accepted and fed by their progenitors. Loss of CerS3 caused 
universal neonatal lethality within 3 to 4 hours after birth.   
In order to examine the epidermal barrier function, skin permeability assays were 
carried out. Staining of control and mutant mice with hemalaun revealed a clear 
impairment of the skin barrier formation at birth (Figure 35B) and at embryonic stage 
E19 (Figure 35C). Whereas control mice could effectively exclude the dye after 
several throughout washes, mutant skin exhibited a strong penetration of the dye, 
indicating a defective epidermal permeability function. 
 To determine whether an additional outward permeability defect existed, 
transepidermal water loss (TEWL) rates were measured. Skin of newborn CerS3d/d 
mice exhibited an over two fold increase in transepidermal fluid evaporation, 
confirming the compromised skin barrier of mutant mice (Figure 35D). Correlating 
with the fluid loss, the body weight of newborn CerS3d/d mice was reduced by 30% 
(Figure 35E). As diminished body weight very likely is a result of dehydration, CerS3 
embryos of one litter were collected at E18.5 ± 0.5, sacrificed and freeze dried after 
determination of wet body weight. With these mice, no differences in body wet or dry 
weight were observed, supporting that differences in wet body weight of newborns 
were exclusively due to water loss (Figure 35F and 35G).  
Results 
 
    
 119 
 
Figure 35. Defective epidermal barrier function of CerS3d/d mice. 
(A) Epidermis of newborn CerS3d/d appears intensively red and shiny compared to 
control littermates. (B) Defective epidermal permeability barrier of CerS3-deficient 
mice shown with the persistence of hematoxylin dye of newborns, and (C) of 
embryonic stage E19 ± 0.5 CerS3d/d mice. (D) Significant increase of TEWL and (E) 
reduced wet body weight of mutant CerS3 mice measured within 3 hours postnatally. 
(F) No significant difference was observed in wet or (G) dry body weight of 
E18.5 ± 0.5 mutant CerS3 embryos compared with control littermates. (H) Increased 
surface pH of mutant CerS3 mice as determined by pH-indicator strips. (I) 
Quantification of epidermal surface pH revealed a 0.6 pH units increase of mutant 
epidermis. Immunofluorescence of paraffin sections of skin from the back of control 
(J) and mutant CerS3d/d (K) mice with anti-CerS3 polyclonal antibody. CerS3 is 
concentrated as distinct dots within the cytoplasm of keratinocytes of the upper SS 
and SG, whereas no signal could be detected in the mutant epidermis. 
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The epidermal permeability barrier is directly regulated by pH, therefore skin 
surface pH of newborn mutant and control littermates was determined by direct 
contact with humidified pH-indicator strips. Control mice exhibited an acidic pH of 
about 5.2, whereas mutant epidermal pH was increased by roughly 0.6 pH units 
(Figure 35H and 35I). 
The lack of a functional CerS3 protein appeared to have direct implications at the 
epidermal barrier function. Although CerS3 expression in the skin have been 
demonstrated at the mRNA level, its exact distribution within the epidermal cell layers 
have not yet been described. Therefore, specific antibodies against the carboxy 
terminus of the CerS3 protein were generated and used for immunofluorescence 
labelling of control and CerS3d/d skin biopsies. In control epidermis, CerS3 was 
distributed in the SS and the SG, concentrated as distinct dots within keratinocytes of 
the upper epidermal layers (Figure 35J). On the contrary, CerS3 expression was not 
detected in any strata of mutant epidermis (Figure 35K), thereby corroborating that 
the lack of exon 7 renders the synthesis of CerS3 dysfunctional. In summary, these 
results demonstrate the pivotal role of CerS3 for a proper epidermal barrier function.  
 
3.3.3. Epidermal “hyper”keratosis and delayed keratinocyte differentiation of 
CerS3 deficient mice 
Light microscopical analyses of semithin sections of mutant CerS3d/d skin revealed a 
strikingly thick and compact stratum corneum, as observed postnatally (Figure 36A 
and 36B) as well as at embryonic stage E18.5 ± 0.5 (supplemental Figure A4A and 
A4B). Thus, the corneocyte layers exhibited a hyperkeratotic phenotype and lacked 
the “basket-weave” appearance typically observed in control skin. Mutant stratum 
corneum exhibited solely stratum compactum, lacking the less cohesive upper layers 
of the stratum disjunctum, which were prominent in control skin. The nucleated 
epidermal layers appeared relatively normal both prenatally and at birth. However, 
large keratohyalin granules (KG) of the uppermost stratum granulosum cells, which 
predominantly contain profilaggrin aggregates, were significantly smaller in CerS3 
deficient mice, both at birth (Figure 36A and 36B, yellow arrows) and at E18.5 
(supplemental Figure A4A and A4B). 
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Figure 36. Alterations of keratinocyte differentiation in CerS3d/d mice. 
(A) Semithin sections of neonatal skin of control and (B) CerS3d/d mice stained with 
PAS and methylene blue-Azur II demonstrating “hyper”keratotic mutant SC. Yellow 
arrows indicate keratohyalin granules reduced in size in CerS3d/d skin. Electron 
micrographs treated with tannic acid of (C) control and (D) mutant upper epidermal 
layers exhibiting the persistence of periderm in mutant skin (green arrows), adjacent 
to the uppermost layer of corneocytes marked by electron-lucent inclusion bodies 
(red arrows). (E) Quantification of SC layers and (F) SC thickness. (G) Quantification 
of Ki67-positive keratinocytes according to the staining intensity. (H) Control and (I) 
CerS3d/d proliferation of basal keratinocytes assessed with Ki67 labelling on paraffin 
embedded sections. No significant increase in proliferation could be observed in 
mutant epidermis. 
 
 
To investigate in detail the anomalies observed in the mutant epidermis, 
ultrastructural analyses were performed (Figure 36C and 36D). The increased 
number of corneocyte layers upon CerS3 deficiency could be confirmed and 
quantified. At birth, no corneocyte layer in either control or mutant mice was shed. 
This could be determined by the presence of the uppermost corneocytes decorated 
by electron-lucent inclusion bodies in both mutant and control skin (Figure 36C and 
36D, red arrows and supplemental Figure A5). Furthermore, the most stricking 
feature of mutant epidermis was the persistence of a continuous periderm (Figure 
36D and supplemental Figure A5, green arrows). The presence of the most 
superficial corneocyte layer in both control and mutant SC, and of the periderm in 
mutant skin indicated that desquamation did not yet occurred in neither both SCs. 
Control mice exhibited about 13 corneocyte layers, whereas mutant SC had over 
40% more of these cell layers (Figure 36E). Additionally, quantification of CerS3d/d 
SC thickness was found to be almost double to its respective control (Figure 36F). 
To address whether mutant epidermis exhibited an enhanced proliferation rate of 
basal keratinocytes that could result in a thickened SC, the expression of the 
proliferative marker Ki67 was examined. No significant alteration of the cellular 
proliferation rates was found associated with CerS3 deficient skin (Figure 36H and 
36I), as quantification of Ki67 immunostaining did not reveal a significant overall 
increase of proliferation in mutant neonatal epidermis (Figure 36G).  
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Epidermal ultrastructural confirmed the reduced size of profilaggrin-containing 
keratohyalin granules in CerS3 deficient epidermis (Figure 36C and 36D). 
The transition of SG keratinocytes to enucleated corneocytes requires drastic 
morphological changes, including the degradation of nuclei, organelles and the 
plasma membrane. However, CerS3 deficiency resulted in a delay of the terminal 
differentiation program of keratinocytes. Mutant epidermis exhibited an incomplete 
degradation of organelle structures within the first and up to the third corneocyte 
layers (supplemental Figure A4C and A4D). Some of these immature corneocytes 
exhibited a TUNEL-positive staining, which indicate the presence of residual DNA in 
the progress to its complete degradation (supplemental Figure A4E and A4F). These 
observations were confirmed by DAPI-postive DNA-containing remmants in the lower 
SC of mutant skin (compare with Figure 41F, yellow arrows). In addition, glycogen 
could be observed in CerS3d/d SC, whereas glycogen in control skin was restricted to 
the viable layers of the epidermis (supplemental Figure A4G and A4H). 
The defective cornification process in dysfunctional CerS3 skin was additionally 
obvious by the presence of the peridermal cell layer overlaying mutant SC (Figure 
36D, supplemental A4B and A5, green arrows). Some of these cells even contained 
nuclear remmants (compare with Figure 39D, 41D and 41J). Although skin of control 
mice displayed a few remnants of these peridermal cells, mutant skin exhibited a 
continuous intact periderm. 
 
3.3.4. Defective corneodesmosomal degradation causes elevated intercellular 
cohesion and persistence of the periderm in CerS3 deficient stratum corneum 
To further investigate the defects in the terminal keratinocyte differentiation induced 
by the lack of CerS3, a detailed analysis of SC ultrastructure was performed. While 
no intact peridermal cell layer could be observed in control epidermis (Figure 37A), 
the presence of this transitional layer was confirmed in neonatal CerS3 depleted 
epidermis (Figure 37B-F, P). A closer look at the peridermal architecture revealed the 
presence of desmosomes (Figure 37D and 37F, red arrows), as well as tight 
junctions (Figure 37F, red star). Therefore, no degradation, disaggregation or 
shedding of periderm cells was initiated neither at E18.5, nor at birth of CerS3 mutant 
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mice. Together with the hyperkeratotic phenotype of CerS3d/d, these findings might 
suggest a defect in the proper desquamation of mutant epidermis. 
Consistent with this hypothesis, corneodesmosomes were found to persist in 
defective CerS3 epidermis. In mutant mice, corneodesmosomes remained abundant 
at all cell layers of the SC (supplemental Figure A5, red arrows), including the most 
superficial corneocyte layer (Figure 37B, black arrow), and were observed along the 
whole corneocyte surface. In contrast, corneodesmosomes were restricted to 
immature, inner corneocytes adjacent to the SG (stratum compactum) in control 
epidermis, and they were lacking at the uppermost SC layers (Figure 37A). As 
expected, the corneodesmosomal degradation as an important step of desquamation 
was initiated at the non-peripheral (basal and apical) surface of inner corneocytes 
and progressed also at the peripheral/lateral intercellular spaces concomitantly with 
cornification in control SC (data not shown).   
The SC of mutant CerS3 mice occasionally exhibited a pair of thin electron-dense 
bands located within the intercellular space (ICS) parallel to the surface of the CE 
(Figure 37C, yellow arrows). In CerS3d/d mice, the space between the limits of the CE 
was much less than 13 nm, which would correspond to the typical ICS occupied by 
lipid lamellae (White et al., 1988). Instead these thin bands, which were visible to the 
uppermost corneocyte layer, seem to correspond to a phospholipid bilayer.  
The defective corneodesmosomal degradation was further analyzed by 
immunolocalization of junctional proteins together with their total quantification by 
immunoblotting. To address whether the loss of CerS3 lead to an aberrant 
expression of desmosomal proteins, the transmembrane cadherin desmoglein 1/2, as 
well as the plaque proteins desmoplakin and plakoglobin were examined. Among 
these studies, the immunolocalization of desmoglein 1/2 exhibited a striking 
difference between mutant and control epidermis. Whereas the expression of this 
cadherin was restricted to desmosomes of keratinocytes within the SS and the SG in 
control mice (Figure 38A), mutant skin expressed desmoglein 1/2 at all the epidermal 
layers including the complete SC and the periderm (Figure 38B). Although the overall 
protein levels were found to be decreased in CerS3d/d mice (Figure 38G), its 
distribution decorating the complete periphery of corneocytes suggests a defective or 
delayed degradation of mutant corneodesmosomes.  
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Figure 37. Persistence of periderm and corneodesmosomes in newborn CerS3 
depleted mice.  
(A) Superficial corneocytes decorated with inclusion body of control mice lacking 
adjacent peridermal remmants or non-peripheral corneodesmosomes. A persistant 
peridermal layer (P) was observed in mutant CerS3 mice (B-F). Non-peripheral 
corneodesmosomes (black arrows) were present between peridermal cells and the 
most superficial corneocytes (B), as well as between the most superficial 
corneocytes and lower adjacent layers (C) of CerS3 depleted mice. Typical 
phospholipid bilayers appeared to be present in the intercellular space between 
corneocytes of mutant SC (C, yellow arrows). Intact periderm in mutant epidermis 
exhibited desmosomes (D and F, red arrows), as well as tight junctions (F, red star). 
Epoxy-embedded sections were treated with tannic acid. 
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In contrast, the expression and concentration of the desmosomal plaque proteins, 
desmoplakin and plakoglobin, were found to be not significantly altered (Figure 38G). 
As expected, desmoplakin expression was found to be restricted to the nucleated 
layers of the epidermis (Figure 38C-D). In addition, the epidermal localization of 
plakoglobin and the cytoskeletal keratins associated with desmosomal complexes, 
K1 and K10, were found similarly expressed in control and mutant CerS3 mice (data 
not shown). 
Regarding the defective degradation of non-peripheral/central corneodesmosomes 
in mutants, our results indicate desmoglein 1/2 to be essential for corneocyte 
cohesions and responsible for persistent cohesions of periderm cells. In addition, 
these findings suggested an impaired proteolysis of the corneocyte plasma 
membrane and consequently a defective formation of a mature cornified cell 
envelope. 
To examine whether the defective degradation of corneodesmosomes in mutant 
SC was caused by the reduced expression of proteolytic enzymes, levels of 
epidermal proteases of the kallikrein and the cathepsin family were analyzed. The 
total protein levels of either cathepsin D and KLK5 were found not significantly 
altered (Figure 38G). However, the epidermal distribution of cathepsin D in 
CerS3d/d mice remarkably differed from their control littermates. Whereas cathepsin D 
was found expressed in all the epidermal layers of control mice including the SC 
(Figure 38E), its expression was markedly decreased at the upper cell layers of the 
SG and the SC of mutant epidermis (Figure 38F). The reduced expression of this 
protease, which has been involved in the degradation of desmosomes during 
desquamation may account for the persistence of corneodesmosome remmants in 
mutant epidermis. 
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Figure 38. Impaired corneodesmosomal degradation in CerS3d/d epidermis.  
(A) Desmoglein 1/2 is strongly expressed in the SS and SG of control mice. (B) In 
addition, the SC of mutant mice had a prominent staining at the periphery of all 
corneocyte layers. To assure that the lipid lamellae do not mask the epitope in 
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control mice, both preparations were subjected to mild alkaline treatment prior to 
immunolabelling. (C-D) No differences in desmoplakin distribution could be observed 
in control and mutant epidermis. (E) Cathepsin D distribution was localized at all 
epidermal cell layers. The uppermost granular keratinocytes displayed the strongest 
immunofluorescence. (F) In CerS3d/d mice, the strongest cathepsin D signal intensity 
was in the SS fading towards the SC. (G) Immunoblot analyses of desmosomal and 
tight junction associated proteins, as well as epidermal proteases. Blots are 
representative of at least 3 animals per group. β-actin was used to normalize protein 
levels. 
 
 
Immunohistochemical analyses of tight junctional proteins were additionally 
performed in order to determine whether in addition to impaired degradation of the 
corneodesmosomal protein desmoglein 1/2, a defect in other types of cell junctional 
complexes existed. The immunolocalization of the tight junctional transmembrane 
protein claudin 1 and the cytoplasmic associated plaque protein cingulin was found 
within keratinocytes of the SS and the SG in both control and mutant epidermis 
(Figure 39A-B and 39C-D). Neither junctional proteins did show a significant 
difference in their signal intensity and main distribution pattern between control and 
mutant epidermis, however claudin 1 expression was distinctively and additionally 
observed in the periderm at the skin surface of mutant mice (Figure 39B, white stars) 
confirming the ultrstructural observations about the presence of intact tight junctions 
between peridermal cells (Figure 37F, red star).  
Regarding the organization of TJs, cingulin expression in CerS3d/d mice exhibited 
conspicuous differences. Whereas typical zonulae occludentes were established in 
control epidermis appearing as continuous fluorescent linear structures at the plasma 
membrane of the upper cell layers of the SG, mutant epidermis displayed weaker 
fluorescent punctuated signals within the uppermost granular keratinocytes. 
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Figure 39. Distribution of tight junctions and associated proteins. 
TJs were visualized with claudin 1 (A-B) and cingulin (C-D). No significant differences 
were observed in their distribution, however claudin 1 exhibited staining on the 
surface of mutant epidermis marking the periderm (white star). Cingulin expression 
exhibited a punctated distribution around keratinocytes of the SS and SG of CerS3d/d 
skin (D), whereas control skin exhibited linear distribution around the cell borders. A 
residual nuclear staining within some peridermal cells could also be detected on the 
surface of CerS3d/d skin (yellow star). (E) F-actin was mainly expressed in the 
nucleated layers of the epidermis in control mice CerS3d/d. (F) F-actin distribution 
differed to control by being also strongly expressed in the lower layers of the SC and 
progressively fading towards the upper corneocytes. Both control and mutant 
epidermis exhibited distinct punctated staining in the outer most corneocyte layer 
(yellow arrows). 
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The distribution pattern of the cytoskeletal protein F-actin, which is associated with 
TJs and adherens junctions, was additionally examined by immunolabeling. Besides 
the intense expression of F-actin at the cell-cell borders of all viable layers of the 
control epidermis (Figure 39E), its distribution in CerS3d/d mice additionally included 
the lower layers of the SC (Figure 39F) indicating a delay or a defect in the final 
cornification process. Furthermore, a pearl-like staining at the surface of both control 
and CerS3 deficient skin was observed. This distinct punctated expression of F-actin 
corresponds to the inclusion bodies observed at the ultrastructural level marking the 
uppermost corneocyte layer (Figure 36C-D and 37A-C). 
Considered together, the findings obtained by the ultrastructural and the 
immunohistochemical analyses indicate an alteration of terminal keratinocyte 
differentiation particularly of the corneodesmosomal degradation upon deficiency of 
CerS3. The reduced expression of specific proteolytic enzymes might account totally 
or partially for the lack of processing of corneodesmosomes, and thereby conserving 
the intercellular cohesion leading to “hyper”keratosis and persistence of the periderm. 
 
3.3.5. Impaired maturation of granular keratinocytes correlates with altered 
expression of cornified envelope proteins 
Previous light microscopical and low magnification ultrastructural analyses revealed 
distinct morphological differences between control and mutant CerS3 epidermis with 
regard to the size of keratohyalin granules both at birth (Figure 36A-D) and at E18.5 
(Figure A4A and A4B). To gain deeper insight into these anomalies, higher 
magnification electronmicrographs were performed. These analyses evidenced the 
pronounced size reduction of keratohyalin granules (KG) in the neonatal mutant 
epidermis as compared to epidermis of control littermates (Figure 40, red arrows).  
 The main constituents of KGs are structural proteins required for the formation of 
the CE, namely profilaggrin, which is associated with the large KGs (or F-granules) 
and loricrin, associated with the small KGs (or L-granules). F-granules displayed a 
fine granular structure of medium electron density (Figure 40A-B, red arrows), 
whereas L-granules appeared as electron-dense granules found often at the 
periphery of F-granules, as well as in the nucleoplasm (Figure 40A-B, yellow arrows). 
CerS3 deficiency resulted in both a significant decrease in the size of F-granules and 
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in the number of L-granules particularly at the periphery of F-granules (Figure 
40A-B). 
To examine whether the expression and processing of these proteins was altered 
upon CerS3 deficiency, immunoblot analyses were performed (Figure 40C). 
Profilaggrin was processed from its high molecular weight polyprotein to the 
monomeric filaggrin (∼ 28 kDa) in control skin. In contrast, an aberrant processing of 
profilaggrin was detected in CerS3d/d mice. The expression of the trimeric form and 
especially the filaggrin dimer (∼ 55 kDa) were increased, whereas the expression 
levels of the monomeric form appeared significantly reduced. The expression levels 
of loricrin were additionally altered. Loricrin is the most prominent structural protein of 
the CE accounting for about 65 to 85% of the total protein mass of the cornified layer 
(Steven and Steinert, 1994). Correspondingly, control mice exhibited high expression 
levels of loricrin (∼ 55 kDa), which were greatly diminished in CerS3 deficient skin. 
 These anomalies in correlation with the morphological data of profilaggrin and 
loricrin-containing KGs suggested a defective/delayed maturation of keratinocytes of 
the upper SG layer due to CerS3 deficiency. 
To evaluate whether the defective formation of KGs affected the distribution of 
structural proteins of the cornified layer, immunolabeling of the key players involved 
in the formation of the CE were performed. As expected, profilaggrin/filaggrin was 
primarily localized to the entire SG layer, where it filled the F-granules of the 
uppermost granular keratinocytes of control epidermis (Figure 41A, white arrows). At 
the SC, filaggrin levels faded along with cornification leaving a residual staining in 
mature corneocytes indicative of the proteolytically cleaved filaggrin molecules. In 
contrast, profilaggrin/filaggrin expression was equally distributed at the uppermost 
granular keratinocytes, as well as within the entire SC of CerS3 deficient skin. At the 
cornified layer, profilaggrin/filaggrin expression did not exhibit a decreased 
expression towards the most superficial corneocytes, as seen in control skin (Figure 
41B). Taken together these morphological findings confirmed a defective or delayed 
profilaggrin processing, which might be a consequence of a delayed maturation of 
granular keratinocytes. 
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Figure 40. Diminished size of F-granules and reduced number of L-granules 
correlates with impaired expression of CE proteins. 
Higher magnification electron micrographs treated with tannic acid of control (A) and 
mutant (B) CerS3d/d keratinocytes of the uppermost SG layer demonstrating altered 
development of KGs. First corneocyte layer is indicated (yellow star). F-granules (red 
arrows) were pronouncedly reduced in size, whereas L-granules (yellow arrows) 
were strongly decreased in number in mutant epidermis. L-granules were also 
localized within the nucleus (N). (C) Defective development of KGs accompanied 
diminished expression levels of monomeric filaggrin, loricrin and transglutaminase 1 
in CerS3 deficient mice. Equal loading of immunoblots was assessed by β-actin 
expression. Blots shown are representative of at least 3 animals per group. 
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 In control epidermis, loricrin expression was identified at the granular layer with 
increased concentration in keratinocytes residing at the border between SG and SC 
(Figure 41C). Ultracryosemithin sections enabled to detect its distribution distinctively 
around the periphery of F-granules (white arrows), as well as within the nuclear 
compartment (white arrowheads). Despite that loricrin has been identified as the 
major component of the CE, most current literature exhibits its expression exclusively 
at the SG. We also failed to detect immunolabeling of loricrin at the cornified layer of 
control skin. However, we assumed that the protein-lipid matrix in the corneocyte 
interstices might mask the epitope recognized by the antibody. Therefore, we applied 
an in situ methanolic mild alkaline treatment on paraffin sections to cleave protein-
bound ceramides and thereby release the antigen. This kind of antigen retrieval 
unveiled the loricrin at all cornified layers of control epidermis (Figure 41E), as 
compared with paraffin sections without methanolic treatment (Figure 41E, inset).  
In addition to loricrin expression in the SG, CerS3 deficient epidermis exhibited 
loricrin immunolabeling decorating the cornified cell envelope without requiring 
antigen retrieval (Figure 41D). As a control, paraffin-embedded sections of mutant 
epidermis were subjected to methanolic alkaline treatment (Figure 41F) or without 
this treatment (Figure 41F, inset), resulting in no alteration of loricrin distribution with 
neither of these procedures. Similar to control, loricrin contained in L-granules was 
localized at the rim of large F-granules of the SG and within nuclei of granular 
keratinocytes (Figure 41D, white arrows and arrowheads). 
In addition, our data demonstrated the necessity of alkaline hydrolysis to visualize 
loricrin within the nuclear compartment. A weak nuclear signal was already observed 
in the lower granular cell layers compared to the strong signal of the uppermost SG 
in control epidermis. However, only a comparably weak nuclear immunofluorescence 
was found in CerS3 deficient skin (Figure 41F). 
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Figure 41. Epidermal distribution of CE proteins.  
Control epidermis exhibited the highest profilaggrin/filaggrin intensity at the SG layer 
(A), whereas in mutant epidermis in addition a strong expression was found in the SC 
(B). F-granules are indicated with white arrows. Semithin sections indicating loricrin 
expression of control (C) and CerS3 dysfunctional epidermis (D) without alkaline 
treatment. Loricrin nuclear localization is indicated with white arrowheads, whereas 
residual nuclei at the SC (F) and periderm (D) are indicated with yellow arrows. 
Paraffin-embedded sections stained with loricrin antibody with prior methanolic 
alkaline hydrolysis to expose antigens residing at the SC of control (E) and mutant 
(F) epidermis. Control paraffin sections without alkaline antigen retrieval (E and F 
insets). Involucrin distribution did not differ pronouncedly between control (G) and 
CerS3d/d (H) skin. In situ transglutaminase activity assay with monodansylcadaverine 
exhibited no pronounced alterations of control (I) and deficient (J) skin. Note residual 
nuclei at the periderm layer are indicated with yellow arrows. 
 
 
In agreement with ultrastructural analyses of mutant keratohyalin granules, loricrin 
distribution confirmed the reduced dimensions of F-granules.  
Together these results indicate that although the expression levels of loricrin were 
reduced with CerS3 deficiency, its general epidermal distribution was not altered. 
Nevertheless, the altered maturation of granular keratinocytes was evidenced by the 
reduced dimensions of KGs, which might be associated with a delayed differentiation 
of keratinocytes as suggested by the presence of residual nuclear contents at the 
first corneocytes and the peridermal layer.  
To further investigate the phenotypic alterations exhibited in a dysfunctional CerS3 
epidermis, focus was shifted towards analyzing the expression and distribution of 
another key CE protein, involucrin. Although no alteration at the total protein level 
was detected by immonoblotting (Figure 40C), a slight delay in expression at the SG 
was observed at the immunofluorescence level in mutant skin (Figure 41G and 41H). 
Our in situ methanolic mild alkaline treatment was additionally performed to visualize 
involucrin in the CE, considering the published covalent interactions of ceramides 
with involucrin. However, involucrin immunolabeling did not exhibit any change in 
their distribution neither with control or mutant epidermis (data not shown). 
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The total protein content of transglutaminase 1 was moderately decreased in 
CerS3d/d epidermis. In vitro, transglutaminase 1 has demonstrated its capability for 
catalyzing the crosslinkage of CE proteins, in addition to potentially catalyze the 
transesterification of ω-hydroxy-ceramides with the carboxy residue of CE proteins. 
To examine whether alterations in transglutaminase 1 activity existed in mutant 
epidermis, an in situ activity assay with monodansylcadaverine as a substrate were 
performed on freshly prepared epidermal cryosections. Although the fluorescence 
intensity associated with the monodansylcadaverine antibody was slightly diminished 
in mutant epidermis, its distribution at the viable layers of the skin did not differ from 
controls (Figure 41I and 41J). 
 
3.3.6. Drastic reduction of epidermal ceramides is associated with altered lipid 
lamellar structures upon CerS3 deficiency  
Cholesterol, as well as polar and neutral lipids, were examined on skin sections of 
CerS3d/d by fluorescence labeling with filipin and nile red, respectively. Both probes 
revealed a pearl-like distribution of lipids in the SC of mutant epidermis, while their 
distribution in the lower epidermal layers did not seem to be altered (Figure 42A and 
42B). In control epidermis, the transition of the polar lipids present at the SG to the 
golden lamellae of neutral lipids at the SC could be clearly seen with nile red staining. 
On the contrary, punctual concentration of lipid species was nicely observed 
predominantly at the upper layers of the SC of CerS3 deficient mice (Figure 42B 
inset, red arrow). 
 The non-lamellar lipid agglomerates correlated at the ultrastructural level with 
electron-light intercellular lentil-like structures in mutant SC. Absence of lamellar unit 
structures that are required for the establishment of a mature lipid barrier was 
obvious between these lipid agglomerates (Figure 42C, red arrow), as the 
intercellular space between corneocytes was maximally reduced. The length 
between the limits of the electron dense CE of two adjacent corneocytes was 
estimated to be about 3 to 4 nm in CerS3d/d mice (Figure 42C, yellow arrow), which is 
less than a third of the determined 13 nm occupied by the intercellular unit lamellar 
structures (White et al., 1988). 
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Figure 42. Altered epidermal lipid content and secretion of CerS3d/d mice. 
Labelling of cholesterol with filipin and polar and netral lipids with nile red (inset) 
revealed the proper linear formation of lipid lamellae on skin sections of control mice 
(A), while exhibiting a dot-like pattern on CerS3d/d skin (B). Ultrastructure of focalized 
lipid agglomerates located within the intercellular space of CerS3d/d SC (C, red 
arrow), as seen at the electron microscopical level in skin sections treated with tannic 
acid. The intercellular space (yellow arrow) was estimated to be about 3–4 nm, 
where mature lamellar membrane unit structures were absent. The presence of 
clearly visible corneodesmosomes (red stars) in mutant SC is also indicated. Mass 
spectrometric quantification of epidermal ceramides (D), glucosyl-ceramides (E) and 
sphingomyelins (F) of wild type, heterozygous and homozygous CerS3 mice. 
Sphingolipids were analysed as non-hydroxy fatty acids (NS), α-hydroxy fatty acids 
(AS), ω-hydroxy fatty acids (OS), linoleic acid esterified ω-hydroxy fatty acids (EOS) 
and protein bound ω-hydroxylated fatty acids (POS). Error bars indicate the SEM 
from 3 animals analyzed per group. Low magnification electron micrograph of CerS3 
mutant interface (G) and corresponding higher magnification mutant interface from 
white-marked rectangle (I). Lipid agglomerates were present in mutant epidermis 
particularly at tri-cellular contact sites or previous contact sites at the SG (red 
arrows). Abundant lamellar material packed in small stacks composed of short 
lamellar discs (I and J) were observed in mutant SC, whereas the interface of control 
mice (H) displayed stacks consisting of lamellar discs with a larger diameter and 
showing initial transformation into lamellar unit structures. 
 
 
To evaluate which lipid species were altered due to the lack of CerS3, thin layer 
chromatography of free extractable lipids was performed (Figure A6A). Most TLC 
bands derived from ceramide (Cer) and glucosylceramide (GlcCer) species were 
extremely reduced or abolished in mutant mice, whereas no stricking differences 
could be observed for heterozygous mice. The structural differences within the Cer or 
GlcCer species resulted in several bands, which differences in the length of their acyl 
chains and hydroxylation produced an unequal mobility through the silica plate. 
Taking into account the different retention of the lipid species, we could distinguish 
between low migrating bands containing hydroxylated lipid species, and upper 
migrating bands with no hydroxylation and increasing mobility with increasing acyl 
chain length. Furthermore, the most fast migrating bands appeared with Cer and 
GlcCer being ω-esterified with another acyl chain, mainly linoleic acid. Both lower 
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migrating bands of Cer and GlcCer appear to be the only ones to be increased with 
CerS3 deficiency. These bands could be associated with α-hydroxylated LC-Cers 
and GlcCers. No major differences of other lipid species were evident. 
To obtain a detailed lipid profile of epidermal extracts, quantitative mass 
spectrometric analyses were performed. CerS3 deficient mice exhibited a general 
drastic reduction of Cers, GlcCers and SMs (Figure 42D-F). Free extractable 
ceramides with no hydroxylation (NS) or with hydroxylation at the α-position (AS)  
were strongly reduced but still present in deficient skin. The majority of epidermal 
ceramides are a special class containing ultra long chain ω-hydroxylated acyl 
moieties (OS). Most of these OS-ceramides are esterified at the ω-position with 
another fatty acid (EOS), predominantly linoleic acid. The second major group is 
ω-esterified to CE-proteins (POS). All three forms of OS-sphingolipid species were 
absent in mutant epidermis. Similar changes were observed for SM and GlcCer 
species in CerS3d/d mice. Wild type and heterozygous mice did not differ significantly 
for any class of sphingolipid analyzed.  
Mass spectrometry enabled us to determine quantitatively the profile of acyl 
moieties linked by an amide bond to the LCB of Cers, GlcCers and SMs (Figure 
A6B). In agreement with TLC analyses, LC-Cer and GlcCer primarily containing 
palmitate (16:0) or hydroxylated palmitic acid (h16:0) residue were slightly elevated in 
CerS3d/d mice. Acyl residues containing lignoceroyl (24:0) were significantly 
diminished, whereas Cers, GlcCers and SMs containing cerotoyl (26:0) or ULC-FA 
residues were completely absent in homozygote CerS3 mutants. The latter ULC-acyl 
moieties are the only source of ω derived sphingolipids. In composite, mass 
spectrometric analyses revealed that CerS3 depleted mice lacked about 90% of all 
epidermal ceramides. 
Continuous lamellar sheets oriented in parallel and filling the intercellular spaces 
of the intermediate and upper SC are built up by fusion from nascent lamellar stacks 
secreted by lamellar bodies (LB) at the SG-SC interface (see section 1.4.2.5.). In 
control mice, these stacks were composed of large discs (Figure 42H), which were 
progressively transformed into the typical lamellar basic structures organized in 
parallel to the PM. In contrast, LB-derived stacks of CerS3 deficient epidermis were 
smaller and lamellar discs displayed a shortened diameter (Figure 42I and 42J). 
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Furthermore, in the upper SC layers non-lamellar material clustered forming 
agglomerates particularly at the tri-cellular contact sites (Figure 42G, red arrow), and 
the intercellular spaces between corneodesmosomes were maximally reduced 
lacking mature lamellar unit structures.  
 
3.3.7. Loss of CerS3 but not of CerS2 function results in a drastic reduction of 
epidermal ceramides/sphingolipids. 
In vitro ceramide synthase assays demonstrate the requirement of CerS3 activity for 
the biosynthesis of ULC-ceramides/sphingolipids, while excluding the role of CerS2 
for their biosynthesis. However, CerS2 transcript levels were significantly expressed 
in murine skin, as observed by quantitative RT-PCR (Figure 43A). To assure our in 
vitro findings and thereby rule out the involvement of CerS2 in the formation of 
essential epidermal sphingolipids in vivo, the epidermal lipid composition of 
CerS2gt/gt mice were analyzed and compared with CerS3d/d. In CerS2gt/gt mice, no 
decrease was observed for any kind of epidermal ceramide species, not even for 
ceramide containing a lignoceroyl residue (24:0), the preferred product of CerS2 
activity (Figure 43B). In contrast, epidermal ceramides with an acyl chain of 24–28 
carbon atoms in length were moderately increased by 15 and 35% in heterozygote 
and homozygote mutant CerS2 mice, respectively (Figure 43C), thus demonstrating 
that CerS2 is not required for the biosynthesis of ω-hydroxy-ceramides with ultra long 
chain acyl residues.  
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Figure 43. Loss of CerS2 activity does not account for reduction in epidermal 
ULC-ceramides.  
(A) Quantitative RT-PCR of Cers transcripts in wild type and mutant CerS3 mice. (B) 
Ceramide profile of CerS2 and CerS3 mutants as compared with their respective wild 
type and heterozygous littermates. No reduction of any ceramide species was 
observed in CerS2gt/gt mice. (C) Mass spectrometry of ceramides and 
glucosylceramides in neonatal wild type and CerS2 deficient epidermis indicating no 
alterations for EOS-ceramides. Error bars indicate SEM with *** for p<0.001 and * for 
p<0.05. 
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3.3.8. Severe pathogenic infection on cultured skin biopsies of CerS3 deficient 
mice 
A specific ratio of SC lipids is critical for proper epidermal barrier function. Alterations 
within this ratio, as well as differences between their lipid species have been 
implicated in multitude of diseases, particularly in atopic dermatitis and psoriasis 
(Coderch et al., 2003). Besides, certain SC have been suggested to have 
antimicrobial activity (Arikawa et al., 2002; Bibel et al., 1992). Among them, 
decreased sphingosine levels have been suggested to play a significant role in the 
vulnerability of microbial infections in patients suffering atopic dermatitis. This 
reduction in sphingosine concentration in diseased SC is probably a consequence of 
diminished ceramide levels. In order to establish whether the lack of major ceramides 
had an influence on the susceptibility of pathogenic infections, skin biopsies of CerS3 
deficient mice were infected with Candida albicans, which is a common opportunistic 
pathogen infecting epidermis of patients with compromised skin integrity. 
 Control skin infected with 1×106 cells of C.albicans exhibited only sporadically and 
in low concentration these pathogens attached to the surface of the skin biopsies 
independently from the incubation time (Figure 44A). In contrast, an extensive growth 
could be already observed as early as 6 h after inoculation of the pathogen in CerS3 
deficient skin (Figure 44B). Histological examinations with increasing incubation 
times with the fungi, demonstrated a prominent increase of C.albicans after 24 h in 
mutant skin (Figure 44C-D), which was more pronounced after 66 h (Figure 44E-F). 
In addition, skin biopsies from mutant embryos at stage of E18.5 ± 0.5 exhibited 
increased pathogenic growth after 24 h post inoculation, as compared with control 
littermates. Pathogenic growth was determined by quantification of the colony 
forming units (CFU) generated from the yeast that infected the skin biopsies (Figure 
A7A). Addition of pathogens onto the SC of cultured skin resulted in a 3.5 fold 
increase of CFU in CerS3 deficient skin.  
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Figure 44. Severe pathogenic infection on cultured skin of CerS3 deficient 
mice.  
Cultured skin from neonatal control and CerS3d/d mice were inoculated with 
C. albicans and incubated for 6 h (A and B), 24 h (C and D) and 66 h (E and F) at 
30 ºC. Paraffin sections of 1 µm thickness were stained with periodic acid-Schiff 
(PAS). Localization of the basement membrane in mutant skin is indicated (black 
arrows).  
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With increasing incubation time, Candida albicans developed pseudohyphae, 
which penetrated the SC and invaded the living epidermal layers down into the 
dermis only in mutant skin. Upon 24 h incubation, deficient CerS3 skin exhibited 
extensive invasive pathogen infiltration into the suprabasal layers (Figure 44D), 
which could not be observed in cultured control skin (Figure 44C). Following the 
invasion phase, increased bud morphology and colony formation could be observed 
within the nucleated epidermal layers (Figure 44F). At 66 h, mutant epidermis 
exhibited pseudohyphae that crossed the basement membrane migrating into the 
dermis, which was marked by the abundance of infiltrated immune cells (Figure 44F).  
In addition to the lipid barrier, microbial growth is greatly inhibited by specialized 
peptides and proteins that serve as an additional defense mechanism. These 
antimicrobials peptides are generally packed and extruded by LB in the intercellular 
space of the SC. Upon recognition of the pathogens by the innate immune response, 
antimicrobial peptides are activated and secreted in order to combat pathogenic 
invasion primarily by disrupting the microbial membrane (Yamasaki and Gallo, 2008). 
To examine whether the increased microbial growth in mutant skin was a 
consequence of an alteration in the expression of these antimicrobial peptides, 
quantification of their transcript levels was determined (Figure A7B). However, 
murine β-defensins, as well as the unique murine cathelicidin expression levels were 
comparable in CerS3 deficient skin and control. Therefore, antimicrobial peptides 
could not account for the differences in microbial growth between control and mutant 
CerS3 skin. 
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4.1. Coexpression of Cers3 and ULC-sphingolipids in mature male 
germs cells and skin  
 
Sphingolipids containing a fatty acid moiety ranging between 16 and 24 carbon 
atoms in length have been found constitutively expressed in the plasma membrane 
of all mammalian cells. However, testicular and epidermal cells additionally express 
high concentrations of sphingolipids with ultra long chain acyl moieties. In testis, 
polyenoic (4 to 6 double bonds) ULC-CoAs of 28 to 32 carbon atoms are 
incorporated into ceramides, which can be further modified generating 
sphingomyelins or complex glycosphingolipids. Sphingolipids containing ULC-PUFA 
residues might be exclusively expressed in maturing male germ cells, since the 
depletion of ULC-PUFA complex GSLs causes azoospermia due to an arrest of the 
spermatogenic cycle at the stage of spermatid formation in GM2S/Galgt1-/- mice 
(Sandhoff et al., 2005). On the other hand, mainly saturated and monounsaturated  
ω-hydroxylated ULC-CoAs of 26 to 36 carbon atoms in length are expressed in highly 
abundant ceramides of the stratum corneum (Sandhoff, 2009). There, ULC-
sphingolipids are required from the late embryonic stage on (E16.5-18.5 in mice) for 
the formation and maintenance of the epidermal permeability barrier, as 
demonstrated with the specific deletion of the glucosylceramide synthase under the 
promoter of keratin 14 (Jennemann et al., 2007). However, the functional role of 
polyenoic ULC-sphingolipids in testicular cells is still elusive. To unveil the molecular 
mechanism by which ULC-sphingolipids enable the progress of spermatogenesis, it 
is a prerequisite to fully understand their biosynthetic requirements. Therefore 
identifying the ceramide synthase/s responsible for their biosynthesis is mandatory.   
 Currently the six members of the ceramide synthase family have been 
characterized regarding their substrate affinity towards a range of acyl-CoAs whose 
length varied from 14 to 26 carbon atoms. From these studies, CerS2 and CerS3 
were reported to best incorporate the longest subset of acyl-CoAs (Laviad et al., 
2008; Mizutani et al., 2006).  
 Analysis of the tissue distribution of CerS3 demonstrated its high expression in 
murine testis and skin, the only tissues reported to contain major concentrations of 
ULC-ceramides. On the other hand, CerS3 could not be detected in brain, liver and 
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colon. These organs express sphingolipids exclusively with conventional acyl 
moieties ranging from 16 to 24 carbon atoms. These results were further confirmed 
by two independent studies (Laviad et al., 2008; Mizutani et al., 2006). In contrast, 
CerS2 has been reported to be ubiquitously expressed, with its highest transcript 
levels found in kidney and liver (Laviad et al., 2008).  
In order to correlate the expression of ULC-sphingolipids with the ceramide 
synthase/s responsible for their biosynthesis, detailed transcript analyses of the Cers 
family were performed in mature mouse testes and neonatal skin. With the exception 
of Cers1, the expression levels of the remaining Cers homologues could be detected 
in either one or both tissues to various extents.  
 Cers3 was the most prominent Cers expressed in testis and the second most 
abundant in skin, only overtaken by 1.5-fold upregulation of Cers2.  In addition to 
ULC-acyl moieties, epidermal sphingolipids contain large quantities of VLC-acyl 
residues with 26 carbon atoms, which have been shown to be acylated to produce 
ceramides by CerS2 in vitro (Laviad et al., 2008). Therefore, it would be expected to 
have abundant Cers2 levels in the epidermis. Whether exclusively CerS2 or in 
addition CerS3 are able to synthesize sphingolipids with cerotoyl moieties will require 
further studies. Nevertheless, it seemed plausible that CerS3 might be the enzyme 
required for the biosynthesis of ULC-sphingolipids, since its mRNA and tissue 
expression correlates with the presence of sphingolipids containing ULC-acyl 
moieties. 
On the other hand, Cers2 mRNA was also expressed in testis, although its 
transcript levels only accounted for 15% of those of Cers3. Since recent studies have 
demonstrated that CerS2 can incorporate acyl-CoAs of 20 to 26 carbon atoms in 
length (Laviad et al., 2008), CerS2 still was a potential candidate capable of 
producing ceramides with unconventional ULC-acyl residues.  
 Both testis and skin expressed fairly abundant levels of Cers5, whereas the 
relative Cers6 expression levels were rather low. Nevertheless, CerS5 and CerS6 
have been reported to incorporate acyl-CoAs with a chain length ranging from 14 to 
18 but not more carbon atoms (Mizutani et al., 2005; Riebeling et al., 2003). Hence, it 
seems unlikely that neither of these two enzymes could catalyze the synthesis of 
sphingolipids using acyl-CoAs with 28 and longer carbon atom chains as substrates. 
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Cers4 exhibited a moderate expression in mouse skin, however its mRNA 
concentration was barely detectable in testis. In skin, Cers4 has been reported to be 
mainly expressed in acinar cells of the sebaceous glands (Meixner, 2009). Besides, 
the highest ceramide synthase activity of CerS4 was achieved with acyl-CoA 
substrates ranging from 18 to 22 carbon atoms, with negligible activities for longer 
fatty acid substrates (Riebeling et al., 2003). Likewise CerS5 and CerS6, it would be 
rather unexpected that CerS4 could catalyze the condensation of ULC-acyl-CoAs 
with a sphingoid base to produce ULC-ceramides.  
Consistent with the correlation of mRNA and tissue expression of the Cers 
homologues in the major tissues expressing ULC-sphingolipids, it was concluded that 
CerS2 and CerS3 are the only potential candidates that might be involved in the 
synthesis of ULC-ceramides. In order to confirm or reject their role in this pathway, 
their transcript expression levels were compared to the concentration of ULC-
sphingolipids during the progress of the first spermatogenic cycle. 
Levels of testicular sphingolipids containing ULC-PUFA moieties were found to be 
increased during juvenile maturation. In particular, mass spectrometric analyses of all 
types of sphingolipids according to their fatty acid residues revealed the presence of 
exclusively conventional fatty acid moieties (of 16 to 24 carbon atoms) during the 
earlier stages of postnatal testicular development (Rabionet et al., 2008). LC- and 
VLC-sphingolipid expression correlated with the elevated mRNA content of Cers5 
and Cers6, as well as of Cers2, whose highest substrate specificities have been 
reported to be precisely acyl-CoAs of 16 and 24 carbon atoms, respectively (Lahiri 
and Futerman, 2005; Laviad et al., 2008). In contrast, Cers3 mRNA levels prior to 
PN 14 were barely detectable.  
From PN 14 to PN 15, Cers3 mRNA was exceptionally upregulated, coinciding 
shortly afterwards with the detection of the first ceramides, sphingomyelins and 
glycosphingolipids containing ULC-PUFA residues. To the contrary, the transcript 
levels of all Cers expressed in murine testis were simultaneously downregulated. 
 The concentration of polyenoic ULC-sphingolipids increased progressively until 
steady state levels were reached between PN 25 and PN 30. In addition, detailed 
analyses of complex fucosylated GSLs demonstrated the concomitantly increase of 
the neutral subset, which exclusively incorporate ULC-PUFAs. On the other hand, 
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fucosylated ganglioside GM1 (FucGM1) was already present from the early stages of 
the first spermatogenic cycle and its concentration increased moderately from PN 14. 
FucGM1 was composed of ULC-PUFAs and a major portion of LC-FAs (h16:0) 
(Rabionet et al., 2008). 
Whereas the overall levels of Cers2, Cers5 and Cers6 remained relatively 
constant from PN 14 to PN 25, Cers3 transcript expression prominently increased 
correlating with the elevated levels of ULC-sphingolipids. The total increase of Cers3 
mRNA from PN 5 to PN 25 was calculated to be more than 700 fold. 
Additionally, Cers3 mRNA was unique among Cers transcript levels to be 
completely depleted in mutant KitW-v/KitW mice testes that lacked ceramides, 
sphingomyelins, and GSLs including FGSLs with ULC-PUFA residues. Infertile 
KitW-v/KitW mice testes are devoid of intact differentiated germ cells, by that 
underpinning that the latter are the source of polyenoic ULC-sphingolipids. Moreover, 
neutral FGSL – which are extremely rich in ULC-PUFAs – were localized by 
immunohistochemistry to differentiated germ cells, i.e. pachytene spermatocytes, 
spermatids and spermatozoa (Sandhoff et al., 2005). Thus, the lack of fertility-
essential neutral FGSL carrying ULC-PUFA residues in conjunction with the absence 
of Cers3 mRNA in infertile KitW-v/KitW mice provided evidence of their requirement in 
differentiating male germ cells and to be crucial for the proper development of 
complete spermatogenesis. 
Furthermore, the acidic subset of FGSL was reduced in mutant mice (Rabionet et 
al., 2008). Previously, its major component FucGM1 was mainly localized in 
spermatogonia stem cells. As a result, FucGM1 additionally was composed of 
significant amounts of palmitic acid (16:0 and h16:0) besides of ULC-PUFA residues 
(Sandhoff et al., 2005). The incorporation of the palmitic acid moiety might be 
catalyzed primarily by Cers6 and/or Cers5 (Mizutani et al., 2005; Riebeling et al., 
2003). In KitW-v/KitW mice, significant transcript levels of both Cers5 and Cers6 were 
detected, thus suggesting their localization in either somatic cells and/or residual 
spermatogonia. Taking into consideration that all Cers expression levels were 
decreased in infertile KitW-v/KitW mice, we additionally determined the percentatge of 
Cers mRNA relative to the total Cers mRNA levels per mice (data not shown). 
Neither Cers5 nor Cers6 relative transcript levels were reduced in mutant testicular 
Discussion 
 
    
 150 
mRNA, which might indicate a major role of these ceramide synthase homologues in 
the synthesis of LC-sphingolipids in testicular somatic cells or type A spermatogonia. 
Relative transcript levels of Cers2 were decreased in sterile KitW-v/KitW mice testes. 
This suggests an expression in basal and eventually adluminal differentiated germ 
cells, although its residual mRNA levels suggest in addition a somatic and/or 
spermatogonial origin. In the latter, CerS2 accounts for the synthesis of non-
fucosylated VLC-sphingolipids.  
In summary, Cers3 mRNA concentration strongly correlates with the expression of 
ULC-sphingolipids in murine skin and differentiated male germ cells, suggesting its 
unique role in the synthesis of these unconventional sphingolipids. During the first 
spermatogenic cycle in mice, their onset of expression coincided beyond PN 14–15, 
simultaneously with the migration of the first primary spermatocytes through the 
blood testis barrier (BTB) and the formation of early pachytene spermatocytes at the 
adluminal compartment of the seminiferous epithelium.   
 
 
Figure 45. Murine spermatogenesis and associated sphingolipid expression. 
Intersticial cells, Sertoli cells and germ cells of the basal compartment express 
sphingolipids with LC- and VLC-FAs, mainly palmitic acid, whereas adluminal germ 
cells and spermatozoa express primarily sphingolipids with ULC-PUFA moieties. PN: 
post natal; SG: spermatogonia; pl/l SC: preleptotene/leptotene spermatocytes; rST: 
round spermatids; eST: elongated spermatids; Sza: spermatozoa; BL: basal lamina; 
IS: intersticial cells; LC: Leydig cells. Scheme modified from (Rabionet et al., 2008).  
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The physiological role of ULC-sphingolipids in spermatogenesis and male fertility 
is currently unknown. However, some indications might suggest their requirement for 
the proper maintenance of the BTB dynamics. The BTB is constituted by an array of 
specialized junctional complexes established by polarized Sertoli cells. Lack of 
polyenoic LC-FAs due to the specific disruption of the ∆6-fatty acid desaturase 
(Fads2) leads to a disruption of the BTB and loss of Sertoli cell polarity, resulting in 
spermatogenesis arrest at the stage of round spermatid formation and ultimately to 
azoospermia (Stoffel et al., 2008). Fads2 blocks the rate-limiting step in the 
desaturation of linoleic (ω6-18:2) to γ-linoleic (ω6-18:3) and of α-linoleic (ω3-18:3) to 
stearidonic acid (ω3-18:4), precursors required for the subsequent elongation and 
further desaturation steps yielding ULC-PUFA synthesis. Although ULC-PUFAs and 
corresponding sphingolipids were not investigated by the authors, in the context of 
their findings, it could be derived that depletion of polyenoic ULC-sphingolipids might 
also alter the structural plasma membrane tight junctional complexes leading to an 
impaired assembly and disassembly of the BTB.  
Besides tight junction and gap junction complexes, the BTB is additionally 
constituted of actin-based adherens junctions, and intermediate filament-based 
desmosome-like junctions. These two latter types of cell-cell adhesion junctions are 
crucial for maintaining the close association between nourishing Sertoli cells and 
developing meiotic germ cells and spermatids. Throughout spermatogenesis, a great 
restructuring of these junctional complexes is required. Their defective 
remodeling/disassembly might lead to the formation of the multinucleated giant cells 
observed upon disruption of the GM2S/Galgt1 gene, wich lack all FGSLs containing 
ULC-PUFA moieties (Rabionet et al., 2008; Sandhoff et al., 2005).  
The functional role of ULC-PUFA sphingolipids might as well be interpreted by 
alternative hypotheses. During the progress of spermatogenesis, developing germ 
cell clones at different stages of differentiation must remain connected by intercellular 
bridges sharing one unique cytosol and plasma membrane. These intercellular 
bridges are lost and multinucleated giant cells are formed in GM2S/Galgt1 deficient 
mice (Sandhoff et al., 2005). Hence, the stability, maintenance and regulation of this 
incomplete cytokinesis, as well as the complex membrane processes during 
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proliferation and elongation of spermatids, could be modulated by this 
unconventional lipid class.  
Structurally, the multiple cis-olefinic moieties might reduce the intercellular Van der 
Waals forces probably driving the local deformation of the lipid bilayer, thus reducing 
the lipid packaging, which might ultimately lead to an increase in membrane 
flexibility. In addition to be relevant for membrane fusion events, the elevated 
membrane fluidity in mature germ cells is believed to be required for motility (Nolan 
and Hammerstedt, 1997; Stoffel et al., 2008). In this regard, polyenoic fucosylated 
GA1 could be localized at the tail of developing spermatozoa by immunolabeling with 
anti-Fuc-GA1 (Sandhoff et al., 2005). In a further study, Furland and coworkers 
linked polyenoic ULC-sphingomyelins and ceramides to the head of spermatozoa. 
The authors reported high levels of sphingomyelin degradation favoring ceramide 
formation upon spermatozoa capacitation. This hydrolysis could play a role in 
prefertilization events required for the correct consummation of the following 
acrosomal reaction (Furland et al., 2007).  
Alternatively, the homeobox domain encoded within the Cers3 gene might have a 
key role in regulating germ cell differentiation, as have been already observed for 
other homeobox-containing genes (Wolgemuth et al., 1987).  
To unveil the functional role of CerS3 and polyenoic ULC-sphingolipids, novel in 
vivo models with germ cell specific depletion of these unconventional lipids will be 
necessary. In this regard, our efforts are currently focused on the conditional 
depletion of CerS3 in premeiotic male germ cells in vivo. 
Future perspectives regarding the modulation of ULC-sphingolipids might have an 
impact in male contraception. In this context, the newly identified CerS3 as a key 
enzyme for the biosynthesis of fertility-essential ULC-ceramides could be targeted to 
induce reversible infertility.  
 
4.2. ULC-sphingolipids are bona fide substrates of CerS3 in living 
mammalian cells 
 
To confirm the role of CerS3 in the biosynthesis of testicular and epidermal ULC-
sphingolipids, enzymatic assays with recombinantly expressed CerS3 in mammalian 
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cells were performed with acyl-CoAs ranging from 16 to 28 carbon atoms in length. In 
contrast to previous CerS assays where either cellular lysates or microsomes were 
used to assess CerS activity, we have established for the first time a CerS assay in 
living mammalian cells. Former in vitro enzymatic assays made extensive use of 
detergents to solubilize cellular membranes (Mandon et al., 1992; Mizutani et al., 
2005; Mizutani et al., 2006; Shimeno et al., 1998). However, it is well established that 
use of detergents might induce artifacts due to aggregation or even inactivation of 
membrane-bound enzymes (Zhou et al., 2001). By establishing a detergent-free 
assay we have been able to preserve the biochemical environment of the enzyme 
with minimal alterations of its in vivo conditions.  
Due to the lack of commercial availability of activated fatty acids longer than 26 
carbon atoms, ULC-acyl-CoAs had to be chemically synthesized. For this synthesis, 
the elegant approach of Lucet-Levannier and coworkers, which is especially 
designed for the preparation of highly lipophilic acyl-CoAs was employed (Lucet-
Levannier et al., 1995). By derivatizing the hydrophilic CoA to the polysilylated CoA, 
the coupling with the extremely hydrophobic ULC-FAs could take place under 
anhydrous organic conditions. This type of preparation differed conspicuously from 
the classical methods, which required the use of a binary mixture of water-organic 
solvent in order to solubilize both the CoA and the activated fatty acids with 
N-hydroxysuccinimide (Al-Arif and Blecher, 1969). The employment of binary 
mixtures leads either to a biphasic system in which the contact of reactants is not 
optimal, or to a homogeneous solution in which the solubilities of both reactants are 
diminished. In either case, the reaction proceeds in an inefficient manner thereby 
drastically reducing its chemical yield. Although the classical methods have been 
employed for the preparation of activated fatty acids in the range of 16 carbon atoms, 
we assumed that the synthesis of ULC-CoAs with an additional 12 carbon atoms and 
its increased accompanying hydrophobicity would render the conventional synthethic 
approach virtually impossible. Additionally, the usage of water results in undesired 
competing reactions due to the hydrolysis of the NHS-activated fatty acids by water. 
Previous to the ceramide synthase assay, overexpression of recombinantly 
expressed proteins was confirmed by flow cytometric analyses, as well as by 
immunoblotting.  Although CerS3 could be detected by Western blot as one single 
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band corresponding to the expression of the fusion EGFP protein, CerS2 exhibited 
four specific bands. These various protein products very likely arise from diverse 
post-translational modifications. A similar finding was observed with the detection of 
mCerS2-HA in overexpressed HEK-293T cells by Mizutani et al., who linked this to 
various N-glycosilation microheterogenities (Mizutani et al., 2005). In addition, the 
authors reported that CerS5 and CerS6 are also N-glycosylated proteins, whereas 
CerS1 and CerS4 are not. Here, we reported that CerS3 produced in overexpressing 
HeLa cells exhibited one unique band, likely indicating the absence of post-
translational glycosilations.  
The ceramide synthase activity was examined by exposing CerS3, as well as 
CerS2 and control EGFP expressing HeLa cells to an acyl-CoA mixture 
(16:0,18:0,20:0,24:0,26:0,28:0), simultaneously with d17:1-sphingosine for 20 h. To 
determine the de novo synthesized ceramides, we took advantage of the lack of 
sphingosine (d17:1) in our mammalian cell culture system. Although sphingosine 
(d18:1) is predominant in most mammalian tissues due to the preference of serine 
palmitoyl transferase towards palmitoyl-CoA (Hanada, 2003), minor amounts of 
various long chain bases including d17:1 have been detected in several tissues, e.g. 
skin (Farwanah et al., 2007). Using this non-endogeneous sphingoid base as a 
substrate, we were able to quantify ceramides with a d17:1 backbone that 
corresponded to newly synthesized metabolites. Quantification of d17:1-ceramides 
could only be carried out with suitable internal standards that were synthesized 
specifically for this purpose in this thesis. 
Upon availability of an equimolar mixture of acyl-CoAs that included an ULC-acyl-
CoA, CerS3 exclusively produced cerotoyl- (26:0-Cer) and montanoyl-ceramides 
(28:0-Cer) in a significant manner, thereby demonstrating its capability for ULC-
ceramide synthesis. Formerly, in vitro CerS3 activity assays performed with 
overexpressed cell lysates indicated that CerS3 has very broad substrate specificity. 
With acyl-CoAs ranging from 16 to 26 carbon atoms, CerS3 exhibited the highest 
activity towards stearoyl-CoA (18:0), with an additional affinity towards behenoyl-CoA 
(20:0) and lignoceroyl-CoA (24:0) (Mizutani et al., 2006). 
In our living cell model, besides the observed affinity of CerS3 towards 26- and 
28-CoAs, no other acyl-CoA substrate did exhibit a significant increase upon CerS3 
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expression. However, preliminary results of our own in vitro CerS3 activity assays 
using cell lysates indicated increased production of lignoceroyl-ceramide (Rabionet 
and Sandhoff, unpublished results), thus partially supporting the findings obtained by 
Mizutani and coworkers. The CerS3 affinity towards shorter chain substrates might 
be overruled in our model by the high levels of endogenously expressed CerS2, 
which has been demonstrated to catalyze primarily the formation of 22- and 
24-ceramides (Laviad et al., 2008). Nevertheless, the present CerS assay 
demonstrated that CerS3 in contrast to CerS2 could catalyze the acylation of 
sphingosine using ULC-CoAs as substrates in living human cells.  
These findings could successfully be confirmed in a yeast model in collaboration 
with Prof. Dr. Howard Riezmann from the University of Geneva (Epstein and 
Riezmann, personal communication). In their model, the ceramide synthase 
specificity of CerS2 and CerS3 was assayed in a mutated yeast strain capable of 
synthesizing montanoyl-CoA. In particular, the mammalian mCerS2 or hCerS3 
proteins were introduced in a S. cerevisiae strain, which was previously depleted of 
the yeast ceramide synthases Lag1p and Lac1p. These strains were further 
transformed with a plasmid encoding a mutated version of the yeast fatty acid 
elongase protein, Sur4p. In this context, the major ceramide species generated by 
expression of CerS2 contained VLC-acyl moieties ranging from 22 to 26 carbon 
atoms in length, as previously reported. However, availability of 28:0-CoA did not 
produce any effect on the relative inositolphosphorylceramide (IPC) concentration, 
and thus supporting our findings that CerS2 is not capable of synthesizing 
sphingolipids with acyl moieties longer than 26 carbon atoms. 
In contrast, CerS3 produced ceramides with stearoyl and cerotoyl moieties in the 
absence of ULC-CoAs, again partially confirming the results of Mizutani and 
coworkers. However, the presence of montanoyl-CoA in the fatty acid pool lead to a 
strong increase of ULC-ceramides, hence corroborating the capability of CerS3 for 
synthesizing ceramides with ultra long chain acyl moieties.  
The specific depletion of CerS3 in vivo definitely established the role of CerS3 in 
the biosynthesis of ULC-ceramides. Quantitative mass spectrometric analyses of 
epidermal extracts revealed the complete lack of sphingolipids containing acyl 
moieties ranging from 26 to 36 carbon atoms in length. Additionally, the 
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concentration of lignoceroyl-sphingolipids was significantly decreased, thus indicating 
CerS3 to have certain affinity towards 24-CoA. Shorter chain acyl residues did not 
show any significant decrease upon CerS3 deficiency. 
Besides, the epidermal sphingolipid profile of CerS2 depleted mice was 
additionally investigated. These investigations lead to the conclusion that CerS2 does 
not play a role in the biosynthesis of ULC-sphingolipids, evidenced by the lack of 
reduction of ULC-ceramides.  
In summary, the in vitro and in vivo findings demonstrated that in the presence of 
ULC-acyl-CoAs, CerS3 preferentially incorporates acyl residues of 24 to 36 carbon 
atoms in length. In contrast, CerS2 is unable to produce ceramides using ULC-CoAs 
as acyl donors. The reported specificities of the remaning ceramide synthase 
homologues that were not included in the present study have all been reported to 
incorporate shorter acyl-CoA substrates. CerS5 and CerS6 primarily incorporate 
palmitic acid, whereas CerS1 incorporates stearic acid, and CerS4 produces 
ceramides ranging from 18 to 22 carbon atoms in length. Taken all together, we 
provide evidence that CerS3 is the only mammalian ceramide synthase capable of 
synthesizing ULC-sphingolipids. With these findings at hand, we are finally able to 
attribute the complete spectrum of acyl chain residue specificities to their respective 
members of the ceramide synthase family (Figure 46). 
 
 
 
Figure 46. Substrate affinity of the ceramide synthases. 
Proposed correlation of the ceramide synthases with their respective substrates, 
according to previous reported affinities and the current study. 
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4.3. CerS3 is essential for epidermal barrier function and survival 
 
To unveil the physiological role of CerS3 and ULC-sphingolipids in vivo, we 
investigated the impact of CerS3 deficiency in mice with a targeted disruption of 
exon 7. This exon includes highly conserved amino acids of the lag1 motif, which has 
been shown to be required for the enzymatic activity of the ceramide synthase 
proteins (Spassieva et al., 2006). Furthermore, the majority of amino acids that 
constitute the floxed exon 7 are predicted to localize within a transmembrane domain 
(Figure 22, TM3), therefore its deletion most probably invers the topology of the 
subsequent protein sequence including the residual part of the lag1 domain 
containing the catalytic activity. In addition and in contrast to control mice, CerS3 
could not be detected in skin biopsies of mutant mice. CerS3 immunolocalization 
analysis performed with a self-designed polyclonal antibody against the last 25 amino 
acids of the C-terminus revealed CerS3 expression within keratinocytes of the upper 
SS and SG of control epidermis. However, CerS3 immunolabeling failed to detect the 
epitope in the skin of mutant mice, thus suggesting a misfolding and/or degradation 
of the truncated protein of which the mRNA is expressed. Together with the 
confirmed deletion of exon 7 by means of PCR, transcript sequencing and Southern 
blot analyses, these results indicate that exon 7 deletion renders CerS3 
dysfunctional. 
CerS3d/d mice exhibited universal premature death within 3 hours postnatally. 
Severe defects of the epidermal barrier function were associated with the neonatal 
mortality in CerS3 deficient mice, evidenced by the rapid body weight loss 
concomitantly with transepidermal water loss, and increased skin permeability. 
According to the current stage of knowledge, the epidermal permeability barrier 
primarily resides in the enucleated layers of the SC, as well as within the typical TJs 
(zonulae occludentes) localized within the SG of the epidermis (Brandner, 2009; 
Kirschner et al., 2010b). The lipid lamellar sheets and the cornified lipid envelope, 
which surround each corneocyte, play a crucial role in maintaining the epidermal 
barrier homeostasis. In particular, abundant and epidermis-unique ceramides with 
hydrophobic ω-hydroxylated-ULC-acyl residues, which to a great extent are esterified 
with linoleic acid (EOS) or with proteins of the CE (POS), have been implicated as 
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critical regulators of the epidermal integrity and barrier function. For instance, 
decreased levels of epidermal ceramides with acyl moieties longer than 26 carbon 
atoms in mice with a targeted disruption of the fatty acid transport protein (Fatp4) 
resulted in severe impairment of the epidermal barrier (Herrmann et al., 2003). In 
Elovl4 deficient mice, lack of ω-hydroxylated-ULC-ceramides, due to the requirement 
of the enzyme for generating fatty acids longer than 28 carbon atoms, lead to early 
postnatal lethality, abnormally compact SC and defective permeability barrier (Li et 
al., 2007; McMahon et al., 2007a; Vasireddy et al., 2007). Furthermore, a harlequin 
ichthyosis mouse model bearing a non functional member of the ABCA family of 
transporters, Abca12, exhibited a thickened epidermis presumably due to lack of 
desquamation caused by a profound reduction of EOS-ceramides, consistent with a 
deficiency for the transport of EOS-ceramide precursors (Zuo et al., 2008). Finally, 
CGI-58 deficient mice lacking EOS- and to great extent also POS-ceramides, 
revealed this enzyme to be critical in the esterification process of OS-(Glc)Cer, with 
the consequent lethal defect of the epidermal permeability barrier (Radner et al., 
2009). 
In concert with the previous mouse models, drastic reduction of major epidermal 
ceramide species led to an impairment of the permeability barrier function in CerS3 
deficient mice. In our CerS3d/d mice, all ceramide classes containing ω-hydroxylated-
ULC-acyl residues, i.e. EOS-Cer, POS-Cer and OS-Cer were lacking in mutant 
epidermis. Consequently, the corresponding sphingomyelin and GlcCer species, 
which serve as precursors for the extracellularly secreted ceramides, were 
accordingly diminished. On the other hand, non-hydroxylated and α-hydroxylated-
ceramides that contain acyl residues up to 26 carbon atoms in length with cerotoyl-
ceramide (26:0 and h26:0) as the dominating species, were profoundly decreased in 
CerS3d/d epidermis. Detailed mass spectrometric analysis of the ceramide species 
according to their acyl residue revealed the completely lack of cerotoyl-ceramides 
(26:0 and h26:0) and the strong reduction of lignoceroyl-ceramides (24:0 and h24:0) 
in mutant epidermis, besides the mentioned depletion of ULC-ceramides. Therefore, 
these findings definitely evidenced the broad substrate affinity of CerS3, which 
primarily acylates sphingoid bases with fatty acids ranging from 26 to 36 carbon 
atoms in length, and to a lesser extent additionally with 24 carbon atoms. The 
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substrate specificity of CerS3 according to this in vivo model perfectly correlates with 
the increased cerotoyl- (26:0) and montanoyl-ceramide (28:0) levels observed upon 
induction of CerS3 in our living cell model, as well as the higher levels of lignoceroyl-
ceramide (24:0) detected using in vitro CerS activity assays with overexpressed 
CerS3 cell lysates. From these results, we concluded that CerS3 is essential for the 
synthesis of ULC-ceramides as they are found in testis and skin. 
The inability to maintain the epidermal barrier homeostasis upon CerS3 deficiency 
could be additionally contributed by the increased or altered paracellular permeability 
due to the presence of immature tight junctions. Instead of typical zonulae 
occludentes with a continuous distribution at the cell-cell borders, the intracellular 
plaque protein cingulin exhibited a discrete and focal distribution at the PM of SG 
keratinocytes of mutant epidermis. The presence of these maculae occludentes 
presumably maintains local but not zonular intercellular sealing at the SG, and thus 
combined with the lack of ω-hydroxylated-ULC-ceramides lead to a severe 
impairment of the epidermal permeability barrier.  
Loss of functional CerS3 resulted in a markedly thick and compact SC that lacked 
the less cohesive layers of the stratum disjunctum. This increased intercellular 
adhesion in mutant SC was associated with the persistence of non-peripheral/central 
corneodesmosomes that abundantly decorate the cell-cell borders of corneocytes at 
all the layers of the SC, and also between the uppermost superficial corneocyte layer 
and the periderm. Immunofluorescence analysis of desmosomal associated proteins 
indicated an impaired degradation of the intercellular cadherin desmoglein 1/2, the 
distribution of which appeared at all layers of mutant epidermis, including a distinctive 
expression at the entire cornified layer and between peridermal cells. In contrast, its 
distribution was restricted to the viable layers in control epidermis. Whereas 
desmosomal cadherins provide the anchoring sites for cell adhesion, intracellular 
plaque proteins are required for proper binding to the intermediate filaments. The 
distribution of the plaque proteins, e.g. desmoplakin and plakoglobin, were not 
significantly altered in mutant epidermis as compared to control. Therefore, the 
persistence of corneodesmosomes appeared to be linked to the defective 
degradation of the transmembrane corneodesmosomal cadherins. Taking into 
consideration that the epitope recognized by the desmoglein 1/2 antibody is localized 
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at the cytoplasmic C-terminal region, it could be assumed that not only the 
extracellular domain, but also the cytoplasmic C-terminal portion of these cadherins 
are still intact. In this regard, the lack of degradation of the phospholipid bilayer in the 
mutant SC might interfere with the proteolytic degradation of the transmembrane 
cadherins. The aberrant persistence of the conventional PM in the intercellular space 
between corneocytes could be occasionally detected at the ultrastructural level. This 
findings were supported by the diminished intercellular space within mutant 
corneocytes that could be estimated around 3 to 4 nm, which might corresponds to 
the hydrophobic core of a phospholipid bilayer.    
The highly regulated terminal cornification leading to desquamation of the 
uppermost corneocytes requires the proteolytic cleavage of these 
corneodesmosomal-associated proteins. From the epidermal proteases investigated, 
specifically the limited distribution of cathepsin D appeared to be involved in the 
thickening of the stratum compactum and the lack of formation of the stratum 
disjunctum of CerS3 deficient epidermis. Besides its constitutive role in the 
proteolytic degradation of intracellular proteins within the lysosomal compartment 
(Zaidi et al., 2008), epidermal cathepsin D has been localized in the intercellular 
space within adjacent corneocytes and has been implicated in the degradation of 
corneodesmosomes (Igarashi et al., 2004). Our findings were further confirmed by 
recent results showing a remarkable increase in the number of corneocyte layers 
resulting from the disruption of the cathepsin D gene in mice (Egberts et al., 2004). At 
the SG, nascent lamellar bodies carrying cathepsin D among other enzymes and 
lipids are predominantly delivered to the apical side of keratinocytes where they 
secrete their contents at the upper SG layers and between the SG-SC interface 
(Ishida-Yamamoto et al., 2004; Raymond et al., 2008). Consistent with the reported 
expression of cathepsin D, its immunolocalization in control skin was found in all the 
epidermal cell layers with the strongest expression at the SG. Contrarily, cathepsin D 
expression remarkably decreased at the SG and was absent in the SC of mutant 
epidermis. Therefore, a reduction in cathepsin D activity at the SG and SC layers of 
CerS3 deficient skin might lead to the impaired degradation of corneodesmosomal 
associated cadherins, and ultimately to a defective formation of the stratum 
disjunctum and persistence of the periderm.  
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At the extracellular space, LB secreted GlcCer and SM species are hydrolyzed to 
generate SC ceramides (Holleran and Takagi, 2006). This final lipid processing takes 
place at the optimum acidic pH of the SG-SC interface. Simultaneously with the 
extrusion of lipids, cathepsin D is secreted to the extracellular space, where the 
acidic pH is additionally required for its proteolytic activity. Previously, it has been 
demonstrated that ceramide directly interacts with cathepsin D resulting in the 
activation of the latter in vitro (Heinrich et al., 1999). Hence, it is reasonable to 
assume that extracellular ceramides might as well activate LB-derived cathepsin D. 
Taking this into consideration, the major lack of ceramide species upon the in vivo 
deficiency of CerS3 might result in the inactivation of the epidermal protease, which 
in turn leads to the persistence and defective degradation of the corneodesmosomes. 
Following this hypothesis further, the major deficiency of epidermal ceramides in 
Elovl4, Fatp4, CGI-58 and Abca12 deficient mice, besides our CerS3d/d mice, could 
explain the thickened and compact SC via the inactivation of the protease 
cathepsin D. However, no survey of the activities of the epidermal proteases in 
particular of cathepsin D, has been conducted yet in the specified mouse models. To 
further develop this hypothesis, the analysis of epidermal proteases should be the 
topic of future investigations.  
The loss of function of cathepsin D could in addition be partially or totally 
contributed by the increased epidermal pH in CerS3 mutant mice. This reduced SC 
acidity might result from a reduced concentration of extracellular free fatty acids, 
which might be derived from the lack of hydrolysis of phospholipids and eventually of 
ceramides. In order to provide more insight into the augmented SC pH in CerS3 
deficient mice, detailed mass spectrometric analysis of isolated SC free fatty acids 
would be required. 
As a consequence of the defective degradation of corneodesmosomes, the 
transient embryonic peridermal layer was found to persist in CerS3 mutant mice. The 
inmmunolocalization of the TJ associated claudin 1 and the demonstration of TJ 
structures at the ultrastructural level, directly proved the presence of the periderm in 
mutant epidermis. In addition, the periderm-specific TJ-associated claudin 6 was 
exclusively detected at the mutant SC (data not shown). These findings were 
additionally supported by the residual nuclear remnants detected within peridermal 
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cells, which could be visualized with the immunolocalization using DAPI as a nuclear 
marker. 
 In Abca12-/- mouse skin, the characteristic features of the lack of desquamation 
in corneocytes and the expanded thicknening of the SC, in correlation with no signs 
of enhanced keratinocyte proliferation, are entirely consistent with our observations in 
CerS3 deficient epidermis (Zuo et al., 2008). However, the lack of desquamation in 
CerS3 deficient mice could not explain the increased number of SC layers, 
considering that corneocyte shedding has not yet been initiated at birth, not even in 
control epidermis. This could be proven by the presence of inclusion bodies 
decorating the outermost corneocyte layer in both control and mutant mice. Taking 
into account that the proliferation rate of basal keratinocytes was not increased in 
mutant epidermis, the origin of the augmented corneocyte layers has to be differently 
reasoned. Currently, we hypothesize that the increase in adhesion at the SC due to 
the persistence of non-peripheral/central, as well as the peripheral/lateral 
corneodesmosomes results in an increased lateral interdigitation surface between 
corneocytes. Therefore, the count of corneocytes in mutant epidermis yields a higher 
virtual number of cell layers than actually are present. 
The in vivo disruption of CerS3 in addition led to defects in the regulation of 
keratinocyte differentiation within the nucleated layers of the epidermis. Impaired 
maturation of SG keratinocytes could be identified by the reduced size of filaggrin-
containing F-granules and by the reduced number of loricrin-containing L-granules. 
These alterations within keratohyalin granules were accompanied by decreased 
levels of loricrin and the aberrant processing of profilaggrin to monomeric filaggrin in 
CerS3d/d mice. In combination with the presence of immature zonulae occludentes 
indicated by the immunolocalization of cingulin, these phenotypic alterations 
evidenced a delayed or defective keratinocyte differentiation at the granular layers of 
mutant epidermis.  
The terminal cornification of keratinocytes is a remarkably coherent process 
involving pronounced morphological changes. Thus, the impaired maturation of 
granular keratinocytes presumably has severe repercussions on their transformation 
to enucleated corneocytes. CerS3 deficient epidermis exhibited various alterations 
that indicate a disturbed or delayed terminal differentiation of corneocytes. At mutant 
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SC, remnants of nuclear material and organelle structures could be detected up to 
the third corneocyte layer. In addition, F-actin expression and residual PAS-positive 
glycogen were also found within the first corneocyte layers. The molecular nature 
leading to these phenotypic alterations might underlie in the presence of the 
homeobox domain encoded in the Cers3 gene. In general, homeobox-containing 
genes regulate embryonic development and cell differentiation by encoding 
transcription factors capable of modulating gene expression (Mark et al., 1997). 
Although reports regarding the regulation of epidermal development and keratinocyte 
differentiation are scarce, several genes of the hox family have been identified to 
influence normal mammalian skin development, i.e. Hoxb13, Hoxa7 and Hoxc4 (La 
Celle and Polakowska, 2001; Mack et al., 2005; Rieger et al., 1994). Considering the 
outstanding alterations due to its dysfunctionality, we suggest that CerS3 could also 
transcriptionally regulate keratinocyte differentiation by targeting proteins required for 
the adequate maturation of granular keratinocytes. In this regard, subcellular 
immunolocalization studies of CerS3 possibly indicate the expression of its 
EGFP-recombinant protein in both the endoplasmic reticulum (ER) and the nuclear 
envelope. Previously, Mizutani and coworkers additionally detected CerS2 and 
CerS6 to the nuclear envelope and the perinuclear region, besides of the ER 
(Mizutani et al., 2005). Whether CerS3 could behave as a master regulator for proper 
development in the skin and may be in other tissues were it could be expressed in 
minor amounts will be the focus of our future investigations. Currently, no ceramide 
synthase homologue containing the homeobox domain, i.e. CerS2–6, has been 
described to influence gene expression. In order to provide insight into the 
biochemical mechanism by which CerS3 could modulate the activity of its target 
genes, specific mutations at the Cers3-homeobox domain, that do not affect 
ceramide synthase activity, should definitely clarify the functional role of CerS3 in 
mammalian epidermis.  
In addition to the defective development of keratinocytes at the SG and SC, 
various abnormalities could also be identified within the corneal layer. The 
extracellular lipid lamellae as well as the CE and the CLE were altered in mutant 
CerS3 mice. Regarding the CE, loricrin and transglutaminase 1 concentrations were 
diminished as determined by immunoblot analysis, whereas involucrin levels remain 
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unaltered upon CerS3 deficiency. The decreased levels of transglutaminase 1 might 
be justified considering that its activation could depend on the activity of the 
epidermal protease cathepsin D (Egberts et al., 2004).  Assuming that extracellular 
ceramides alter the activation of cathepsin D, this could sequentially lead to 
transglutaminase 1 inactivity. Although the covalent attachment of ω-hydroxy-ULC-
ceramides to involucrin has been demonstrated in vitro via transglutaminase 1 
transesterification (Nemes et al., 1999), involucrin expression could not be detected 
at the SC of neither mutant or control CerS3 mice even after a harsh in situ alkaline 
hydrolysis on paraffin sections (2 h, 1 M KOH, data not shown). Therefore, it is at 
least questionable whether involucrin is involved in the linkage of these specific 
epidermal ceramides to the CE in vivo. Furthermore, mice lacking involucrin did not 
reveal alterations of the CE integrity, neither showing a significant compromised 
epidermal barrier function (Djian et al., 2000). On the other hand, loricrin distribution 
at the cornified layer could be detected after mild alkaline hydrolysis in paraffin 
sections (1 h, 0.1 M KOH) in both control and mutant CerS3 mice, and its total 
concentration was reduced accordingly with transglutaminase 1 in deficient 
epidermis. However, neither absence of loricrin or the CE proteins envoplakin and 
periplakin resulted in severe alterations of the CLE (Jarnik et al., 2002; Sevilla et al., 
2007). All together these findings suggest a compensatory redundancy of the CE 
components. Whether transglutaminase 1 is capable to attach epidermal ceramides 
to either involucrin, loricrin, envoplakin, periplakin or other CE proteins in vivo 
remains elusive.  
The metabolic defect of CerS3 mice resulted in a critical reduction of secreted LB-
derived sphingolipids that gave rise to shorter discs, smaller stacks and disorganized 
lamellar sheets, which failed to align in parallel to the PM and to transform into the 
lamellar basic unit structures. At the upper SC interstices, focal and non-lamellar lipid 
agglomerates were sporadically localized within the cornified layers, predominantly at 
the tricellular contact sites. The complete lack of lamellar basic unit structures in 
mutant SC could be associated with the increased cohesion between corneocytes 
established by both central and lateral corneodesmosomes, that may inhibit the 
homogeneous distribution and the establishment of a continuous lipid layer.  
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 Likewise, loss of transglutaminase 1 function in mice also leads to incomplete and 
irregularly deformed lipid lamellae that were sparsely distributed within the 
extracellular space (Kuramoto et al., 2002). Both lack of EOS-ceramides and 
transglutaminase 1 presumably results in an abnormal formation of the CLE due to 
the impaired attachment of ceramides to proteins of the CE, thus leading to the 
absence of POS-ceramides. Therefore, one might speculate that POS-ceramides 
confer stability to the lipid lamellae providing the adequate membrane fluidity, which 
might be required for lamellar fusion events in order to form the continuous lamellar 
sheets. Otherwise, disorganized lamellar sheets yielding severe dysregulations of the 
permeability barrier might take place. 
Similarly to CerS3 deficiency, mice devoid of transglutaminase 1 exhibited 
reduced desquamation (Kuramoto et al., 2002). Whether this pseudohyperkeratosis 
is a “physical compensation for the defective cutaneous permeability barrier” as 
suggested by Kuramoto and colleagues remains elusive. However, if the defective 
corneocyte shedding in transglutaminase 1 deficient mice is as well due to the 
persistence of corneodesmosomes spread over the entire corneocyte surface, these 
could in addition contribute to the altered distribution of the lamellae giving rise to 
lipidic aggregates.  
In conjunction, the epidermal abnormalities described here for CerS3 deficient 
mice evidenced a severe impairment of the epidermal barrier function. Alterations 
within the cornification process leading to loss of barrier function have been 
described in the pathogenesis of various skin disorders, e.g. ichthyosis and atopic 
dermatitis (Jungersted et al., ; Schmuth et al., 2007). Several of these pathologies 
exhibiting an imbalance of extracellular lipid species at the cornified layer have been 
associated with an increased vulnerability towards microbial infections (Arikawa et 
al., 2002). As shown here, dysfunctional CerS3 skin exhibited a drastic increase in 
pathogenic growth upon infection of biopsies with Candida albicans. Pathogens 
appear to adhere eagerly on the surface of mutant mice, which apparently exert no 
resistance to invasion. Following surface attachment, yeast cells developed polarized 
pseudohyphae and infected the living layers down to the dermis, where they initiated 
colonization of the tissue. Considering that expression levels of murine antimicrobial 
peptides, i.e. defensins and cathelicidin, were not altered in CerS3 mutant mice, we 
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therefore assumed that lack of epidermal ceramides or its direct metabolites might 
primarily instigate the pathogenic microbial activity. In this regard, sphingosine levels 
have been distinguished from SC lipids with respect to provide a barrier against 
pathogens at the skin surface. Extracellular sphingosines concentrate in the SC 
towards the stratum disjunctum, arising from the permanent degradation of lamellar 
ceramide. Sphingosine, as well as phytoshingosine and sphinganine, efficiently 
inhibited the growth of various bacteria and yeast strains – namely Staphylococcus 
aureus, Streptococcus pyogenes, Micrococcus luteus, Propionibacterium acnes, 
Brevibacterium epidermidids and Candida albicans, but not Escherichia coli and 
Serratia marcescens –, whereas various phospholipids and sphingolipids, among 
them ceramide(d18:1,18:0) and mixed galactocerebrosides, demonstrated to be 
ineffective in vitro (Bibel et al., 1992). Furthermore, decreased levels of sphingosine 
were associated with increased acquired vulnerability to colonization by S. aureus in 
patients suffering from atopic dermatitis (Arikawa et al., 2002). In these patients, 
reduced levels of protein-bound ω-hydroxy-ULC-ceramides (POS) have been 
demonstrated (Macheleidt et al., 2002). In CerS3 deficient mice, 90% reduction of 
epidermal ceramides, including POS-ceramides, presumably results in extremely 
reduced levels of sphingosine. In order to corroborate this hypothesis, future 
investigations should include the determination of sphingosine concentration in 
mutant SC as compared with controls. Additionally, an increased SC pH might 
contribute to the severe pathogenic infection exhibited by CerS3 deficient mice (Fluhr 
and Elias, 2002).  
In summary, the present study provides conclusive evidences regarding the 
essential role of CerS3 for the biosynthesis of epidermal ULC-ceramides and the 
epidermal barrier function. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5. Conclusion 
Conclusion 
 
    
 168 
Despite the remarkable progress of the last two decades in defining the enzymatic 
requirements of the major sphingolipid biosynthethic pathways, few metabolic key 
steps still remain elusive at the molecular level. To ensure our full understanding of 
how sphingolipids modulate cellular functions, it is necessary to completely resolve 
their metabolism. In this context, the present thesis aimed to elucidate the 
biosynthethic requirements of ULC-sphingolipids in order to gain insight into their 
functional roles. 
 Within the ceramide synthase family, CerS3 expression levels distinctively 
correlated with the presence of ULC-sphingolipids in skin and testis. Using in vitro 
CerS3 overexpression studies in living human cells, combined with in vivo deficiency 
studies in mice, we demonstrated CerS3 substrate specificity towards acyl-CoAs 
ranging from 24 to 36 carbon atoms. Hence, we concluded that the biosynthesis of 
ULC-sphingolipids exclusively requires a functional CerS3 with no redundancy 
provided by any other ceramide synthase member. 
 The physiological role of CerS3 in the formation and maintenance of the epidermal 
permeability barrier was conclusive. Although ULC-sphingolipids were first described 
in human epidermis in 1975 (Gray and Yardley, 1975), interest in their functionality 
did not arise until recent reports associated skin pathologies with imbalances in 
epidermal lipids. In particular, decreased levels of ceramides have been 
demonstrated to contribute to the pathology of atopic dermatitis, psoriasis, ichthyosis, 
and xerosis (Coderch et al., 2003). Despite that no human epidermal disorder has yet 
been associated with alterations of the Cers3 gene, the present thesis revealed 
several important findings that should contribute to its prognosis. This unidentified 
skin disorder might be characterized by a drastic increase of transepidermal water 
loss, a markedly thick and compact stratum corneum with eventually reduced levels 
of epidermal proteases, altered expression of cornified envelope proteins and 
reduced levels of ω-hydroxy-ULC-ceramides as the symptomatic hallmark. Various 
pathologies classified within the heterogeneous family of ichthyoses share several of 
these features, for instance harlequin ichthyosis and lamellar ichthyosis. Currently, 
the genetic factor of some of these ichthyoses has not yet been identified (Oji et al., 
2010). In order to correlate a skin disorder to alterations within the Cers3 gene, future 
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investigations should focus on analyzing epidermal human biopsies from patients 
with symptomatic similarities as here described for CerS3.  
 The complex molecular events presumably altered upon CerS3 deficiency might 
as well contribute to the pathogenesis of other skin diseases. In this regard, the 
homeobox domain encoded in the CerS3 gene might transcriptionally regulate the 
expression of crucial genes involved in the maturation and terminal differentiation of 
keratinocytes. Furthermore, mutations within the homeobox domain not affecting 
enzymatic activity could contribute to developmental abnormalities in other organs 
where CerS3 is expressed only in traces. 
 In addition, the homeobox domain might as well play a crucial role in modulating 
the expression of genes associated with male germ cell differentiation. Although we 
previously reported the essential role of complex ULC-sphingolipids for proper 
development of the spermatogenic cycle (Rabionet et al., 2008; Sandhoff et al., 
2005), the premature death of CerS3d/d mice prevented the characterization and 
specific identification of its functional role in mature male germ cells. Future studies 
with germ cell specific depletion of CerS3 might clarify the physiological role of this 
enzyme in male fertility and thus could provide new perspectives on human disorders 
characterized by male sterility. 
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Carbon chain length of 
saturated fatty acids 
IUPAC nomenclature Trivial name 
C14 Tetradecanoic Myristic 
C16 Hexadecanoic Palmitic 
C18 Octadecanoic Stearic 
C20 Eicosanoic Arachidic 
C22 Docosanoic Behenic 
C24 Tetracosanoic Lignoceric 
C26 Hexacosanoic Cerotic 
C28 Octacosanoic Montanic 
C30 Triacontanoic Melissic 
C32 Dotriacontanoic Lacceroic 
C34 Tetratriacontanoic Geddic 
C36 Hexatriacontanoic Henxatriacontylic 
 
Table A1. Nomenclature of saturated fatty acids. 
The nomenclature of fatty acids commonly specified in this study are described with 
their trivial name and according to IUPAC rules. 
 
Carbon chain length of 
saturated fatty acids 
IUPAC nomenclature Trivial name 
C18:1, ω-9 cis-9-octadecenoic Oleic 
C18:2, ω-6 cis-9,12-octadecadienoic Linoleic 
C18:3, ω-6 cis-6,9,12-octadecatrienoic γ-Linolenic 
C20:3, ω-6 cis-8,11,14-eicosatrienoic Dihomo γ-Linolenic 
C20:4, ω-6 cis-5,8,11,14-eicosatretraenoic Arachidonic 
C22:4, ω-6 cis-7,10,13,15-docosatetraenoic  
C24:1, ω-9 cis-15-tetracosaenoic Nervonic 
C24:4, ω-6 cis-9,12,15,18- tetracosaenoic  
C18:3, ω-3 cis-9,12,15-octadecatrienoic Linolenic 
C18:4, ω-3 cis-6,9,12,15-octadecatetraenoic  
C20:4, ω-3 cis-8,11,13,17-eicosatetraenoic  
 
Table A2. Nomenclature of unsaturated fatty acids. 
The nomenclature of fatty acids commonly specified in this study are described with 
their trivial name and according to IUPAC rules. 
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Species Enzyme name 
Fatty acyl-CoA 
substrate 
Homo sapiens /  
Mus musculus 
CerS1 18 
CerS2 22-24 
CerS3 18-24 ? 
CerS4 18-22 
CerS5 16 
CerS6 14-16 
Caenorhabditis elegans 
Hyl-1 24-26 
Hyl-2 20-22 
Lagr-1 ? 
Saccharomyces cerevisiae 
Lag1 26 
Lac1 26 
Lip1 26 
Drosophila melanogaster Schlank 14-18 
 
Table A3. The ceramide synthases in various eukaryotic organisms. 
Substrate preferences of H. sapiens and M. musculus (Laviad et al., 2008; Mizutani 
et al., 2006; Riebeling et al., 2003; Venkataraman et al., 2002; Weinmann et al., 
2005), C. elegans (Menuz et al., 2009), S. cerevisiae (Schorling et al., 2001; Vallee 
and Riezman, 2005), and D. melanogaster (Bauer et al., 2009), as reported 
according to the current literature. 
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Mouse           MFQTFRKWFWSERYWLPPTIKWSDLEDHDGLVFVKASHLYITIPYAFLLMVVRYFFEKFV 60 
Human           MFWTFKEWFWLERFWLPPTIKWSDLEDHDGLVFVKPSHLYVTIPYAFLLLIIRRVFEKFV 60 
                ** **::*** **:*********************.****:********:::* .***** 
 
Mouse           ATPLANALGIKKTQHKIKPNAILENFFKHSTSKPSHTDIYGLAKKCNLTERQVERWLRIR 120 
Human           ASPLAKSFGIKETVRKVTPNTVLENFFKHSTRQPLQTDIYGLAKKCNLTERQVERWFRSR 120 
                *:***:::***:* :*:.**::********* :* :********************:* * 
 
Mouse           QKQNKPCRLQKFQESCWRFTFYLLITMAGAVFLYDKPWAYDLWEVWNDYPRQPLLPSQYW 180 
Human           RNQERPSRLKKFQEACWRFAFYLMITVAGIAFLYDKPWLYDLWEVWNGYPKQPLLPSQYW 180 
                ::*::*.**:****:****:***:**:** .******* ********.**:********* 
 
Mouse           YYILEMSFYWSLVFSLSTDIKRKDFLAHVIHHLAAISLMSFSWCANYIRSGTLVMFIHDI 240 
Human           YYILEMSFYWSLLFRLGFDVKRKDFLAHIIHHLAAISLMSFSWCANYIRSGTLVMIVHDV 240 
                ************:* *. *:********:**************************::**: 
 
Mouse           SDIWLESAKMFSYAGWKQTCNTLFFIFTVVFFISRFIIFPFWILYCTLILPLHYLEPFFS 300 
Human           ADIWLESAKMFSYAGWTQTCNTLFFIFSTIFFISRLIVFPFWILYCTLILPMYHLEPFFS 300 
                :***************.**********:.:*****:*:*************:::****** 
 
Mouse           YIFLNLQLMILQGLHVYWGYFILKMLNRCIFTQNVQDVRSDNEEEEEEEEEEEAESTKGK 360 
Human           YIFLNLQLMILQVLHLYWGYYILKMLNRCIFMKSIQDVRSDDEDYEEEEEEEEEEATKGK 360 
                ************ **:****:********** :.:******:*: ******** *:**** 
 
Mouse           ETEYLKNGLGTNRHLIANGQHGR 383 
Human           EMDCLKNGLRAERHLIPNGQHGH 383 
                * : ***** ::****.*****: 
 
Figure A1. Mouse amino acid sequence of CerS3 compared to human 
homologue. 
CerS3 mRNA isolated from mouse testis was subjected to reverse transcription and 
subsequently sequenced. The mouse and human protein sequences are compared 
here together in a blast. Conserved amino acid are annotated (*), as well as 
observed conserved substitutions (:) and semi-conserved substitutions (.).  
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Figure A2. Thin layer chromatography of synthesized internal standard 
ceramides. 
(A) TLC of a crude ceramide product separated with CHCl3/CH3OH/glacial AcOH 
(188/11/1) as a solvent system. Residual reactants and side-products are indicated. 
Bands were visualized by staining with copper reagent. (B) For quantification of 
purified ceramide standards, a dilution series of ceramide in a known concentration, 
here Cer(d18:1, 14:0), were spotted next to the ceramide of unknown concentration. 
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Figure A3. Flow cytometric analyses according to GFP fluorescence of stable 
cell lines expressing CerS3 and transiently transfected cells expressing CerS2. 
HeLa cells expressing CerS2 or CerS3 were subjected to flow cytometric analyses 
prior to being used for ceramide synthase assays. Transfection efficiency (%) was 
determined according to relative fluorescence intensity of 1 × 104 cells, considering 
fluorescence positive cells those with signal intensity over ≳101. 
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Figure A4. “Hyper”keratosis and delayed keratinocyte maturation in CerS3d/d 
mice. 
Light micrographs of semithin Epon sections of neonatal (A-B) and embryonic (A’-B’) 
skin of control (A) and CerS3d/d (B) mice stained with PAS-methylene blue-Azur II. 
Mutant SC is distinctively compact and thicker at birth and at embryonic stage E18.5 
± 0.5, as compared to controls. Periderm persisted in mutant skin at E18.5, as well 
as after birth (green arrows). (C-D) Electron micrographs revealed delayed 
cornification/degradation of organellar structures (yellow stars) in the first corneocyte 
layer of CerS3d/d mice. (E-F) TUNEL staining performed on paraffin sections of 
control and mutant epidermis. TUNEL-positive corneocytes and superficial 
peridermal layer indicated remnants of nuclear structures in mutant epidermis (red 
arrows), as compared to control mice (E). PAS staining of semithin Epon sections of 
control (G) and mutant CerS3d/d (H) skin for detection of glycogen. Residual glycogen 
was exclusively detected in the superficial layers of mutant SC (black arrows). 
Comparable staining for both control and mutant was observed predominantly within 
the SS and SG. 
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Figure A5. Persistence of corneodesmosomes in the entire SC of CerS3 
deficient skin. 
Electron micrograph of the upper layers of the neonatal CerS3d/d skin exhibiting the 
persistant periderm (green arrow) and corneodesmosomes within the enitre SC (red 
arrows).  
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Figure A6. Epidermal sphingolipid profile of CerS3d/d mice. 
(A) TLC of epidermal sphingolipids stained with copper sulfate/phosphoric acid and 
developed at 180 ºC for 8 and 16 min. Each lane corresponds to 0.5 mg dry weight of 
epidermis. Lipid standards are annotated in black, and epidermal lipids in red. (B) 
Mass spectromtric quantification of ceramide, glucosylceramide and sphingomyelin 
species. Lipid species with a fatty acid moiety longer than 24 carbon atoms were 
strongly reduced or completely missing in CerS3d/d epidermis (red arrows). Error bars 
represent the SEM of 3 analysed extracts. 
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Figure A7. Increased pathogenic growth is not associated with decreased 
expression rates of antimicrobial peptides in CerS3 mutant mice.  
(A) Quantification of C. albicans growth after 24 h infection of cultured skin biopsies 
of embryonic E18.5 ± 0.5 control and mutant mice. Growth was determined by colony 
forming units of yeast cultured on Sabouroud agar plates for 48 h at 37 ºC. (B) 
Transcript expression levels of murine defensins (mBD1–4) and cathelicidin 
(mCamp) in skin of newborn CerS3+/+ and CerS3d/d, as determined by qRT-PCR. No 
significant changes in the expression levels of any of the examined antimicrobial 
peptides was detected in mutant mice. Relative fold expression was calculated using 
the ∆∆CT mtehod. Normalized ∆CT values were compared to normalized ∆CT of 
control wild type mCamp-mRNA. 
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List of abbreviations 
 
AcOH  Acetate 
Amp       Ampicillin 
APS  Ammonium persulfate 
BL       Basal lamina 
BSA       Bovine serum albumin 
BTB  Blood-testis barrier 
cDNA      Complementary DNA 
CE  Cornified envelope 
CFU  Colony forming units 
CLE  Corneocyte-lipid envelope 
Cer  Ceramide 
CerS      Ceramide synthase 
CoA  Coenzyme A 
CTS  Cathepsin 
DCC  Dicyclohexylcarbodiimide    
DCU  Dicyclohexylurea 
DMEM      Dulbecco’s modiﬁed Eagle's medium 
DMSO      Dimethyl sulfoxide 
dNTP  Deoxyribo nucleotide triphosphate 
Dox       Doxycycline 
dT  deoxyribo thymine 
DTT  Dithiothreitol 
e.g.       Exempli gratia 
EB       Eluation buffer 
ECL  Enhanced chemiluminescence 
EGFP      Enhanced green fluorescent protein 
Elovl       Elongation of very long chain fatty acids 
EOS       ω-hydroxy-FA esterified to primarily linoleic acid 
ER  Endoplasmic reticulum 
ESI-MS/MS  Electrospray ionization tandem mass spectrometry 
List of abbreviations 
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eST       Elongated spermatid 
Etc.       Et cetera 
FA       Fatty acid 
FFA       Free fatty acid 
FACS      Fluorescence-activated cell sorting 
FCS       Fetal calf serum 
F-granules    Filaggrin/profilaggrin containing granules 
FGSL  Fucosylated glycosphingolipids 
GAPDH  Glyceraldehyde 3-phosphate dehydrogenase 
Gb  Globo 
Gg  Ganglio 
GlcCer  Glucosylceramide 
GSL  Glycosphingolipid 
HP-TLC  High performance TLC 
HRP  Horseradish peroxidase 
ICS       Intercellular space 
i.e.       Id est 
IS  Interstitium 
IS  Internal standard 
Kan       Kanamycin  
Kbp       Kilo base pair 
KG       Keratohyalin granule 
KLK       Kallikrein 
LacCer      Lactosylceramide 
Lass       Longevity assurance  
LB       Lamellar body 
LB       Lysogeni broth or Luria-Bertani broth 
LC  Leydig Cell 
LC  Long chain 
LCB  Long chain base 
L-granules  Loricrin containing granules 
lSC  Leptotene spermatocyte 
List of abbreviations 
 
  
 
 199 
MBS       Modified bovine serum 
mCAT1      Murine cationic aminoacid transporter 1 
MoMLV      Moloney murine leukemia virus 
NHS       N-hydroxysuccinimide 
NS       Non-hydroxy-FA 
OS       ω-hydroxy-FA  
PAS       Periodic acid Schiff 
PBS       Phosphate buffered saline 
PC       Phosphatidylcholine 
PCR       Polymerase chain reaction 
PDI  Protein disulfide isomerase 
PFA  Paraformaldehyde 
PGK  Phosphoglycerate kinase 
plSC  Preleptotene spermatocyte  
PM  Plasma membrane 
PN  Postnatal 
POS       ω-hydroxy-FA esterified to proteins 
PUFA  Polyunsaturated fatty acids 
rb  Residual body 
rST  Round spermatid 
r.t.  Room temperature 
RPMI      Roswell park memorial institute medium 
rtTA2-M2     Optimized reverse tetracycline-controlled transactivator 
SB  Stratum basale 
SC  Stratum corneum 
SC  Short chain 
SC  Spermatocyte 
SDS-PAGE  Sodium dodecyl sulphate polyacrylamide gel electrophoresis 
SG  Stratum granulosum 
SG  Spermatogonia  
SL  Sphingolipid 
SM  Sphingomyelin 
List of abbreviations 
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SMS       Sphingomyelin synthase 
SOC       Super optimal broth with catabolite repression 
ST  Spermatid 
Sza  Spermatozoa 
Ta        Annealing temperature         
TAE        Tris-acetate-EDTA 
TE       Tris base-EDTA 
TEWL  Transepidermal water loss 
THF  Tetrahydrofuran 
TLC  Thin layer chromatography 
TLC  Tram-Lag-CLN8 domain 
TM  Transmembrane 
TRE       Tetracycline-responsive element  
TUNEL  Terminal dUTP nick-end labeling 
ULC  Ultra long chain 
VLC  Very long chain 
ZO       Zonulae occludentes 
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